OBO_ID (LABEL):	GO_0007568 (aging)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC1937008	7/2007	S43-PMC1937008	["caption (table-wrap): table 1\n\nincluded studies on maternal obesity and women's infant feeding intentionsauthors, year of publication, country, and year(s) of studyparticipantsdefinitionsresults barnes et al, 1997 [34], bristol, uk, 1991-112birth cohort, (avon longitudinal study of parents and children) n = 11,907multivariate analysis, n = 8431 for 1stweek and n = 8392 for 4 monthsintention: asked at 32 weeks (4 time periods, 4 options for each)Eating disorder examination questionnaire, including 'shape concern' and 'weight concern' items (> 2 indicated marked concern) intention to bf 1 week old infant: shape concern normal or 1.22 (95%ci: 1.10, 1.35)weight concern normal or 1.20 (95%ci, 1.07, 1.35) intention to bf infant up to 4 months: shape concern normal or 1.30 (95%ci: 1.19, 1.42)weight concern normal or 1.26 (95%ci: 1.14, 1.40)multivariate analysis: intention to bf 1 week old infant: shape concern normal or 1.25 (95%ci: 1.09, 1.42)weight concern normal ns intention to bf infant up to 4 months: shape concern normal or 1.26 (95%ci: 1.13, 1.42)weight concern normal or 1.16 (95%ci: 1.02, 1.32)(adjusted for demographic variables, smoking, maternal attitudes to baby)foster et al 1996 [41], manchester, uk, yr of study not statedantenatal cohort n = 38eating disorder examination: shape concern (sc).body satisfaction scale:general satisfaction (gs).measurement of bmi not mentioned in text bf intention and bmi: ns shape concern: intended to bf median 0.29intended to formula feed median 1.05 (i.e."]	N/A	N/A	[('GO_0007568', 'aging', 449, 'Eating')]
PMC2100429	9/2007	S77-PMC2100429	['non-Vegetarian Foods are meat, fish and eggs\nmaternal Vitamin B12And Folate status women in whom Vitamin B12, Folate and related measurements were not available had similar Pre-Pregnant weight, ses and weight gain at 28\xa0weeks of Pregnancy compared with those who were studied.']	N/A	N/A	[('NCBITaxon_7955', 'Danio rerio', 4, 'vegetarian'), ('CHEBI_33290', 'food', 15, 'foods'), ('CHEBI_10124', 'zolmitriptan', 54, 'vitamin B12and'), ('CHEBI_30863', '5-azaorotic acid', 69, 'folate'), ('CHEBI_33279', 'vitamin D5', 97, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 97, 'vitamin B12'), ('CHEBI_30863', '5-azaorotic acid', 110, 'folate'), ('GO_0007568', 'aging', 173, 'pre'), ('GO_0007565', 'female pregnancy', 177, 'pregnant'), ('GO_0007565', 'female pregnancy', 229, 'pregnancy')]
PMC2148036	9/2007	S58-PMC2148036	['Pre-Pregnancy body mass index (bmi), a measure of overall maternal adiposity, was calculated as weight in kilograms divided by height in meters squared.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy')]
PMC2526009	10/2008	S30-PMC2526009	['an additional 112 Rats began the cross-sectional ( n \u2009=\u200932–2.5 months; n \u2009=\u200932–27.5 months) and longitudinal ( n \u2009=\u200948) Aging studies.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 18, 'rats'), ('GO_0007568', 'aging', 120, 'aging')]
PMC2526009	10/2008	S35-PMC2526009	['for the Aging study Rats began training at 2 months of age.']	N/A	N/A	[('GO_0007568', 'aging', 8, 'aging'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 20, 'rats')]
PMC2526009	10/2008	S48-PMC2526009	['the behavioral procedures for the longitudinal and cross-sectional Aging studies used this same standard procedure.']	N/A	N/A	[('GO_0007568', 'aging', 67, 'aging')]
PMC2526009	10/2008	S84-PMC2526009	['neurochemical analysis of Acetylcholine release\nBrains were taken from all of the Rats that completed the behavioral portion of the longitudinal Aging study approximately 1 week following the last session.']	N/A	N/A	[('CHEBI_15355', 'acetylcholine', 26, 'acetylcholine'), ('UBERON_0000955', 'brain', 48, 'Brains'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 82, 'rats'), ('GO_0007568', 'aging', 145, 'aging')]
PMC2526009	10/2008	S116-PMC2526009	['caption (fig): figure 2\n\neffects of Prenatal Choline supplementation on spatial Memory performance in a 12-arm radial maze in longitudinal and cross-sectional Aging studies .']	N/A	N/A	[('GO_0007565', 'female pregnancy', 36, 'prenatal'), ('CHEBI_15354', 'choline', 45, 'choline'), ('GO_0007613', 'memory', 80, 'memory'), ('GO_0007568', 'aging', 159, 'aging')]
PMC2526009	10/2008	S119-PMC2526009	['in panel (b) , total errors (mean\u2009±\u2009sem) are plotted as a function of the first block of 3 sessions during the cross-sectional Aging study for separate groups of 2.5 and 27.5 month-old Rats in the con and the sup treatment conditions.']	N/A	N/A	[('GO_0007568', 'aging', 127, 'aging'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 185, 'rats')]
PMC2529404	9/2008	S4-PMC2529404	['we gave Mice unlimited or no access to Sucrose for a short period post-weaning and measured Sucrose-Seeking, Food Consumption, and weight gain in adulthood.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 8, 'mice'), ('CHEBI_17992', 'sucrose', 39, 'sucrose'), ('CHEBI_17992', 'sucrose', 92, 'sucrose'), ('GO_0007568', 'aging', 99, '-seeking'), ('CHEBI_33290', 'food', 109, 'food'), ('GO_0007631', 'feeding behavior', 109, 'food consumption')]
PMC2582131	11/2008	S40-PMC2582131	['data collection\nfrom structured questionnaire and medical records, we obtained information of covariates including maternal age, educational attainment, height, Pre-Pregnancy weight, Reproductive and medical histories, and medical histories of first-degree family members.']	N/A	N/A	[('GO_0007568', 'aging', 161, 'pre'), ('GO_0007565', 'female pregnancy', 165, 'pregnancy'), ('GO_0000003', 'reproduction', 183, 'reproductive')]
PMC2582131	11/2008	S42-PMC2582131	['Pre-Pregnancy body mass index (bmi) was calculated as Pre-Pregnancy weight in kilograms divided by height in meters squared.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy'), ('GO_0007568', 'aging', 54, 'pre'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy')]
PMC2639379	12/2008	S54-PMC2639379	['we asked each participant, "in the past 3 months, on average, how many hours per week have you spent engaged in vigorous recreational activities or sports such as Jogging, swimming, cycling, aerobic dance, skiing, or other similar activities?"']	N/A	N/A	[('GO_0007568', 'aging', 163, 'jogging')]
PMC2639379	12/2008	S89-PMC2639379	['caption (table-wrap): table 2\n\nodds ratios and predicted prevalences (in selected subgroups) of excessive Gestational weight gain calculated from multivariable logistic regression model*Pre-Pregnancy weight status perceptionnormal weight womenoverweight/obese womenaccurate assessors n = 898 overassessors n = 131 accurate assessors n = 438 underassessors n = 70 multivariable odds ratios (95% ci) 1.0 (referent)2.0 (1.3, 3.0)2.9 (2.2, 3.9)7.6 (3.4, 17.0) participant characteristics modeled†predicted prevalence of excessive Gestational weight gain (prevalence ratio) ‡\u2003aged 23 y, non-white, parous, lower income, less education§37%54% (1.5)64% (1.7)82% (2.2)\u2003aged 23 y, white, parous, lower income, less education§45%62% (1.4)70% (1.6)86% (1.9)\u2003aged 32 y, white, nulliparous, higher income, well-educated ||49%66% (1.3)74% (1.5)88% (1.8)\n* data from 1537 mothers participating in project viva.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 106, 'gestational'), ('GO_0007568', 'aging', 186, 'Pre'), ('GO_0007565', 'female pregnancy', 190, 'pregnancy'), ('GO_0007565', 'female pregnancy', 526, 'gestational')]
PMC2738951	9/2009	S24-PMC2738951	['Aging in key systems\n\n3.1.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Aging')]
PMC2780862	12/2009	S44-PMC2780862	['epigenetic changes induced by Aging.']	N/A	N/A	[('GO_0007568', 'aging', 30, 'aging')]
PMC2784897	12/2007	S211-PMC2784897	["participants\nall analyses reported in this monograph are based on data collected as part of the twins' Early development study (teds), a longitudinal study involving a representative sample of all twins Born in england and wales in 1994, 1995, and 1996 (oliver & plomin, 2007;trouton, spinath, & plomin, 2002)."]	N/A	N/A	[('GO_0007568', 'aging', 103, 'Early'), ('GO_0007567', 'parturition', 203, 'born')]
PMC2885310	5/2010	S47-PMC2885310	['Pre-Pregnancy weight and height were also based on self-reports made during the interview.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy')]
PMC2885310	5/2010	S48-PMC2885310	['Pre-Pregnancy body mass index (bmi) was calculated as weight in kilograms divided by height in meters squared.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy')]
PMC2939583	8/2010	S77-PMC2939583	['the ecage project (study of Food intake and Eating behavior of Pregnant women) was conducted in two cities (bento gonçalves (city 1) and porto alegre (city 2)) in the southernmost state in brazil, it has a population of 10,582,840 inhabitants, child mortality rate of 13.20/1000 liveborns (fee rs, 2006), Life expectancy at Birth of 72.05 years (fee rs, 2000), illiteracy rate of 6.65% (fee rs, 2000), unemployment rate of 6.4% [59] (ibge/brazilian household sampling survey - pnad 2005), and gdp per capita of r$ 15,812.55 (fee rs, 2007).']	N/A	N/A	[('CHEBI_33290', 'food', 28, 'Food'), ('GO_0007568', 'aging', 44, 'Eating'), ('GO_0007565', 'female pregnancy', 63, 'Pregnant'), ('UBERON_0000104', 'life cycle', 305, 'life'), ('GO_0007567', 'parturition', 324, 'birth')]
PMC2939583	8/2010	S93-PMC2939583	['Eating behaviors : Eating disorder examination - questionnaire (ede-q)[62,63], validated into portuguese[64].']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Eating'), ('GO_0007568', 'aging', 19, 'Eating')]
PMC2939583	8/2010	S119-PMC2939583	['after three unsuccessful attempts of telephone contact, participants received a domiciliary visit\n\nmeasures at 5-6 months Postpartum (mother)\nEating behaviors, mental disorders, experience of violence, tobacco and alcohol Consumption were measured as in the baseline (see baseline section above for details).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 122, 'postpartum'), ('GO_0007568', 'aging', 142, 'Eating'), ('GO_0007631', 'feeding behavior', 222, 'consumption')]
PMC2940790	8/2010	S60-PMC2940790	['caption (table-wrap): table 1\n\ncharacteristics of the study population recruited from three us cities during 2000-4population characteristicsptdsgaabirth weight (g)n%%%meansdtotal population2039100953382586maternal race/ethnicity\u2003non-hispanic white116957753486596\u2003non-hispanic black609301273167545\u2003hispanic1859963427632\u2003other7347--3400459\u2003missing3maternal age (years)\u2003< 25599291173255558\u200325-2965732863393572\u200330-3456428743486587\u2003≥35219111163425642highest maternal education level\u2003high school or less573281393235616\u2003some college440221053340600\u2003college degree or higher102550743482544maternal smoking\u2003yes99516123073578\u2003no194095953398583maternal Alcohol use\u2003yes322963410702\u2003no200798663381585pre-Pregnancy bmi (kg/m2)\u2003< 19.823211893291535\u200319.8-25.9101650853410553\u200326.0-29.933316763421535\u2003> 29.9407201453349713\u2003missing51310163255771vitamin use\u2003yes102750753461573\u2003no1012501173302590caffeine intake (mg/day)\u2003none51925943410613\u20031-15046823853385557\u2003151-300387191163344617\u2003> 30066533973380567marital status\u2003married139068753466536\u2003not married648321383200646\u2003missing1parity\u2003nulliparous991491063323591\u2003parous104851843438577employed during past 4 months\u2003yes143070953372580\u2003no60830973406602annual household income ($)\u2003< 30,000637311273245629\u200330,001-60,00053526773437545\u200360,001-80,00032116653460498\u2003> 80,00046523833504571\u2003missing81420103078614recreational activityb\u2003yes110954963423572\u2003no930461053332600vigorous recreational activityc\u2003yes40120873412559\u2003no163880953374593swimming\u2003yes65158663471549\u2003no1388321063340599infant gender\u2003male104551973419585\u2003female99449953343586study site\u2003site 192946653459581\u2003site 2761371163329593\u2003site 3349171383294562\naterm births only\nbany recreational physical activity or exercise, such as brisk walking, Jogging, swimming, biking, tennis, soccer, or dancing\ncany recreational physical activity or exercise, such as brisk walking, Jogging, swimming, biking, tennis, soccer, or dancing that caused large increases in breathing and Heart rate\nsga = small for Gestational age; ptd = Preterm Delivery; sd = standard deviation; bmi = body mass index\n\nBirth weight\ncompared to the lowest quartile, the unadjusted mean Birth weight in grams was higher for the upper three quartiles of total Water Intake, 60 (95% ci: -1, 122), 67 (95% ci: 5, 128), and 83 (95% ci: 21, 145) grams, respectively (table2).']	N/A	N/A	[('CHEBI_30879', 'alcohol', 642, 'alcohol'), ('GO_0007565', 'female pregnancy', 691, 'pregnancy'), ('GO_0007568', 'aging', 1717, 'jogging'), ('GO_0007568', 'aging', 1843, 'jogging'), ('UBERON_0000948', 'heart', 1942, 'heart'), ('GO_0007565', 'female pregnancy', 1969, 'gestational'), ('GO_0007565', 'female pregnancy', 1992, 'preterm'), ('GO_0007567', 'parturition', 2000, 'delivery'), ('GO_0007567', 'parturition', 2058, 'Birth'), ('GO_0007567', 'parturition', 2124, 'birth'), ('CHEBI_15377', 'water', 2196, 'water'), ('GO_0007631', 'feeding behavior', 2202, 'intake')]
PMC2940790	8/2010	S65-PMC2940790	['caption (table-wrap): table 2\n\nBirth weight results for daily bottled, cold tap, total tap, and total Water Intake\u2003follow-up dataaverage of baselineand follow-up dataunadjusted adjustedaadjustedaexposuren (%)β95% ciβ95% ciβ95% cibottled Water\u2003none448 (25%)refrefref\u2003any1329 (75%)12(-38, 63)31(-20, 82)43(-27, 113)cold tap Water ( ounces )b\u20030-27424 (24%)refrefref\u2003> 27-53455 (25%)12(-50, 74)9(-53, 72)25(-38, 88)\u2003> 53-91444 (25%)74(11, 136)52(-11, 116)44(-19, 107)\u2003> 91453 (26%)77(14, 139)49(-14, 111)65(2, 128)per 20 ounce12.3(3.9, 20.7)8.5(0.1, 16.9)8.5(-1.5, 18.5)total tap Water ( ounces )b\u20030-30443 (25%)refrefref\u2003> 30-61445 (25%)41(-21, 103)44(-18, 106)10(-52, 73)\u2003> 61-96496 (28%)100(40, 161)78(17, 139)34(-30, 97)\u2003> 96392 (22%)85(21, 149)43(-21, 107)46(-17, 109)per 20 ounce12.0(4.0, 20.1)6.8(-1.3, 15.0)5.3(-4.3, 15.1)total Water ( ounces )b\u20030-51452 (25%)refrefref\u2003> 51-78439 (25%)60(-1, 122)27(-34, 87)10(-50, 71)\u2003> 78-114442 (25%)67(5, 128)39(-22, 99)55(-6, 116)\u2003> 114441 (25%)83(21, 145)50(-11, 111)37(-25, 98)per 20 ounce9.8(1.6, 18.1)7.3(-0.8, 15.5)5.2(-4.7, 15.2)\naadjusted for race, education level, annual household income, smoking, Pre-Pregnancy bmi, vitamin use, parity, employed during last 4 months, infant gender, and study site\nbcategorical exposure cutpoints for average data results were slightly higher than the follow-up data\nbmi= body mass index.']	N/A	N/A	[('GO_0007567', 'parturition', 31, 'Birth'), ('CHEBI_15377', 'water', 102, 'water'), ('GO_0007631', 'feeding behavior', 108, 'intake'), ('CHEBI_15377', 'water', 237, 'water'), ('CHEBI_15377', 'water', 322, 'water'), ('CHEBI_15377', 'water', 576, 'water'), ('CHEBI_15377', 'water', 831, 'water'), ('GO_0007568', 'aging', 1148, 'pre'), ('GO_0007565', 'female pregnancy', 1152, 'pregnancy')]
PMC2940790	8/2010	S70-PMC2940790	['caption (table-wrap): table 3\n\nsmall-for-Gestational-age resultsafor daily bottled, cold tap, total tap, and total Water intakefollow-up dataaverage of baselineand follow-up data exposuren (%)unadjusted rr (95% ci)adjusted rr (95% ci)badjusted rr (95% ci)bbottled Water\u2003none448 (26%)111\u2003any1258 (74%)1.1 (0.7, 1.7)0.9 (0.5, 1.4)1.4 (0.6, 3.0)cold tap Water ( ounces )c\u20030-27403 (24%)111\u2003> 27-53439 (26%)0.9 (0.5, 1.5)1.2 (0.6, 2.3)1.1 (0.6, 2.2)\u2003> 53-91429 (25%)0.9 (0.5, 1.6)1.3 (0.7, 2.4)1.4 (0.7, 2.6)\u2003> 91439 (26%)0.7 (0.4, 1.2)0.9 (0.5, 1.9)1.1 (0.5, 2.1)per 20 ounce1.0 (0.9, 1.0)1.0 (0.9, 1.1)1.0 (0.9, 1.1)total tap Water ( ounces )c\u20030-30423 (25%)111\u2003> 30-61426 (25%)0.7 (0.4, 1.3)0.9 (0.5, 1.7)1.2 (0.6, 2.2)\u2003> 61-96476 (28%)0.7 (0.4, 1.2)0.8 (0.5, 1.6)1.3 (0.7, 2.6)\u2003> 96380 (22%)0.7 (0.4, 1.2)0.9 (0.5, 1.9)1.1 (0.6, 2.2)per 20 ounce1.0 (0.9, 1.1)1.0 (0.9, 1.1)1.0 (0.9, 1.1)total Water ( ounces)c\u20030-51434 (25%)111\u2003> 51-78418 (25%)0.7 (0.4, 1.2)0.8 (0.4, 1.4)0.9 (0.5, 1.6)\u2003> 78-114424 (25%)0.6 (0.3, 1.0)0.6 (0.3, 1.0)0.5 (0.2, 1.0)\u2003> 114427 (25%)0.8 (0.5, 1.4)0.9 (0.5, 1.6)1.0 (0.6, 1.8)per 20 ounce1.0 (0.9, 1.1)1.0 (0.9, 1.1)1.0 (0.9, 1.1)\naterm sga models restricted to infants Born to non-hispanic white, non-hispanic black, or hispanic women\nbadjusted for race, education level, annual household income, smoking, Pre-Pregnancy bmi, vitamin use, parity, employed during last 4 months, infant gender, and study site\nccategorical exposure cutpoints for average data results were slightly higher than the follow-up data\nbmi= body mass index; rr= risk ratio\n\nptd\nas shown in table4, rrs and 95% cis for ptd comparing women who reported drinking > 51-78, > 78-114, and > 114 versus 0-51 ounces of total Water per day based on the follow-up data were 1.0 (0.7, 1.6), 1.0 (0.7, 1.6), and 1.2 (0.8, 1.8).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 41, 'gestational'), ('CHEBI_15377', 'water', 115, 'water'), ('CHEBI_15377', 'water', 264, 'water'), ('CHEBI_15377', 'water', 351, 'water'), ('CHEBI_15377', 'water', 623, 'water'), ('CHEBI_15377', 'water', 891, 'water'), ('GO_0007567', 'parturition', 1194, 'born'), ('GO_0007568', 'aging', 1331, 'pre'), ('GO_0007565', 'female pregnancy', 1335, 'pregnancy'), ('CHEBI_15377', 'water', 1715, 'water')]
PMC2945165	10/2010	S36-PMC2945165	['Blood samples were centrifuged, and aliquots of Plasma or Serum were used for Glucose and Insulin measurements by the hospital clinical laboratory or frozen (at −80°c) until assessed by the laboratory of experimental diabetes and Aging, the mount sinai school of medicine (new york, ny).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001969', 'blood plasma', 48, 'plasma'), ('UBERON_0001977', 'blood serum', 58, 'serum'), ('CHEBI_17234', 'glucose', 78, 'glucose'), ('PR_000045358', 'insulin family protein', 90, 'insulin'), ('GO_0007568', 'aging', 230, 'Aging')]
PMC2984417	10/2010	S79-PMC2984417	['Pre-Pregnancy body mass index (bmi), a measure of overall maternal adiposity, was calculated as (self-reported) weight in kilograms divided by height in meters squared.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy')]
PMC2987887	11/2010	S32-PMC2987887	['characteristics assessed using the questionnaire (i.e., self-administered) included maternal age, height, Pre-Pregnancy weight, Reproductive and medical history including her history of migraine, average nightly sleep duration (before and during Pregnancy), vital exhaustion during early Pregnancy, and perceived stress during early Pregnancy.']	N/A	N/A	[('GO_0007568', 'aging', 106, 'pre'), ('GO_0007565', 'female pregnancy', 110, 'pregnancy'), ('GO_0000003', 'reproduction', 128, 'reproductive'), ('GO_0007565', 'female pregnancy', 246, 'pregnancy'), ('GO_0007565', 'female pregnancy', 288, 'pregnancy'), ('GO_0007565', 'female pregnancy', 333, 'pregnancy')]
PMC2987887	11/2010	S57-PMC2987887	['in multivariable models, we adjusted for maternal age (continuous), parity (nulliparous, multiparous), history of pre-Gestational hypertension (no, yes), and Pre-Pregnancy body mass index (≤ 18.5, 18.5-24.9, 25-29.9, ≥ 30 kg/m2).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 118, 'gestational'), ('GO_0007568', 'aging', 158, 'pre'), ('GO_0007565', 'female pregnancy', 162, 'pregnancy')]
PMC2991548	10/2010	S148-PMC2991548	['caption (table-wrap): table\xa06\n\nthemes in Postnatal questionnaires until the age of 4\xa0yearsmain themes2\xa0months6\xa0months12\xa0months18\xa0months24\xa0months30\xa0months36\xa0monthse48\xa0monthsmother\xa0general health\xa0\xa0quality of Life [187,188]++\xa0\xa0Pregnancy complications+\xa0\xa0life events+\xa0social and demographic factors\xa0\xa0housing conditionsa++++\xa0\xa0working conditions+\xa0\xa0educational level and household income++\xa0\xa0social support\xa0mental health and stress+\xa0\xa0parenting [189,190]++\xa0\xa0depressive symptoms [191]+\xa0\xa0psychopathology [192]+++child\xa0diet and physical activity\xa0\xa0dietb[193]++++/s\xa0\xa0Eating behaviour [194]++\xa0\xa0television Watching, physical activity+++\xa0\xa0day-care+++\xa0childhood health and diseases\xa0\xa0quality of life [195]++\xa0\xa0fever and infectious diseases [196,198]++++++\xa0\xa0asthma related symptoms and eczema [199–204]+++++\xa0\xa0accidents+++\xa0\xa0seizuresc[205]++++++\xa0\xa0Abdominal pain, Stool pattern [206]+++\xa0\xa0doctors visit+++++\xa0behaviour and Cognition\xa0\xa0sleeping, crying and soothing [207,208]+++++\xa0\xa0temperament [209]+\xa0\xa0Motor Development [210]+++++\xa0\xa0behaviour and emotional problems [211–217]d+++\xa0\xa0pain perception [218–220]++\xa0\xa0Language Development [221]++\xa0\xa0non verbal Cognition [222]++\xa0\xa0executive function [223]+\n+\xa0=\xa0assessment in whole cohort.']	N/A	N/A	[('GO_0007567', 'parturition', 41, 'postnatal'), ('UBERON_0000104', 'life cycle', 206, 'life'), ('GO_0007565', 'female pregnancy', 224, 'Pregnancy'), ('GO_0007568', 'aging', 552, 'Eating'), ('GO_0007605', 'sensory perception of sound', 589, 'watching'), ('UBERON_0000916', 'abdomen', 823, 'Abdominal'), ('UBERON_0001988', 'feces', 839, 'stool'), ('GO_0050890', 'cognition', 896, 'cognition'), ('GO_0009653', 'anatomical structure morphogenesis', 973, 'Motor development'), ('GO_0001654', 'eye development', 1080, 'Language development'), ('GO_0050890', 'cognition', 1121, 'cognition')]
PMC3052301	3/2011	S110-PMC3052301	['thus, following the body Weight development until one year of age (d21, d180, d360), the reduced body mass in the c-hp group was highly significant ( p<0.0001) whereby the difference became less prominent with Aging.10.1371/journal.pone.0017443.g005\n\ncaption (fig): figure 5\nbody weight and fat content at day 360.']	N/A	N/A	[('GO_0007596', 'blood coagulation', 25, 'weight'), ('GO_0007568', 'aging', 210, 'aging')]
PMC3081498	7/2006	S70-PMC3081498	['Eating three small to moderate size meals and three snacks per day is appropriate.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Eating')]
PMC3096515	5/2011	S54-PMC3096515	['over time, prevalence of immediate Pre-Conception and trimester-specific use of Anti-Infective Drugs increased.']	N/A	N/A	[('GO_0007568', 'aging', 35, 'pre'), ('GO_0007620', 'copulation', 39, 'conception'), ('CHEBI_50917', 'oxa-steroid', 80, 'anti-infective drugs')]
PMC3111740	5/2011	S149-PMC3111740	['within Individuals, telomere length tracks with Cardiovascular health, mets and Aging.']	N/A	N/A	[('NCBITaxon_1', 'root', 7, 'individuals'), ('UBERON_0004535', 'cardiovascular system', 48, 'cardiovascular'), ('GO_0007568', 'aging', 80, 'aging')]
PMC3170266	8/2011	S4-PMC3170266	['Food group servings and Nutrient intakes were compared to the australian guide to healthy Eating (aghe) and australian Nutrient reference values (nrvs).']	N/A	N/A	[('CHEBI_33290', 'food', 0, 'Food'), ('CHEBI_33284', 'nutrient', 24, 'nutrient'), ('GO_0007568', 'aging', 90, 'Eating'), ('CHEBI_33284', 'nutrient', 119, 'Nutrient')]
PMC3170266	8/2011	S51-PMC3170266	["australian guide to healthy Eating\naustralia's national Food selection guide is the australian guide to healthy Eating (aghe) [26]."]	N/A	N/A	[('GO_0007568', 'aging', 28, 'Eating'), ('CHEBI_33290', 'food', 56, 'food'), ('GO_0007568', 'aging', 112, 'Eating')]
PMC3170266	8/2011	S83-PMC3170266	["caption (table-wrap): table 3\n\ndaily Food group Consumption and the percentage of women achieving daily Food group recommendations for Adults 19-60 years in the australian guide to healthy Eating, for the young cohort of the australian longitudinal study on women's health by Pregnancy statustrying to Conceive( n 454)Pregnant( n 606)Birth < 12 mths ago( n 829)other( n 5597)all( n 7486) medianiqrmedianiqrmedianiqrmedianiqrmedianiqrfood group intakes breads/cereals (g/d)194149-264202154-267213***158-282201150-272202151-273fruit (g/d)245143-383308***188-485258141-393248140-383253144-391vegetables (g/d)164125-219154119-214179***135-236159116-216161119-218dairy (g/d)383232-439407***287-511393***237-457360227-424379229-435meat/alternatives (g/d)147105-20013596-188156***114-206142103-197143104-198extras (g/d)13392-18313996-193156***110-21413093-18313395-188 Food group servings breads/cereals (servings/d)2.51.8-3.22.6***2.0-3.52.7***2.1-3.62.41.8-3.12.51.9-3.2fruit (servings/d)1.81.0-2.72.2***1.3-3.51.91.0-2.81.81.0-2.71.81.0-2.8vegetables (servings/d)2.21.6-2.92.11.6-3.02.4***1.8-3.22.11.5-2.92.21.6-3.0dairy (servings/d)1.81.3-2.32.0***1.6-2.61.9***1.4-2.31.71.2-2.21.71.2-2.2meat/alternatives (servings/d)1.61.1-2.11.51.1-2.01.7***1.2-2.21.51.1-2.11.51.1-2.1extras (servings/d)4.12.9-5.44.13.0-5.74.5***3.3-6.24.23.1-5.84.23.1-5.8mean95% cimean95% cimean95% cimean95% cimean95% ci meeting recommendations1 breads/cereals (%)11.99.1-15.214.0**11.4-17.015.7***13.3-18.310.39.5-11.111.310.6-12.0fruit (%)41.436.8-46.155.4***51.4-59.545.441.9-48.842.941.6-44.244.143.0-45.2vegetables (%)13.010.0-16.410.98.5-13.613.511.3-16.011.510.7-12.411.811.0-12.5dairy (%)36.331.9-41.050.3***46.3-54.444.4***41.0-47.832.431.1-33.635.434.3-36.5meat/alternatives (%)89.0**85.7-91.782.379.1-85.387.5*85.0-89.684.383.3-85.284.783.9-85.6extras (%)16.112.8-19.814.912.1-17.910.9*8.8-13.213.812.9-14.713.712.9-14.5 other daily energy Intake (kj)74877269-77057929***7729-81308277***8099-845573677309-742875217467-7575total Food weight (g)13931355-14311519***1482-15561480***1450-151013651354-137513921382-1401energy density (kj/g)5.45.4-5.55.3***5.2-5.45.7***5.6-5.75.55.4-5.55.55.4-5.5\nci, confidence interval."]	N/A	N/A	[('CHEBI_33290', 'food', 37, 'food'), ('GO_0007631', 'feeding behavior', 48, 'consumption'), ('CHEBI_33290', 'food', 104, 'food'), ('UBERON_0007023', 'adult organism', 135, 'adults'), ('GO_0007568', 'aging', 189, 'Eating'), ('GO_0007565', 'female pregnancy', 276, 'pregnancy'), ('GO_0007631', 'feeding behavior', 302, 'conceive'), ('GO_0007565', 'female pregnancy', 318, 'Pregnant'), ('GO_0007567', 'parturition', 334, 'Birth'), ('CHEBI_33290', 'food', 862, 'Food'), ('GO_0007631', 'feeding behavior', 1922, 'intake'), ('CHEBI_33290', 'food', 2010, 'food')]
PMC3170266	8/2011	S87-PMC3170266	['the australian guide to healthy Eating: background information for nutrition educators .']	N/A	N/A	[('GO_0007568', 'aging', 32, 'Eating')]
PMC3195813	10/2010	S66-PMC3195813	['Pre-Pregnancy body mass index (bmi) was calculated (kg/m2) and categorized into two categories (1) underweight/normal ≤24.9 and 2) overweight/obese 25+.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy')]
PMC3205727	10/2011	S62-PMC3205727	['the Eating inventory (ei) [28] was used to assess Cognitive restraint and disinhibition.']	N/A	N/A	[('GO_0007568', 'aging', 4, 'Eating'), ('GO_0050890', 'cognition', 50, 'cognitive')]
PMC3252281	12/2011	S56-PMC3252281	['relying on data from the 2004 canadian community health survey, a greater proportion of the diets of aboriginal women living off-reserve, compared to non-aboriginal women, consisted of snack Foods including soft drinks (considered other Foods by the canada Food guide to healthy Eating of 1992) [43].']	N/A	N/A	[('CHEBI_33290', 'food', 191, 'foods'), ('CHEBI_33290', 'food', 237, 'Foods'), ('CHEBI_33290', 'food', 257, 'Food'), ('GO_0007568', 'aging', 279, 'Eating')]
PMC3304528	2/2012	S81-PMC3304528	[');ngi/nwo-fundednetherlands consortium for healthy Ageing(ncha) (#05060810, b.t.h.']	N/A	N/A	[('GO_0007568', 'aging', 51, 'Ageing')]
PMC3321454	3/2012	S10-PMC3321454	['in the Kidney, the number of Nephrons is reduced through exposure to maternal undernutrition, and with Ageing, low-protein-exposed Animals develop Glomerular injury and progressive loss of Renal function [10,12,13].']	N/A	N/A	[('UBERON_0002113', 'kidney', 7, 'kidney'), ('UBERON_0001285', 'nephron', 29, 'nephrons'), ('GO_0007568', 'aging', 103, 'ageing'), ('NCBITaxon_33208', 'Metazoa', 131, 'animals'), ('UBERON_0000074', 'renal glomerulus', 147, 'glomerular'), ('UBERON_0002113', 'kidney', 189, 'renal')]
PMC3321454	3/2012	S154-PMC3321454	['Mitochondrial copy number and the Expression of the Mitochondrial Genes decline with Ageing [31].']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 0, 'Mitochondrial'), ('GO_0010467', 'gene expression', 34, 'expression'), ('GO_0005739', 'mitochondrion', 52, 'mitochondrial'), ('SO_0002129', 'mt_tRNA', 52, 'mitochondrial genes'), ('GO_0007568', 'aging', 85, 'ageing')]
PMC3335729	3/2012	S94-PMC3335729	['the Mexl -Peal interactions do not account for the loss of Genomic Imprinting or the developmental defects.']	N/A	N/A	[('PR_000010229', 'membrane-bound transcription factor site-1 protease', 4, 'Mexl'), ('PR_000007227', 'ETS translocation variant 4', 10, 'Peal'), ('GO_0007568', 'aging', 59, 'genomic'), ('SO_0001026', 'genome', 59, 'genomic'), ('GO_0071514', 'genetic imprinting', 67, 'imprinting')]
PMC3356951	4/2012	S58-PMC3356951	['older adults\nolder Adults are at high risk of developing Vitamin D insufficiency because of Aging.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 19, 'adults'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007568', 'aging', 92, 'aging')]
PMC3356951	4/2012	S75-PMC3356951	["[33] a variety of factors reduce the skin's Production Of Vitamin D3, including increased skin pigmentation, Aging, and the topical application of a Sunscreen."]	N/A	N/A	[('GO_0016042', 'lipid catabolic process', 44, 'production of vitamin D3'), ('CHEBI_33279', 'vitamin D5', 58, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 58, 'vitamin D3'), ('GO_0007568', 'aging', 109, 'aging'), ('CHEBI_82049', 'Methylselenopyruvate', 149, 'sunscreen')]
PMC3407995	7/2012	S446-PMC3407995	['the primary outcome was maternal/neonatal circulating 25(Oh)D concentration at Delivery, with secondary outcomes of a 25(Oh)D concentration of 80 nmol/l or greater achieved and the 25(Oh)D concentration required to achieve maximal 1,25-Dihydroxyvitamin D(3) Production.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 54, '25(OH)D'), ('GO_0007567', 'parturition', 79, 'delivery'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 181, '25(OH)D'), ('CHEBI_65032', 'dihydrochanoclavine-I aldehyde(1+)', 231, '1,25-dihydroxyvitamin D(3)'), ('GO_0007568', 'aging', 253, 'D ...'), ('GO_0007128', 'meiotic prophase I', 258, 'production')]
PMC3436647	4/2012	S168-PMC3436647	["the mother is enrolled in the study after consenting at the enrollment clinic visit, and the study proband's eligibility is confirmed by a valid ados [109] and an age-appropriate iq test (for example, mullen scales of Early Learning for infancy to 68 months of age; or the kaufman brief intelligence test, second edition, for ages 4 years to 90 years)."]	N/A	N/A	[('GO_0007568', 'aging', 218, 'Early'), ('GO_0007612', 'learning', 224, 'Learning')]
PMC3462678	4/2012	S139-PMC3462678	['self-identified health benefits included feeling good, getting fit and having fun, better energy levels, stress reduction, improved self-esteem, weight loss and healthy Aging.']	N/A	N/A	[('GO_0007568', 'aging', 169, 'aging')]
PMC3462678	4/2012	S143-PMC3462678	['Eating, uh, Healthy Eating, it’s true, but i don’t watch my diet.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Eating'), ('GO_0051615', 'histamine uptake', 12, 'healthy eating')]
PMC3500842	6/2011	S57-PMC3500842	['carnivorous Animals live on herbivorous Animals, to fall victim to death themselves and so spread abroad newly Germinating life in the Plant world.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 12, 'animals'), ('NCBITaxon_33208', 'Metazoa', 40, 'animals'), ('GO_0007568', 'aging', 111, 'germinating'), ('NCBITaxon_33208', 'Metazoa', 135, 'plant')]
PMC3514205	10/2012	S32-PMC3514205	['characteristics measured using the questionnaire included maternal age, height, Pre-Pregnancy weight, Reproductive and medical history including her history of psychiatric disorders, average nightly sleep duration during Pregnancy, vital exhaustion during early Pregnancy, and perceived stress during early Pregnancy.']	N/A	N/A	[('GO_0007568', 'aging', 80, 'pre'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('GO_0000003', 'reproduction', 102, 'reproductive'), ('GO_0007565', 'female pregnancy', 221, 'pregnancy'), ('GO_0007565', 'female pregnancy', 262, 'pregnancy'), ('GO_0007565', 'female pregnancy', 307, 'pregnancy')]
PMC3514205	10/2012	S58-PMC3514205	['in multivariable models, we adjusted for maternal age (continuous), parity (nulliparous, multiparous), history of pre-Gestational hypertension (no, yes), and Pre-Pregnancy body mass index (≤18.5, 18.5-24.9, 25–29.9, ≥30 kg/m2).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 118, 'gestational'), ('GO_0007568', 'aging', 158, 'pre'), ('GO_0007565', 'female pregnancy', 162, 'pregnancy')]
PMC3520859	11/2012	S80-PMC3520859	['fruit and vegetable Intake was assessed against australian guide to healthy Eating (aghe) recommendations for Pregnancy (four and five serves daily, respectively) [43].']	N/A	N/A	[('GO_0007631', 'feeding behavior', 20, 'intake'), ('GO_0007568', 'aging', 76, 'Eating'), ('GO_0007565', 'female pregnancy', 110, 'pregnancy')]
PMC3559868	1/2013	S71-PMC3559868	['a greater percentage of women with low Pre-Pregnancy weight had insufficient weight gains in the 2nd(42%) and 3rd(65%) trimesters while a greater percentage of women who were overweight (63%, 55% in the 2ndand 3rdtrimesters, respectively) and obese (50%, 60% in the 2ndand 3rdtrimesters, respectively) prior to Conception had excessive weight gains.10.1371/journal.pone.0054704.t001\n\ncaption (table-wrap): table 1\n2ndand 3rdtrimester weight gain†according to maternal characteristics.']	N/A	N/A	[('GO_0007568', 'aging', 39, 'pre'), ('GO_0007565', 'female pregnancy', 43, 'pregnancy'), ('GO_0007620', 'copulation', 311, 'conception')]
PMC3559868	1/2013	S78-PMC3559868	['Pregnant women with low Pre-Pregnancy weight had a mean weight gain in the 2ndtrimester near the lower limit recommended, and below this limit in the 3rdtrimester.10.1371/journal.pone.0054704.t002\n\ncaption (table-wrap): table 2\n2ndand 3rdtrimester Gestational weekly weight gain according to pre-Pregnancy body mass index category according institute of medicine/nrc 2009.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Pregnant'), ('GO_0007568', 'aging', 24, 'pre'), ('GO_0007565', 'female pregnancy', 28, 'pregnancy'), ('GO_0007565', 'female pregnancy', 248, 'gestational'), ('GO_0007565', 'female pregnancy', 296, 'pregnancy')]
PMC3559868	1/2013	S79-PMC3559868	['brazilian study of Gestational diabetes (ebdg) (n\u200a=\u200a2,244).weekly weight gain (kg/week)iom/nrc 2009 recommendation2ndtrimester3rdtrimesterp value† Pre-Pregnancy bmi (kg/m2)mean (sd)<18.5 (n \u200a=\u200a120)0.44 - 0.580.46 (0.28)0.37 (0.32)0.00218.5–24.9 (n \u200a=\u200a1479)0.35 - 0.500.45 (0.25)0.41 (0.29)<0.00125.0–29.9 (n \u200a=\u200a505)0.23 - 0.330.43 (0.28)0.39 (0.31)0.013≥30.0 (n \u200a=\u200a140)0.17 - 0.270.27 (0.27)0.37 (0.28)<0.001\nsd, standard deviation.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 19, 'Gestational'), ('GO_0007568', 'aging', 147, 'Pre'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy')]
PMC3570294	11/2012	S138-PMC3570294	['caption (table-wrap): table 2\n\nbivariate pre-post comparison of measured outcome variables by treatment group\xa0 baseline sample (n\u2009=\u200986)follow-up sample (n\u2009=\u200986) \xa0 attitudes, %strongly agreemean (%)95%cicontrol n\u2009=\u200938 (%)text4baby n\u2009=\u200948 (%)mean (%)95%cicontrol n\u2009=\u200938 (%)text4baby n\u2009=\u200948 (%)p- value* Eating 5 or more fruits and vegetables per day is important to the health of my developing baby62.7951.70, 72.9871.0556.2554.6543.55, 65.4263.1647.920.281taking a Prenatal Vitamin is important to the health of my developing baby62.7951.70, 72.9865.7960.4251.1640.14, 62.1057.8945.830.125I am prepared to be a new mother43.0232.39, 54.1539.4745.8334.8824.92, 45.9242.1129.170.276if i visit my health care provider on a regular basis, i will be a healthy new mother48.2437.26, 59.3447.3748.9447.6236.60, 58.8154.0542.550.937if i visit my health care provider on a regular basis, my baby will be healthy44.1733.48, 55.3047.3741.6745.3534.58, 56.4552.6339.580.879smoking will harm the health of my developing baby53.4942.41, 64.3255.2652.0847.6736.79, 58.7350.0045.830.449drinking Alcohol will harm the health of my developing baby52.3341.27, 63.2155.2650.0044.1833.48, 55.3039.4747.920.288taking Prenatal Vitamins will improve the health of my developing baby47.6736.79, 58.7355.2641.6746.5135.68, 57.5950.0043.750.880 behaviors have you ever gone online to search for pre-Natal care information?31.4021.81, 42.3031.5831.2536.1425.88, 47.4332.4339.130.517in last 30\u2009days, did you smoke?5.811.91, 13.055.266.251.160.03, 6.312.630.000.098since you found out about your Pregnancy, have you consumed Alcoholic beverages?3.530.73, 9.972.634.261.180.03, 6.382.700.000.314ate 3 or more servings of fruit a day59.3048.17, 69.7863.1656.2562.3551.18, 72.6467.5758.330.685ate 3 or more servings of vegetables a day36.0525.97, 47.1234.2137.5034.1224.18, 45.2040.5429.170.793\n* p-value presented represents the difference between the baseline and follow-up sample means.']	N/A	N/A	[('GO_0007568', 'aging', 301, 'Eating'), ('GO_0007565', 'female pregnancy', 464, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 473, 'vitamin'), ('CHEBI_15883', "P(1),P(4)-bis(5'-guanosyl) tetraphosphate", 585, '125I'), ('CHEBI_30879', 'alcohol', 1078, 'alcohol'), ('GO_0007565', 'female pregnancy', 1194, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 1203, 'vitamins'), ('GO_0007567', 'parturition', 1371, 'natal'), ('GO_0007565', 'female pregnancy', 1565, 'pregnancy'), ('CHEBI_33566', 'catechols', 1594, 'alcoholic')]
PMC3581200	3/2013	S65-PMC3581200	['direct pathway Hepatic Glycogen Synthesis was estimated as the3h disintegrations per minute in Hepatic Glycogen divided by the inflowing [3H]Glucose-specific radioactivity.']	N/A	N/A	[('GO_0007568', 'aging', 15, 'hepatic'), ('UBERON_0002107', 'liver', 15, 'hepatic'), ('CHEBI_24384', 'glycogens', 23, 'glycogen'), ('GO_0005978', 'glycogen biosynthetic process', 23, 'glycogen synthesis'), ('UBERON_0002107', 'liver', 95, 'hepatic'), ('CHEBI_24384', 'glycogens', 103, 'glycogen'), ('CHEBI_29238', 'tritium atom', 138, '3H'), ('CHEBI_17234', 'glucose', 141, 'glucose')]
PMC3581200	3/2013	S88-PMC3581200	['nhgu ( d ), fractional extraction ( e ), and net Hepatic Glycogen Synthesis (Carbon retention) ( f ) during the clamp period were greatest in the n group.']	N/A	N/A	[('GO_0007568', 'aging', 49, 'hepatic'), ('UBERON_0002107', 'liver', 49, 'hepatic'), ('CHEBI_24384', 'glycogens', 57, 'glycogen'), ('GO_0005978', 'glycogen biosynthetic process', 57, 'glycogen synthesis'), ('CHEBI_33306', 'carbon group element atom', 77, 'carbon')]
PMC3581200	3/2013	S141-PMC3581200	['in p, Hepatic Glycogen Synthesis calculated from net Hepatic carbon retention initially lagged behind that in n (fig.']	N/A	N/A	[('GO_0007568', 'aging', 6, 'hepatic'), ('UBERON_0002107', 'liver', 6, 'hepatic'), ('CHEBI_24384', 'glycogens', 14, 'glycogen'), ('GO_0005978', 'glycogen biosynthetic process', 14, 'glycogen synthesis'), ('UBERON_0002107', 'liver', 53, 'hepatic')]
PMC3581200	3/2013	S195-PMC3581200	['after a mixed meal, Hepatic Glycogen Synthetic rates are several times higher in Pregnant versus nonpregnant Dogs (5) and Rats (26).']	N/A	N/A	[('GO_0007568', 'aging', 20, 'hepatic'), ('UBERON_0002107', 'liver', 20, 'hepatic'), ('CHEBI_24384', 'glycogens', 28, 'glycogen'), ('GO_0005978', 'glycogen biosynthetic process', 28, 'glycogen synthetic'), ('GO_0007565', 'female pregnancy', 81, 'pregnant'), ('NCBITaxon_33208', 'Metazoa', 109, 'dogs'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 122, 'rats')]
PMC3583094	10/2011	S48-PMC3583094	['it was decided to fill the Pre-Pregnancy forms for all the included women with appropriate spacing intervals (or interpregnancy interval) who were under the coverage of a health center.']	N/A	N/A	[('GO_0007568', 'aging', 27, 'pre'), ('GO_0007565', 'female pregnancy', 31, 'pregnancy')]
PMC3583094	10/2011	S63-PMC3583094	['results\nin the first phase of the project, the total number of 468 women Aging 15 to 49 years old who had Pregnancy and labor during the past year were studied from whom 231 women (49.4%) were allocated in the case and 237 (50.6%) in the control group.']	N/A	N/A	[('GO_0007568', 'aging', 73, 'aging'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy')]
PMC3583094	10/2011	S71-PMC3583094	['the results of the second and third phases covered 1695 and 1686 women Aging 15 to 49 years old under pre-Pregnancy cares in the case and control groups, respectively.']	N/A	N/A	[('GO_0007568', 'aging', 71, 'aging'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy')]
PMC3607807	3/2013	S5-PMC3607807	['Eating breakfast is also beneficial for Cognition.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Eating'), ('GO_0050890', 'cognition', 40, 'cognition')]
PMC3608974	2/2013	S75-PMC3608974	['Lumbo-Sacral-Joint efforts during Gait and hueter-vollkmann effect.']	N/A	N/A	[('UBERON_0002741', 'diagonal band of Broca', 0, 'Lumbo'), ('UBERON_0001456', 'face', 6, 'sacral'), ('UBERON_0004905', 'articulation', 13, 'joint'), ('GO_0007568', 'aging', 34, 'gait')]
PMC3642194	5/2013	S74-PMC3642194	['global Genomic Dna Methylation\nchanges in Genomic Dna Methylation were analyzed using luminometric methylation assay (luma).']	N/A	N/A	[('GO_0007567', 'parturition', 7, 'Genomic'), ('SO_0001026', 'genome', 7, 'Genomic'), ('GO_0006306', 'DNA methylation', 15, 'DNA Methylation'), ('GO_0007568', 'aging', 42, 'genomic'), ('SO_0001026', 'genome', 42, 'genomic'), ('GO_0006306', 'DNA methylation', 50, 'DNA methylation')]
PMC3650563	1/2013	S34-PMC3650563	['Pre Pregnancy nutritional status was defined and categorized using body mass index [bmi = weight (kg)/height (m2)], according to the institute of medicine (iom) (10) criteria: underweight < 19.8, 19.8-26.0 -normal weight.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy')]
PMC3653849	5/2013	S84-PMC3653849	['elevated nadh/Nad ratio favors Free Radical Production[35], inhibits Tca Cycle and Fatty Acid Oxidation[36],[37], while increases the generation of Lactate for Hepatic Gluconeogenesis[38].']	N/A	N/A	[('GO_0036367', 'light adaption', 14, 'NAD'), ('CHEBI_26519', 'radical', 31, 'free radical'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 31, 'free radical production'), ('GO_0006099', 'tricarboxylic acid cycle', 69, 'TCA cycle'), ('CHEBI_35366', 'fatty acid', 83, 'fatty acid'), ('GO_0019395', 'fatty acid oxidation', 83, 'fatty acid oxidation'), ('CHEBI_24996', 'lactate', 148, 'lactate'), ('GO_0007568', 'aging', 160, 'hepatic'), ('UBERON_0002107', 'liver', 160, 'hepatic'), ('GO_0006094', 'gluconeogenesis', 168, 'gluconeogenesis')]
PMC3660294	5/2013	S167-PMC3660294	['†iifas score and Pre-Pregnancy bmi were entered into models as continuous variables, while multiparity and Maternal education were entered as categorical factors.']	N/A	N/A	[('GO_0007568', 'aging', 17, 'pre'), ('GO_0007565', 'female pregnancy', 21, 'pregnancy'), ('GO_0007618', 'mating', 107, 'maternal')]
PMC3662163	3/2013	S106-PMC3662163	['≠ never Gave Birth (parity = 0) is the reference category.']	N/A	N/A	[('GO_0007568', 'aging', 8, 'gave birth')]
PMC3674738	5/2013	S62-PMC3674738	['seizures are present in almost all cases, and mri findings have included signal alterations in the Basal Ganglia and Diencephalon, as well as Agenesis of the Corpus Callosum.']	N/A	N/A	[('UBERON_0002420', 'basal ganglion', 99, 'basal ganglia'), ('UBERON_0001893', 'telencephalon', 117, 'diencephalon'), ('GO_0007568', 'aging', 142, 'agenesis'), ('UBERON_0002336', 'corpus callosum', 158, 'corpus callosum')]
PMC3690969	7/2013	S125-PMC3690969	['several measures of Neurodevelopmental outcomes were obtained for charge participants, including mullen scales of Early Learning (msel) (33) for Cognitive function and the vineland adaptive behavior scales (vabs) (34) for assessments of Social and Adaptive Behaviors on all study children, as well as the direct assessment of autism using the ados, given to those recruited with a diagnosis of autism (35).']	N/A	N/A	[('GO_0007399', 'nervous system development', 20, 'neurodevelopmental'), ('GO_0007568', 'aging', 114, 'Early'), ('GO_0007612', 'learning', 120, 'Learning'), ('GO_0050890', 'cognition', 145, 'cognitive'), ('GO_0007618', 'mating', 237, 'social ...'), ('GO_0051866', 'general adaptation syndrome', 248, 'adaptive behaviors')]
PMC3702421	6/2013	S52-PMC3702421	['Pre-Pregnancy weight, weight gain, dietary intake, physical activity, and smoking exposure), selected paternal factors (e.g.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy')]
PMC3710985	7/2013	S87-PMC3710985	['caption (table-wrap): table\xa02\n\nPerinatal outcomes of exposed and healthy comparison groupsvariableexposed grouphealthy comparison groupp valuematernal characteristics(n=133)(n=133)meansdmeansd\u2003age at Conception (months)*378.3361.79383.6153.920.459\u2003Pre-Pregnancy weight (kg)†74.2720.8664.5613.01<0.001\u2003maternal Pregnancy weight gain (kg)†15.019.3314.685.570.535n%n%\u2003Vitamin use‡11387.613199.2<0.001\u2003Alcohol use‡86.0129.10.343\u2003smoking‡2418.000.0<0.001\u2003Breastfeeding‡,§6962.210095.2<0.001\u2003hypertension‡1410.564.50.063\u2003Gestational diabetes‡118.353.80.122\u2003hypothyroidism¶75.321.50.172pregnancy outcomes for live births(n=113)(n=116)meansdmeansd\u2003Gestational age†39.031.8639.471.490.091\u2003Birth weight*3405.07583.673365.69511.090.591n%n%\u2003congenital malformations¶76.232.60.211\u2003Preterm Delivery‡1210.654.30.071\u2003small for Gestational age (<10th centile)‡1311.6108.80.495\u2003large for Gestational age (>90th centile)‡1311.643.50.022delivery and neonatal outcomes for live births(n=113)(n=116)n%n%\u2003method of Delivery‡0.042\u2003\u2003Vaginal7869.08976.7\u2003\u2003c-section repeat54.497.8\u2003\u2003c-section emergency1715.01512.9\u2003\u2003c-section schedules1311.532.6\u2003forceps/vacuum used‡108.91614.00.229\u2003Fetal distress‡2022.51514.30.140\u2003admitted to the nicu‡2325.3119.50.002\u2003pna signs‡1516.565.20.007\n*independent t test.']	N/A	N/A	[('GO_0036268', 'swimming', 31, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 31, 'Perinatal'), ('GO_0007620', 'copulation', 200, 'conception'), ('GO_0007568', 'aging', 248, 'Pre'), ('GO_0007565', 'female pregnancy', 252, 'pregnancy'), ('GO_0007565', 'female pregnancy', 310, 'pregnancy'), ('CHEBI_33229', 'vitamin (role)', 365, 'Vitamin'), ('CHEBI_30879', 'alcohol', 398, 'Alcohol'), ('UBERON_0000165', 'mouth', 450, 'Breastfeeding'), ('GO_0007565', 'female pregnancy', 515, 'Gestational'), ('GO_0007565', 'female pregnancy', 640, 'Gestational'), ('GO_0007567', 'parturition', 680, 'Birth'), ('GO_0007128', 'meiotic prophase I', 768, 'Preterm'), ('GO_0007567', 'parturition', 776, 'delivery'), ('GO_0007565', 'female pregnancy', 811, 'gestational'), ('GO_0007565', 'female pregnancy', 870, 'gestational'), ('GO_0007567', 'parturition', 992, 'delivery'), ('UBERON_0008806', 'buccal funnel', 1008, 'Vaginal7869'), ('GO_0008618', '7-methylguanosine metabolic process', 1155, 'Fetal')]
PMC3710985	7/2013	S111-PMC3710985	['caption (table-wrap): table\xa04\n\nPerinatal outcomes of monotherapy and polytherapy subgroupsvariablemonotherapypolytherapyp valuematernal characteristics(n=37)(n=96)meansdmeansd\u2003age at Conception (months)*375.6060.09379.4062.720.752\u2003Pre-Pregnancy weight (kg)†73.9418.6474.4121.790.750\u2003maternal Pregnancy weight gain (kg)†14.9810.8415.028.790.953n%n%\u2003Vitamin use‡3391.78086.00.554\u2003Alcohol use‡25.466.31.000\u2003smoking‡513.51919.80.399\u2003breastfeeding‡,§2374.24657.50.104\u2003hypertension‡25.41212.50.348\u2003Gestational diabetes‡25.499.40.518\u2003hypothyroidism¶25.455.21.000pregnancy outcomes for live births(n=32)(n=83)meansdmeansd\u2003Gestational age†39.702.0738.771.720.005\u2003Birth weight*3426.60721.613396.83526.460.810n%n%\u2003congenital malformations¶00.078.40.187\u2003Preterm Delivery‡412.989.80.733\u2003small for Gestational age (<10th centile)‡39.71012.30.758\u2003large for Gestational age (>90th centile)‡26.51113.60.349delivery and neonatal outcomes for live births(n=32)(n=83)n%n%\u2003method of Delivery‡0.324\u2003\u2003Vaginal2374.25467.1\u2003\u2003c-section repeat00.056.1\u2003\u2003c-section emergency619.41113.4\u2003\u2003c-section schedules26.51113.4\u2003Forceps/vacuum used‡00.01012.30.059\u2003Fetal distress‡312.01726.60.139\u2003admitted to the nicu‡416.01928.80.210\u2003pna signs‡14.01421.20.060\n*independent t test.']	N/A	N/A	[('GO_0036268', 'swimming', 31, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 31, 'Perinatal'), ('GO_0007620', 'copulation', 183, 'conception'), ('GO_0007568', 'aging', 231, 'Pre'), ('GO_0007565', 'female pregnancy', 235, 'pregnancy'), ('GO_0007565', 'female pregnancy', 292, 'pregnancy'), ('CHEBI_33229', 'vitamin (role)', 348, 'Vitamin'), ('CHEBI_30879', 'alcohol', 378, 'Alcohol'), ('GO_0007565', 'female pregnancy', 492, 'Gestational'), ('GO_0007565', 'female pregnancy', 614, 'Gestational'), ('GO_0007567', 'parturition', 654, 'Birth'), ('GO_0007622', 'rhythmic behavior', 742, 'Preterm delivery'), ('GO_0007565', 'female pregnancy', 784, 'gestational'), ('GO_0007565', 'female pregnancy', 842, 'gestational'), ('GO_0007567', 'parturition', 962, 'delivery'), ('UBERON_0034872', 'stratum oriens of uncal CA3', 978, 'Vaginal2374'), ('UBERON_0004341', 'primitive streak', 1087, 'Forceps'), ('GO_0008618', '7-methylguanosine metabolic process', 1123, 'Fetal')]
PMC3718280	6/2013	S45-PMC3718280	['results\n\nstudy population characteristics\nthe mean Pre-Pregnancy bmi was 38.6 ± 7.0 kg/m2for the ob group, and 22.8 ± 1.5 kg/m2for the lc group (p<0.0001) (table 1).']	N/A	N/A	[('GO_0007568', 'aging', 51, 'pre'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy')]
PMC3735637	11/2012	S72-PMC3735637	['table oneshows baseline and Pre-Pregnancy characteristics comparing women with and without a gdm history during the 20 years of the cardia study.']	N/A	N/A	[('GO_0007568', 'aging', 28, 'pre'), ('GO_0007565', 'female pregnancy', 32, 'pregnancy')]
PMC3751294	8/2013	S93-PMC3751294	['“Cognitive Aging” refers to the inevitable Cognitive decline that occurs with Aging, with no evidence of dementia.']	N/A	N/A	[('GO_0050817', 'coagulation', 1, 'Cognitive aging'), ('GO_0050890', 'cognition', 43, 'cognitive'), ('GO_0007568', 'aging', 78, 'aging')]
PMC3751294	8/2013	S293-PMC3751294	['abbreviations\nad: alzheimer’s disease; bmi: body mass index; Crp: C-Reactive Protein; Dha: Docosahexaenoic Acid; Epa: Eicosapentaenoic Acid; hfcs: high-Fructose Corn Syrup; il-1: Interleukin-1; Il-6: Interleukin-6; ilsa: italian longitudinal study on Aging; omega-3 Fa: omega-3 Fatty Acids; satsa: swedish adoption/twin study of Aging; t2d: type 2 diabetes; tg: Triglycerides; mets: Metabolic syndrome; mmse: mini-mental state examination.']	N/A	N/A	[('PR_000005890', 'crooked neck-like protein 1', 61, 'CRP'), ('PR_000005890', 'crooked neck-like protein 1', 66, 'C-reactive protein'), ('CHEBI_17874', 'dihydrozeatin', 86, 'DHA'), ('CHEBI_78869', 'octacosapentaenoic acid', 91, 'Docosahexaenoic acid'), ('CHEBI_34733', 'EPN', 113, 'EPA'), ('CHEBI_31001', 'octacosanoic acid', 118, 'Eicosapentaenoic acid'), ('CHEBI_28757', 'fructose', 152, 'fructose'), ('CHEBI_33306', 'carbon group element atom', 161, 'corn'), ('CHEBI_46950', 'sultam', 166, 'syrup'), ('PR_000008988', 'interleukin-1 family member 5', 179, 'Interleukin-1'), ('PR_000008988', 'interleukin-1 family member 5', 194, 'Il-6'), ('PR_000001470', 'interleukin-28B', 200, 'Interleukin-6'), ('GO_0007568', 'aging', 251, 'Aging'), ('CHEBI_30751', 'formic acid', 266, 'FA'), ('CHEBI_35366', 'fatty acid', 278, 'fatty acids'), ('GO_0007568', 'aging', 329, 'Aging'), ('CHEBI_17855', 'triglyceride', 362, 'Triglycerides'), ('GO_0008152', 'metabolic process', 383, 'Metabolic')]
PMC3756974	8/2013	S15-PMC3756974	['Catechin eliminates Free Radicals and decreases Cholesterol level preventing cancer development, high Blood pressure, Arterial sclerosis, Thrombosis, Heart attacks and Brain strokes and Aging arrestment [5].']	N/A	N/A	[('CHEBI_3461', 'Casuarictin', 0, 'Catechin'), ('CHEBI_26519', 'radical', 20, 'free radicals'), ('CHEBI_16113', 'cholesterol', 48, 'cholesterol'), ('UBERON_0000178', 'blood', 102, 'blood'), ('UBERON_0001637', 'artery', 118, 'arterial'), ('GO_0007596', 'blood coagulation', 138, 'thrombosis'), ('UBERON_0000948', 'heart', 150, 'heart'), ('UBERON_0000955', 'brain', 168, 'brain'), ('GO_0007568', 'aging', 186, 'aging')]
PMC3759332	9/2013	S279-PMC3759332	['qrt-pcr\nml3 Animals were staged by selecting Animals that had undergone the l2/l3 molt and then Aging them an additional 24 hours.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 12, 'animals'), ('NCBITaxon_33208', 'Metazoa', 45, 'animals'), ('GO_0007568', 'aging', 96, 'aging')]
PMC3773919	9/2013	S415-PMC3773919	['in a randomized, double-blind, Placebo-controlled, and prospective trial of 90 children Aging 1–3 years with moderate-to-severe ad who were treated with a Mixture of Probiotics with Fructooligosaccharide for 8 weeks versus placebo at the final visit, the percentage significant decrease in scorad was 33% in the Probiotic group compared with 19% in the placebo group.']	N/A	N/A	[('CHEBI_26130', 'biological pigment', 31, 'placebo'), ('GO_0007568', 'aging', 88, 'aging'), ('CHEBI_60004', 'mixture', 155, 'mixture'), ('CHEBI_26346', 'prostaglandins J', 166, 'probiotics'), ('CHEBI_24111', 'fructoside', 182, 'fructooligosaccharide'), ('CHEBI_73033', 'pterocarpan', 312, 'probiotic')]
PMC3773919	9/2013	S460-PMC3773919	['in a randomized, double-blind, and placebo-controlled study, 54 infants Aging 1–55 months with moderate-to-severe ad were randomized to receive lgg or placebo during an 8-week intervention phase.']	N/A	N/A	[('GO_0007568', 'aging', 72, 'aging')]
PMC3816674	12/2012	S86-PMC3816674	['during the Aging process, when Tissue damage occurs, Stem Cells tend to divide rapidly to replenish the impairment.']	N/A	N/A	[('GO_0007568', 'aging', 11, 'aging'), ('UBERON_0000479', 'tissue', 31, 'tissue'), ('CL_0000034', 'stem cell', 53, 'stem cells')]
PMC3817352	10/2013	S61-PMC3817352	['inadequacy of gwg was defined as below adequacy of gwg and excessive of gwg was defined as above adequacy of gwg according to the chinese Pre-Pregnancy bmi classification standard and the 2009 iom gwg recommendations.']	N/A	N/A	[('GO_0007568', 'aging', 138, 'pre'), ('GO_0007565', 'female pregnancy', 142, 'pregnancy')]
PMC3829207	11/2013	S236-PMC3829207	['abbreviations\nan: anorexia nervosa; r-an: restricting anorexia nervosa; bp-an: binge-purging anorexia nervosa; ed: Eating disorder; apa: american psychiatric association; nice: national institute for health and care excellence; m: meter; kg: kilogram; kcal: kilocalories; abw: average body weight; bmi: body mass index; rda: recommended daily allowances; ekg: electrocardiogram; Epa: Eicosapentaenoic Acid; Dha: Docosahexaenoic Acid; cw: control women.']	N/A	N/A	[('GO_0007568', 'aging', 115, 'Eating'), ('CHEBI_34733', 'EPN', 379, 'EPA'), ('CHEBI_31001', 'octacosanoic acid', 384, 'Eicosapentaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 407, 'DHA'), ('CHEBI_78869', 'octacosapentaenoic acid', 412, 'Docosahexaenoic acid')]
PMC3850030	9/2013	S310-PMC3850030	['the consequences of Aging are an increase in the Stem Cell pool size, increased Self-Renewal and Production Of Cells with Expression of Myeloid-specific Genes and Genes commonly Expressed in Myeloid leukemia.']	N/A	N/A	[('GO_0007568', 'aging', 20, 'aging'), ('CL_0000034', 'stem cell', 49, 'stem cell'), ('GO_0051235', 'maintenance of location', 80, 'self-renewal ...'), ('GO_0008283', 'cell proliferation', 97, 'production of cells'), ('GO_0010467', 'gene expression', 122, 'expression'), ('CL_0000763', 'myeloid cell', 136, 'myeloid'), ('SO_0000704', 'gene', 153, 'genes'), ('SO_0000704', 'gene', 163, 'genes'), ('GO_0010467', 'gene expression', 178, 'expressed'), ('CL_0000763', 'myeloid cell', 191, 'myeloid')]
PMC3850328	3/2013	S28-PMC3850328	['this conference was held in collaboration with the university of california, los angeles (ucla, los angeles, ca, usa), johns hopkins bloomberg school of public health (baltimore, md, usa), ryerson university (toronto, canada), leyden academy on vitality and Ageing (leiden, netherlands), united nations population fund (unfpa, tehran, iran), iran academy of medical sciences (tehran, iran), centre for women and family in the president institution (tehran, iran), iran society of midwifery (tehran, iran), association of Food and nutritional health supporter of iran (tehran, iran), iran society of gastroenterologists and hepatologists (tehran, iran), iran association of clinical laboratory doctors (tehran, iran), iran society of endocrinology (tehran, iran), iran obesity society (tehran, iran), Breast Feeding promotion society (tehran, iran), and iran society for Reproductive medicine (tehran, iran).']	N/A	N/A	[('GO_0007568', 'aging', 258, 'Ageing'), ('CHEBI_33290', 'food', 521, 'Food'), ('UBERON_0000310', 'breast', 800, 'Breast'), ('GO_0007631', 'feeding behavior', 807, 'Feeding'), ('GO_0000003', 'reproduction', 870, 'Reproductive')]
PMC3873449	12/2013	S69-PMC3873449	['Pre-Pregnancy body mass index (bmi) was calculated using measured height and self-reported pre-Pregnancy weight [weight (kg)/height (m)2].']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy'), ('GO_0007565', 'female pregnancy', 95, 'pregnancy')]
PMC3873449	12/2013	S83-PMC3873449	['Pre-Pregnancy bmi in most women (95.2%) was < 25.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy')]
PMC4018969	5/2014	S207-PMC4018969	['caption (table-wrap): table 2\n\nmeasurement of mediatorsmediatorsmeasurewhen social supportsocial support exercise and Eating habits scales [89] (plus intervention specific social support questions)b, 36w, 6\xa0m, 12\xa0mself-efficacyweight efficacy lifestyle scale [90] and multidimensional self efficacy for exercise scale [91,92]b, 36w, 6\xa0m, 12\xa0mself-Regulationshortened self-Regulation questionnaire [93]b, 36w, 6\xa0m, 12\xa0mmotivationtreatment self-Regulation questionnaire (for diet and physical activity) [94]b, 36w, 6\xa0m, 12\xa0m\n(b\u2009=\u2009baseline; 36w\u2009=\u200936\xa0weeks Gestation; 6\xa0m\u2009=\u20096\xa0months Postpartum; 12\xa0m =12\xa0months Postpartum).']	N/A	N/A	[('GO_0007568', 'aging', 118, 'Eating'), ('GO_0010468', 'regulation of gene expression', 346, '-regulationShortened'), ('GO_0051131', 'chaperone-mediated protein complex assembly', 371, '-Regulation'), ('GO_0051131', 'chaperone-mediated protein complex assembly', 442, '-Regulation'), ('GO_0007565', 'female pregnancy', 553, 'gestation'), ('GO_0007565', 'female pregnancy', 579, 'postpartum'), ('GO_0007565', 'female pregnancy', 607, 'postpartum')]
PMC4037119	5/2014	S85-PMC4037119	['the Aging Brain is characterized by functional and Metabolic changes, including an increased vulnerability to insults and disease [41].']	N/A	N/A	[('GO_0007568', 'aging', 4, 'aging'), ('UBERON_0000955', 'brain', 10, 'brain'), ('GO_0008152', 'metabolic process', 51, 'metabolic')]
PMC4037119	5/2014	S348-PMC4037119	['for example, in a sample of 1025 elderly men (mean age: 68 years) from the boston veterans affairs normative Aging study, general linear models at both the cross-sectional and longitudinal levels did not reveal any significant association between Fatty Fish or N-3 Pufa Intake and performance on a battery of cognitive tests after a 6-year follow-up [211].']	N/A	N/A	[('GO_0007568', 'aging', 109, 'Aging'), ('CHEBI_38677', 'famphur', 247, 'fatty fish'), ('CHEBI_80445', '9,10-EOT', 261, 'n-3 PUFA'), ('GO_0007631', 'feeding behavior', 270, 'intake')]
PMC4051747	5/2014	S163-PMC4051747	['caption (table-wrap): table 3\n\neffects of text4baby and covariates on improvements in outcome variables from baseline to follow-up.effect of intervention and time on strong agreement (unadjusted)effect of intervention and time on strong agreement (fully adjusted, for age [quintile], parity, imputed marital status and race, and use of inverse probability weighting to account for attrition)a(n=459)(n=943 for baseline sample)or (95% ci), p valueor (95% ci), p value attitudes Eating 5 or more fruits and vegetables per day is important to the health of my developing baby1.49 (0.96-2.31), p =.0751.47 (0.83- 2.63), p =.189taking a Prenatal vitamin is important to the health of my developing baby1.68 (0.96-2.94), p =.0691.73 (0.80-3.73), p =.164i am prepared to be a new mother1.07 (0.673-1.57), p =.8041.28 (0.74-2.23), p =.555if i visit my health care provider on a regular basis, i will be a healthy new mother1.52 (1.01-2.31), p =.0461.66 (0.98-2.81), p =.058if i visit my health care provider on a regular basis, my baby will be healthy1.22 (0.83-1.80), p =.3201.32 (0.81-2.16), p =.268smoking will harm the health of my developing baby1.63 (0.74-3.61), p =.2262.25 (0.64-7.92), p =.204secondhand Smoke will not harm the health of my developing baby (reverse coded*)1.14 (0.81-1.58), p =.4500.82 (0.47-1.44), p =.491drinking Alcohol will harm the health of my developing baby2.06 (1.00-4.31), p =.0502.19 (0.87-5.52), p =.095taking Prenatal Vitamins will improve the health of my developing baby1.33 (0.84-2.10), p =.2211.91 (1.08-3.34), p =.024 behaviors have you ever gone online to search for Prenatal care information?0.91 (0.45-1.87), p =.8100.72 (0.21-2.43), p =.592in the last 30 days, did you smoke?0.86 (0.38-1.97), p =.7261.16 (0.41-3.27), p= .768since you found out about your Pregnancy, have you consumed Alcoholic beverages?0.49 (0.15-1.61), p =.2410.57 (0.14-2.36), p =.436ate 3 or more servings of fruit a day1.04 (0.68-1.60), p =.8421.07 (0.63-1.84), p =.758ate 3 or more servings of vegetables a day1.29 (0.83-1.97), p =.2491.17 (0.42-3.27), p =.795\naindicates change to “strongly disagree” (reverse coded).']	N/A	N/A	[('GO_0007568', 'aging', 477, 'Eating'), ('GO_0007565', 'female pregnancy', 632, 'prenatal'), ('CHEBI_30958', 'Sudan I', 1204, 'smoke'), ('CHEBI_30879', 'alcohol', 1332, 'alcohol'), ('GO_0007565', 'female pregnancy', 1439, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 1448, 'vitamins'), ('GO_0007565', 'female pregnancy', 1603, 'prenatal'), ('GO_0007565', 'female pregnancy', 1795, 'pregnancy'), ('CHEBI_33566', 'catechols', 1824, 'alcoholic')]
PMC4099383	7/2014	S163-PMC4099383	['the free play, mullen scales of Early Learning, and still face procedures are conducted at 6\xa0months of age.']	N/A	N/A	[('GO_0007568', 'aging', 32, 'Early'), ('GO_0007612', 'learning', 38, 'Learning')]
PMC4109981	7/2014	S82-PMC4109981	['Pregnacare 6.4(75)3.2(37)10.7(125)11.8(138) ordinary multivitamins 1.1(13)0.3(3)2.0(24)2.8(33) Vitamin D 3.8(45)1.8(21)2.0(23)3.1(36) iron 3.4(40)0.9(11)2.4(28)3.3(39) omega 3 1.4(17)0.9(11)4.1(48)4.4(52) vitamin c 2.0(23)0.7(8)2.4(28)3.8(44) Zinc 0.5(6)0.7(8)0.9(11)2(23)other preconception health behaviours Eating a healthy diet 16.1(189)5.2(61)22.5(264)24.8(291) healthy weight 10.0(117)3.9(46)5.1(60)15.0(176) Caffeine 8.7(102)4.4(52)13(152)22.2(260) Alcohol 13.3(156)5.0(59)15.3(180)26.3(309) smoking 13.1(154)4.5(53)13.6(160)23.5(272) street Drugs 6.9(81)3(35)7.6(89)16.4(192) immunisations 6.9(81)2.7(32)3.6(42)9.0(106) stopping contraception 9.4(110)2.9(34)8.2(96)13.7(161) Conception/fertility advice 10.0(117)5.0(59)6.7(79)12.4(146) Dental care 5.8(68)2.0(23)5.5(64)9.5(111) sti check 7.6(89)3.2(38)3.6(42)10.4(122)\n*includes finding out themselves, internet and books etc.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Pregnacare'), ('CHEBI_28384', 'vitamin K', 95, 'Vitamin D'), ('CHEBI_27377', "Unsym-bis(4'-chlorophenyl)ethylene", 243, 'Zinc'), ('GO_0007568', 'aging', 310, 'Eating'), ('CHEBI_27732', 'caffeine', 415, 'Caffeine'), ('CHEBI_30879', 'alcohol', 456, 'Alcohol'), ('CHEBI_23888', 'drug', 549, 'drugs'), ('GO_0006936', 'muscle contraction', 683, 'Conception'), ('UBERON_0001091', 'calcareous tooth', 744, 'Dental')]
PMC4109981	7/2014	S142-PMC4109981	['a randomised trial of Pre-Pregnancy advice from health professionals would provide stronger evidence for or against this interpretation.']	N/A	N/A	[('GO_0007568', 'aging', 22, 'pre'), ('GO_0007565', 'female pregnancy', 26, 'pregnancy')]
PMC4113768	7/2014	S1059-PMC4113768	['methods: the study was conducted in 1255 community-dwelling older men and women of the longitudinal Aging study amsterdam (lasa).']	N/A	N/A	[('GO_0007568', 'aging', 100, 'Aging')]
PMC4113768	7/2014	S1159-PMC4113768	['methods: this study was performed within the longitudinal Aging study amsterdam, an ongoing cohort study of a representative sample of the dutch older population ( n = 1509 for the development sample and n = 1100 for the validation sample).']	N/A	N/A	[('GO_0007568', 'aging', 58, 'Aging')]
PMC4113768	7/2014	S1174-PMC4113768	['methods: data from three different cohorts were used: two cohorts of the longitudinal Aging study amsterdam (lasa-i, 1995/1996, n = 1260; lasa-ii, 2008/2009, n = 365) and the baseline measurement of the b-Vitamins for the prevention of osteoporotic fractures (b-proof) study (2008–2011, n = 1319).']	N/A	N/A	[('GO_0007568', 'aging', 86, 'Aging'), ('CHEBI_33277', 'gamma-tocotrienol', 205, 'vitamins')]
PMC4113768	7/2014	S2373-PMC4113768	['methods: two answer the first two research aims, data of the longitudinal Aging study amsterdam (lasa) were used, an ongoing cohort study.']	N/A	N/A	[('GO_0007568', 'aging', 74, 'Aging')]
PMC4113768	7/2014	S3392-PMC4113768	['le12 5rd, uk\nbrekhoff, l., department of paediatrics, ziekenhuisgroep twente, hengelo, the netherlands\nbremner, s., asthma uk centre for applied asthma research, centre for primary care and public health, blizard institute, queen mary university of london, london e1 2ab, uk\nbrenner, h., division of clinical epidemiology and Aging research, german cancer research center, heidelberg, germany\nbrüske, i., institute of epidemiology i, helmholtz zentrum münchen- german research center for environmental health, neuherberg, germany\nBucca, g., department of microbial and cellular sciences, school of biosciences and medicine, faculty of health and medical sciences, university of surrey, guildford, surrey gu2 7xh, uk\nbuhary, b.m., specialized diabetes and endocrine center, king fahad medical city, king saud bin abdulaziz university for health sciences, riyadh 11525, saudi arabia\nburghaus, i., university of bochum, department of medical informatics, biometry and epidemiology, bochum, germany\nburild, a., division of Food chemistry, national Food institute, technical university of denmark, soeborg, dk\nbusch, m.a., department of epidemiology and health monitoring, robert koch institute, 12101 berlin, germany\nbyberg, l., department of surgical sciences, uppsala university, sweden\ncamargo, c.a.']	N/A	N/A	[('GO_0007568', 'aging', 326, 'Aging'), ('UBERON_0012477', 'dorsal part of neck', 530, 'Bucca'), ('CHEBI_33290', 'food', 1019, 'Food'), ('CHEBI_33290', 'food', 1044, 'Food')]
PMC4113768	7/2014	S3393-PMC4113768	['jr., department of emergency medicine, and division of rheumatology, allergy, and immunology, department of medicine, massachusetts general hospital, harvard medical school, boston, usa\ncantwell, m.m., cancer epidemiology & health services research group, centre for public health, queen’s university belfast, northern ireland\ncarlisi, a., clinical chemistry, university hospital of liège, liège, belgium\ncarroll, a., children’s university hospital, dublin, ireland\ncarroll, d., cancer epidemiology & health services research group, centre for public health, queen’s university belfast, northern ireland\ncarson, e.l., northern ireland centre for Food and health (niche), university of ulster, coleraine, bt52 1sa\ncasey, c., Nutrition & Metabolism group, centre for public health, queen’s university belfast, belfast, bt12 6bj, uk\ncashman, k.d., school of Food and nutritional sciences, university college cork, cork, ireland\ncavadino, a., university college london, uk\ncavalier, e., department of clinical chemistry, university of liège, chu sart-tilman, liège belgium\ncerda, j., department of public health, school of medicine, pontificia universidad católica de chile, santiago, chile\nchaloner, c., department of clinical biochemistry, central manchester nhs foundation trust, manchester m13 9wl, uk\nchambers, s.t., department of pathology, university of otago, christchurch, new zealand\nchandra, n., indian institute of science, bangalore, india\nchaplin, g., department of geography, the pennsylvania state university, pa 16802, usa\ncheetham, t.d., institute of Human genetics, newcastle university, international centre for life, newcastle upon tyne ne1 3bz, uk\nchen, m., melbourne Sexual health centre, carlton, victoria 3053, australia\nchope, g., campden bri, chipping campden, gloucestershire gl55 6ld, uk\nchoudhury, a., queen’s hospital, romford, uk\nchowdhury, t.a., blizard institute, barts and the london school of medicine and dentistry, queen mary university of london e1 2ab, uk\nchrousos, g.p., biomarkers research program, biochemistry department, college of science, king saud university, riyadh 11451, kingdom of saudi arabia, ksa\nchugh, r. institute of home economics, delhi university, delhi, india\ncifuentes, l., division of pediatrics, school of medicine, pontificia universidad católica de chile, santiago, chile\nclark, d.a., barts health nhs trust, london uk\ncleal, j.k., institute of developmental sciences, university of southampton, southampton so16 6yd, uk\ncoad, j., institute of Food nutrition and Human health, massey university, palmerston north, new zealand\ncole, z.a., mrc lifecourse epidemiology unit, university of southampton, university hospital southampton nhs foundation trust, southampton so16 6yd, uk\ncoleman, h.g., cancer epidemiology & health services research group, centre for public health, queen’s university belfast, northern ireland\ncollerton, j., institute for Ageing and health, newcastle university, newcastle ne4 5pl, uk\nconlon, c., nutrition and dietetics division, college of health, massey university, auckland\ncooper, c., mrc lifecourse epidemiology unit, university of southampton, university hospital southampton nhs foundation trust, southampton so16 6yd, uk\ncooper, p., mrc lifecourse epidemiology unit, university of southampton, university hospital southampton nhs foundation trust, southampton so16 6yd, uk\ncorrigan, c., king’s college london, london uk\ncoussens, a.k., clinical infectious diseases research initiative, university of cape town, observatory 7925, south africa\ncox, g., department of biochemistry, st. james’s hospital, dublin 8, ireland\ncrane, j., medicine, university of otago, wellington 6021, nz\ncristi, f., division of pediatrics, school of medicine, pontificia universidad católica de chile, santiago, chile\ncross, l., asthma uk centre for applied asthma research, centre for primary care and public health, blizard institute, queen mary university of london, london e1 2ab, uk\ncutolo, m., research laboratories and academic division of clinical rheumatology, department of internal medicine, university of genova, genova, italy\nczeizel, e., foundation for the community control of hereditary diseases, budapest, hungary\nda silva, s., clinical department, laboratoires smb sa, brussels belgium\ndamas, p., burn centre and general intensive care department, university hospital of liège, liège, belgium\ndarling, a.l., department of nutritional sciences, faculty of health and medical sciences, university of surrey, guildford gu2 7xh, uk\ndavies, j.h., paediatric endocrinology, university hospital southampton nhs foundation trust, southampton, so16 6yd, uk\ndavies, k., institute for Ageing and health, newcastle university, newcastle ne4 5pl, uk\ndavies, l., mrc lifecourse epidemiology unit, university of southampton, uk\nde jongh, r.t., department of internal medicine and endocrinology, vu university medical center, amsterdam, the netherlands\nde lusignan, s., department of health care management and policy, faculty of business, economics and law, university of surrey, guildford, surrey gu2 7xh, uk\nde niet, s., clinical department, laboratoires smb sa, brussels belgium\ndecuman, s., department of rheumatology, ghent university hospital, ghent, belgium\ndel pistoia, m., pediatrics department, university of pisa, pisa, italy\nden heijer, m., department of internal medicine and Endocrinology, vu university medical center, amsterdam, the netherlands\ndennison, e.m., mrc lifecourse epidemiology unit, university of southampton, university hospital southampton nhs foundation trust, southampton so16 6yd, uk\ndetrick, b., johns hopkins university, pathology, baltimore, md, usa\ndieffenbach, a.k., division of clinical epidemiology and Aging research, german cancer research center (dkfz), heidelberg, germany\ndiehm, c., srh-klinikum karlsbad-langensteinbach, department of internal medicine/vascular medicine, karlsbad, germany\ndiez, u., children’s hospital, municipal hospital “st.']	N/A	N/A	[('CHEBI_33290', 'food', 646, 'Food'), ('GO_0006754', 'ATP biosynthetic process', 724, 'Nutrition'), ('GO_0008152', 'metabolic process', 736, 'Metabolism'), ('CHEBI_33290', 'food', 855, 'Food'), ('NCBITaxon_10088', 'Mus <genus>', 1565, 'Human'), ('GO_0007565', 'female pregnancy', 1686, 'Sexual'), ('UBERON_2001052', 'primordial hindbrain channel', 1686, 'Sexual'), ('CHEBI_33290', 'food', 2506, 'Food'), ('NCBITaxon_10088', 'Mus <genus>', 2525, 'Human'), ('GO_0007568', 'aging', 2909, 'Ageing'), ('GO_0007568', 'aging', 4665, 'Ageing'), ('GO_0006897', 'endocytosis', 5365, 'Endocrinology'), ('GO_0007568', 'aging', 5719, 'Aging')]
PMC4113768	7/2014	S3398-PMC4113768	['uk\nfletcher, s., department of Nephrology, university hospitals of coventry and warwickshire nhs trust, cv2 2dx, uk\nflorkowski, c.m., department of pathology, university of otago, christchurch, new zealand\nflynn, a., school of Food and nutritional sciences, university college cork, cork, ireland\nflynn, m., Food safety authority of ireland, dublin, ireland\nford, l., department of clinical biochemistry, sandwell and west birmingham hospitals nhs trust, birmingham b18 7qh, uk\nforouhi, n.g., mrc epidemiology unit, university of cambridge school of clinical medicine, box 285 institute of Metabolic science, cambridge biomedical campus, cambridge, cb2 0qq, uk\nfoskett, a., school of sport and exercise, massey university, auckland\nfoster, t., department of paediatrics, ealing hospital, london ub1 3hw, uk\nfouda, m., medicine department, king khalid university hospital, riyadh 11451, saudi arabia\nfox, m.j., centre for the developing Brain, division of imaging sciences and biomedical engineering, king’s college london, st thomas’ hospital, london, se1 7eh, uk\nfrancis, r.m., institute for Ageing and health, newcastle university, newcastle ne4 5pl, uk\nfrandsen, h.l., division of Food chemistry, national Food institute, technical university of denmark, soeborg, dk\nfraser, w.d., norwich medical school, university of east anglia, norwich nr4 7tj, uk\nfrazier, a.l., brigham and women’s hospital, boston, ma 02115, usa\nfuskevåg, o.m., department of clinical pharmacology, university of north norway, tromsø, norway\ngad, m.z., biochemistry department, faculty of pharmacy and biotechnology, german university in cairo, egypt\ngadisseur, r., clinical chemistry, university hospital of liège, liège, belgium\ngalvin, k., school of Food and nutritional sciences, university college cork, cork, ireland\ngamborg, m., institute of preventive medicine, bispebjerg and frederiksberg hospital, the capital region, copenhagen, denmark\ngandhi, b., centre for primary care and public health, barts and the london school of medicine, queen mary university of london, london e1 2ab, uk\ngandy, s.j., dept of medical physics, nhs tayside, ninewells hospital, dundee dd1 9sy\ngarratt, e., southampton institute of developmental sciences, university of southampton, southampton, uk\ngebski, v., nhmrc clinical trials centre, sydney medical school, university of sydney\ngeissler, s., institute for agricultural and nutritional sciences, martin-luther-university halle-wittenberg, germany\ngibney, m.j., ucd institute of Food and health, university college dublin, dublin, ireland\ngiguere, p., department of anesthesia, critical care and pain medicine, massachusetts general hospital, boston, ma 02114, usa\ngiles, g.g., centre for epidemiology and biostatistics, melbourne school of population and global health, the university of melbourne, melbourne, victoria 3010, australia\ngill, p.s., primary care clinical sciences, university of birmingham, birmingham, b15 2tt, uk\ngillberg, c., institute of health and wellbeing, university of glasgow, glasgow g3 8sj, uk\ngluckman, p.d., liggins institute, university of auckland, new zealand\ngodfrey, k.m., mrc Lifecourse epidemiology unit, university of southampton, university hospital southampton nhs foundation trust, southampton so16 6yd, uk\ngoldberg, g.r., mrc Human nutrition research, elsie widdowson laboratory, fulbourn road, cambridge, cb1 9nl, uk\ngoldring, s.t., department of paediatrics, imperial college london, uk\ngoliath, r., clinical infectious diseases research initiative, university of cape town, observatory 7925, south africa\ngonzález, g., department of endocrinology, school of medicine, pontificia universidad católica de chile, santiago, chile\ngori, m., pediatrics department, university of pisa, pisa, italy\ngranic, a., institute for Ageing and health, newcastle university, newcastle ne4 5pl, uk\ngrant, c.c., paediatrics: child & youth health, university of auckland, auckland 1142, nz\ngrant, w.b., sunlight, nutrition and health research center, san francisco, ca 94164-1603, usa\ngray, s.r., Musculoskeletal research programme, university of aberdeen, aberdeen, uk\ngreenwald, s., blizard institute, barts and the london school of medicine and dentistry, queen mary university of london e1 2ab, uk\ngreiller, c.l., centre for primary care and public health, blizard institute, queen mary university of london, e1 2ab, uk\ngrieve, a., environmental research group, mrc-phe centre for environmental health, king’s college london, london se1 9nh, uk\ngriffin, b., department of nutritional sciences, university of surrey, guildford gu2 7xh\ngriffin, s.j., mrc epidemiology unit, university of cambridge school of clinical medicine, box 285 institute of Metabolic science, cambridge biomedical campus, cambridge, cb2 0qq, uk\ngriffiths, c.j., asthma uk centre for applied asthma research, centre for primary care and public health, blizard institute, queen mary university of london, london e1 2ab, uk\ngrigg, j., blizard institute, barts and the london school of medicine and dentistry, queen mary university of london, london e1 2at, uk\ngrigg, j., centre for paediatrics, blizard institute, queen mary university of london, e1 2ab, uk\ngrimnes, g.,tromsø Endocrine research group, department of clinical medicine, the arctic university of norway, tromsø, norway\ngrimwood, k., griffith health, gold coast campus, griffith university and the gold coast university hospital, southport, queensland 4222, australia\ngupta, a., johns hopkins university, medicine, baltimore, md, usa\nhabib.']	N/A	N/A	[('UBERON_0001052', 'rectum', 31, 'Nephrology'), ('CHEBI_33290', 'food', 227, 'Food'), ('CHEBI_33290', 'food', 308, 'Food'), ('GO_0008152', 'metabolic process', 590, 'Metabolic'), ('UBERON_0000955', 'brain', 936, 'Brain'), ('GO_0007568', 'aging', 1093, 'Ageing'), ('CHEBI_33290', 'food', 1184, 'Food'), ('CHEBI_33290', 'food', 1209, 'Food'), ('CHEBI_33290', 'food', 1729, 'Food'), ('CHEBI_33290', 'food', 2498, 'Food'), ('UBERON_0001281', 'hepatic sinusoid', 3130, 'Lifecourse'), ('NCBITaxon_10088', 'Mus <genus>', 3286, 'Human'), ('GO_0007568', 'aging', 3780, 'Ageing'), ('UBERON_0002204', 'musculoskeletal system', 4040, 'Musculoskeletal'), ('GO_0008152', 'metabolic process', 4693, 'Metabolic'), ('GO_0009790', 'embryo development', 5193, 'Endocrine')]
PMC4113768	7/2014	S3400-PMC4113768	['usa\nheymans, m.w., department of epidemiology and biostatistics, emgo institute for health and care research, vu university medical center, amsterdam, the netherlands\nhidetoshi, m., department of pediatrics, jikei university school of medicine, 18-19-3 nishishinbashi, minato-ku, tokyo, jp\nhiggins, r., department of Nephrology, university hospitals of coventry and warwickshire nhs trust, cv2 2dx, uk\nhill, c., population health department, qimr berghofer medical research institute\nhill, t.r., school of agriculture, Food and rural development, newcastle university, newcastle ne1 7ru, uk\nhiroshi, t., department of pediatrics, jikei university school of medicine, 18-19-3 nishishinbashi, minato-ku, tokyo, jp\nhitman, g.a., blizard institute, barts and the london school of medicine and dentistry, queen mary university of london e1 2ab, uk\nhodge, a.m., cancer epidemiology centre, cancer council victoria, carlton, victoria 3053, australia\nhodges, l., school of sport and exercise, massey university, palmerston north, new zealand\nhofbauer, l.c., division of endocrinology, diabetes, and bone diseases, dresden technical university medical center, dresden, germany\nholroyd, c., mrc lifecourse epidemiology unit, university of southampton, university hospital southampton nhs foundation trust, southampton so16 6yd, uk\nhooper, r.l., asthma uk centre for applied research, centre for primary care and public health, barts and the london, school of medicine and dentistry, queen mary university of london, uk\nhoti, m., Genome centre, barts and the london school of medicine and dentistry, john vane science centre, charterhouse square, london ec1m 6bq, uk\nhourihane, j.o’b., department of paediatrics and child health, university college cork, ireland\nhouston, j.g., dept of clinical imaging, university of dundee, ninewells hospital, dundee dd1 9sy\nhowie-esquivel, j., university of california san francisco, department of physiological nursing, san francisco, ca 94143, usa\nhoyos-bachiloglu, r., division of pediatrics, school of medicine, pontificia universidad católica de chile, santiago, chile\nhuang, c., department of paediatrics, ealing hospital ico, london ub1 3hw, uk\nhuang, y., georgia prevention center, institute of public and preventive health, georgia regents university, georgia 30912, usa\nhunter, s.j., regional centre for endocrinology and diabetes, royal victoria hospital, belfast, bt12 6ba.uk\nhusemoen, l.l., research centre for prevention and health, the capital region of denmark, glostrup university hospital, denmark\nhutchinson, m.s., tromsø Endocrine research group, institute of clinical medicine, university of tromsø, norway\nhyppönen, e., centre for paediatric epidemiology and biostatistics, institute of child health, university college london, london wc1n 1eh, uk\nhyppönen, e., school of population health and sansom institute, university of south australia, adelaide, australia\nida, h., department of pediatrics, jikei university school of medicine, tokyo, japan\ningelsoon, e., department of medical sciences, uppsala university, sweden\ningham, t.r., department of medicine, university of otago wellington, po box 7343 wellington south, wellington 6242, new zealand\ninskip, h.m., mrc lifecourse epidemiology unit, university of southampton, uk\niqbal, r., department of community health sciences, aga khan university, karachi 3500\nireland, s.e., dept of clinical pharmacology, university of dundee, ninewells hospital, dundee dd1 9sy\nislam, k., queen mary, university of london, london uk\nismail, a., department of Endocrinology & Metabolism, national institute of nutrition, hyderabad, india\niturriaga, c., division of pediatrics, school of medicine, pontificia universidad católica de chile, santiago, chile\nivison, f.m., department of clinical biochemistry, central manchester nhs foundation trust, manchester m13 9wl, uk\njablonski, n., department of anthropology, the pennsylvania state university, pa 16802, usa\njacobsen, r., institute of preventive medicine, bispebjerg and frederiksberg hospital, nordre fasanvej 57, 2000 frederiksberg, denmark\njagger, c., institute for Ageing and health, newcastle university, newcastle ne4 5pl, uk\njakeman, p., physical education and sport sciences department, university of limerick, ireland\njakobsen, j., division of Food chemistry, national Food institute, technical university of denmark, soeborg, dk\njamaludin, j., environmental research group, mrc-phe centre for environmental health, king’s college london, london se1 9nh, uk\njames, w.y., queen mary, university of london, london uk\njamil, n.a., Musculoskeletal research programme, university of aberdeen, aberdeen, uk\njandrain, b., department of clinical pharmacology, atc sa, liège belgium\njarjou, l.m.a., mrc keneba, the gambia, west africa\njavaid, m.k., nihr Musculoskeletal biomedical research unit, university of oxford, uk\njefferson, k., department of Urology, university Hospitals of coventry and warwickshire nhs trust, cv2 2dx, uk\njennings, l.c., department of pathology, university of otago, christchurch, new zealand\njensen, c.b., institute of preventive medicine, bispebjerg and frederiksberg hospital, the capital region, copenhagen, denmark\njessup, w., nutrition and dietetics division, college of health, massey university, auckland\njohansson, g., family medicine and preventive medicine, department of public health and caring sciences, uppsala university, bmc box 564, s-751 22 uppsala, sweden\njohnsen, m., tromsø endocrine research group, department of clinical medicine, university of tromsø, 9037 tromsø, norway\njohnson, c.s., roswell park cancer institute, elm and carlton streets, buffalo, new york 14263.']	N/A	N/A	[('UBERON_0001052', 'rectum', 317, 'Nephrology'), ('CHEBI_33290', 'food', 519, 'Food'), ('SO_0001026', 'genome', 1519, 'Genome'), ('UBERON_0005063', 'left ventricular compact myocardium', 2567, 'Endocrine'), ('GO_0006897', 'endocytosis', 3547, 'Endocrinology'), ('GO_0008152', 'metabolic process', 3563, 'Metabolism'), ('GO_0007568', 'aging', 4110, 'Ageing'), ('CHEBI_33290', 'food', 4294, 'Food'), ('CHEBI_33290', 'food', 4319, 'Food'), ('UBERON_0002204', 'musculoskeletal system', 4578, 'Musculoskeletal'), ('UBERON_0002204', 'musculoskeletal system', 4795, 'Musculoskeletal'), ('UBERON_0000085', 'morula', 4891, 'Urology'), ('UBERON_0001447', 'tarsal bone', 4911, 'Hospitals')]
PMC4113768	7/2014	S3407-PMC4113768	['affiliated with rappaport faculty of medicine, the technion, haifa, israel\nkelly, f.j., environmental research group, mrc-phe centre for environmental health, king’s college london, london se1 9nh, uk\nkennedy, g., vascular and inflammatory diseases research unit, university of dundee, ninewells hospital, dundee dd1 9sy\nkenny, l.c., the irish centre for Fetal and neonatal translational research, department of obstetrics and gynaecology, university college cork, ireland\nkepa, m., department of general practice and primary health care, university of auckland, private bag 92019, auckland 1142, new zealand\nkerse, n., department of general practice and primary health care, university of auckland, private bag 92019, auckland 1142, new zealand\nkhan, f., division of Cardiovascular and diabetic medicine, university of dundee, uk\nkhan, k.s., centre for primary care and public health, barts and the london school of medicine, queen mary university of london, london e1 2ab, uk\nkiely, m., school of Food and nutritional sciences, university college cork, cork, ireland\nkilander, l., department of public health and caring sciences, uppsala university, sweden\nkilbane, m.t., Metabolism laboratory, st. vincent’s university hospital, dublin, ireland\nkilpin, k., queen mary, university of london, london uk\nkim, s., king’s college london, uk\nkimball, s., trials by design, toronto, ont, canada\nkimlin, m.g., institute of health and biomedical innovation, queensland university of technology, brisbane, queensland 4059, australia\nkinsella, m., school of Food and nutritional sciences, university college cork, cork, ireland\nkirkby, j.c., portex respiratory unit, university college london, institute of child health, london, uk\nkirkwood, t., institute for Ageing and health, newcastle university, newcastle ne4 5pl, uk\nkirman, j., department of microbiology and immunology, university of otago, po box 56 dunedin 9054, new zealand\nkisenge, r., department of paediatrics and child health, muhimbili university of health and allied sciences, dar es salaam, tanzania\nkivimaki, m., department of epidemiology and public health, university college london, wc1e 6bt, uk\nkjærgaard, m., division of internal medicine, university hospital of north norway, tromsø, norway\nklassen, k.m., northwest academic centre, university of melbourne, st albans, victoria 3021, australia\nknol, d.l., emgo institute for health and care research, department of epidemiology and biostatistics, vu university medical center, amsterdam, nl\nknop, j., institute of preventive medicine, bispebjerg and frederiksberg hospital, the capital region, copenhagen, denmark\nkočovská, e., institute of health and wellbeing, university of glasgow, glasgow g3 8sj, uk\nkratzsch, j., institute of laboratory medicine, clinical chemistry and molecular diagnostics, university hospital leipzig, leipzig, germany\nkruger, m.c., college of health, massey university, palmerston north\nkukhareva, p.v., north carolina state university, raleigh, nc.']	N/A	N/A	[('GO_0008618', '7-methylguanosine metabolic process', 355, 'Fetal'), ('UBERON_0004535', 'cardiovascular system', 768, 'Cardiovascular'), ('CHEBI_33290', 'food', 999, 'Food'), ('GO_0008152', 'metabolic process', 1174, 'Metabolism'), ('CHEBI_33290', 'food', 1550, 'Food'), ('GO_0007568', 'aging', 1752, 'Ageing')]
PMC4113768	7/2014	S3410-PMC4113768	['usa department of Food, nutrition & Bioprocessing sciences\nmandami, m., whittington health, uk\nmanderson, j.g., regional centre for endocrinology and diabetes, royal victoria hospital, belfast, bt12 6bj, uk\nmanji, k.p., department of paediatrics and child health, muhimbili university of health and allied sciences, dar es salaam, tanzania\nmannan, n., blizard institute, barts and the london school of medicine and dentistry, queen mary university of london e1 2ab, uk\nmarleen, s., department of obstetrics and Gynaecology, the royal london hospital, barts health nhs trust, london e1 1bb, uk\nmarlin, n., asthma uk centre for applied asthma research, centre for primary care and public health, blizard institute, queen mary university of london, london e1 2ab, uk\nmartineau, a.r., asthma uk centre for applied asthma research, centre for primary care and public health, blizard institute, queen mary university of london, london e1 2ab, uk\nmartineau, a.r., centre for primary care and public health, barts and the london school of medicine and dentistry, queen mary university of london, london e1 2ab, uk\nmartin-ruiz, c., institute for Ageing and health, newcastle university, newcastle ne4 5pl, uk\nmathers, j.c., Human nutrition research centre, newcastle university, newcastle ne1 7ru, uk\nmazzilli, s.a., boston university school of medicine, 72 e. concord street, boston, ma 02118.']	N/A	N/A	[('CHEBI_33290', 'food', 18, 'Food'), ('GO_0007225', 'patched ligand maturation', 36, 'Bioprocessing'), ('UBERON_0001950', 'neocortex', 511, 'Gynaecology'), ('GO_0007568', 'aging', 1137, 'Ageing'), ('NCBITaxon_10088', 'Mus <genus>', 1215, 'Human')]
PMC4113768	7/2014	S3414-PMC4113768	['pearce, s.h., institute of Human genetics, newcastle university, international centre for life, newcastle upon tyne ne1 3bz, uk\npei, j.j., wuxi maternity and child health care hospital, nanjing medical university, wuxi, 214002, china\npenn, n., king’s college london school of medicine\npenson, s., campden bri, chipping campden, gloucestershire gl55 6ld, uk\nperna, l., division of clinical epidemiology and Aging research, german cancer research center (dkfz), heidelberg, germany\npetchey, m., biochemistry department, university hospitals of coventry and warwickshire nhs trust, coventry, cv2 2dx, uk\npeters, b., king’s college london, uk\npetrovic, k.e., division of general neurology, department of neurology, general hospital and medical university of graz ,8036, austria\nphinney, k.w., Biomolecular measurement division, national institute of standards and technology, gaithersburg, maryland, usa\npilarski, a., king’s college london school of medicine\npizzorni, c., research laboratories and academic division of clinical rheumatology, department of internal medicine, university of genova, genova, italy\npoulton, s., department of paediatrics, imperial college london, uk\npourshahidi, l.k., northern ireland centre for food and health (niche), university of ulster, coleraine, bt52 1sa\npower, c., centre for paediatric epidemiology and biostatistics, institute of child health, university college london, london wc1n 1eh, uk\nprentice, a., mrc Human nutrition research, elsie widdowson laboratory, fulbourn road, cambridge, cb1 9nl, uk\npriest, p.c., department of preventive and social medicine, university of otago, dunedin, new zealand\nquilter, m.l., institute of Food nutrition and Human health, massey university, palmerston north, new zealand\nquraishi, s.a., department of anesthesia, critical care and pain medicine, massachusetts general hospital, boston, ma 02114, usa\nrabenberg, m., department of epidemiology and health monitoring, robert koch institute, 12101 berlin, germany\nraftery, t., department of medicine, trinity centre for health science, st. james’s hospital, dublin 8, ireland\nräikkönen, k., institute of behavioural sciences, university of helsinki, 00014 university of helsinki, finland\nrajakulasingam, r.k., homerton university hospital, london uk\nrajput, m., institute of home economics, delhi university, delhi, india\nrandhawa, j., guy’s and st thomas’ foundation trust\nrasmussen, l.b., national Food institutte, technical univercity of denmark, dk-2860 søborg, denmark\nrasvi, s., institute of Genetic medicine, newcastle university, newcastle ne2 4hh, uk\nravn-haren, g., national Food institutte, technical univercity of denmark, dk-2860 søborg, denmark\nraymond, k., institute of preventive medicine, bispebjerg and frederiksberg hospital, the capital region, copenhagen, denmark\nrehman, a., department of microbiology and molecular genetics, university of the punjab, lahore, pakistan.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 27, 'Human'), ('GO_0007568', 'aging', 406, 'Aging'), ('CHEBI_33694', 'biomacromolecule', 789, 'Biomolecular'), ('NCBITaxon_10088', 'Mus <genus>', 1447, 'Human'), ('CHEBI_33290', 'food', 1669, 'Food'), ('NCBITaxon_10088', 'Mus <genus>', 1688, 'Human'), ('CHEBI_33290', 'food', 2426, 'Food'), ('SO_0000704', 'gene', 2524, 'Genetic'), ('CHEBI_33290', 'food', 2611, 'Food')]
PMC4113768	7/2014	S3415-PMC4113768	['rehman, a.m., mrc tropical epidemiology group, lshtm, keppel st, london, wc1e 7ht, uk\nrhein, h.m., sighthill health centre, 380 calder road, edinburgh eh11 4au, scotland, uk\nrickard, a.p., mrc epidemiology unit, university of cambridge school of clinical medicine, box 285 institute of Metabolic science, cambridge biomedical campus, cambridge, cb2 0qq, uk\nrifas-shiman, s.l., harvard medical school, boston, ma 02115, usa\nrobertson, f., department of nutritional sciences, university of surrey, guildford gu2 7xh\nrobinson, s., department of medicine, imperial college london, uk\nrobinson, s.m., mrc lifecourse epidemiology unit, university of southampton, southampton, so16 6yd, uk\nröder, s., core facility studies, helmholtz centre for environmental research—ufz, leipzig, germany\nroth, h.j., department of Endocrinology/oncology, limbach laboratory, heidelberg, germany\nrothenbacher, d., institute of epidemiology and medical biometry, ulm university, ulm, germany\nrousseau, a.f., burn centre and general intensive care department, university hospital of liège, liège, belgium\nrousseau, b., groupe de recherche nutritionnelle, yoplait, boulogne 92641 cedex, france\nrowden, j., paediatrics: child & youth health, university of auckland, auckland 1142, nz\nrowe, m., clinical biochemistry department, homerton university hospital nhs foundation trust, homerton row, london e9 6sr, uk\nrutherford, m.a., centre for the developing Brain, division of imaging sciences and biomedical engineering, king’s college london, st thomas’ hospital, london, se1 7eh, uk\nsabico, s., biomarkers research program, department of biochemistry, college of science, king saud university, riyadh, 11451 saudi arabia\nsachdev, h.p.s., sitaram bhartia institute of science and research, delhi, india\nsaeed, t., gulab devi hospital, lahore, pakistan\nsaggese, g., pediatrics department, university of pisa, pisa, italy\nsanchez, a., department of epidemiology and public health, university college london, wc1e 6bt, uk\nsandle, l.n., department of chemical pathology, central manchester university hospitals nhs foundation trust, trafford general hospital, manchester, m41 5sl, uk\nsarin, p., college of medical and Dental sciences, university of birmingham, birmingham, b15 2tt, uk\nsarwar, s., resident Nephrology, aga khan university, karachi 3500\nsaum, k.u., division of clinical epidemiology and Aging research, german cancer research center (dkfz), heidelberg, germany\nscheen, a., division of diabetes, nutrition and Metabolic disorders, chu sart tilman, university of liege, liège, belgium\nscheidt-nave, c., department of epidemiology and health monitoring, robert koch institute, 12101 berlin, germany\nschirmer, h., department of clinical medicine, faculty of health sciences, the arctic university, tromsø, norway\nschmidt, h., research unit for Genetic epidemiology, institute of molecular biology and biochemistry, center of molecular medicine, medical university of graz, 8010 graz, austria\nschmidt, r., division of general neurology, department of neurology, general hospital and medical university of graz ,8036, austria\nschoenmakers, i., mrc Human nutrition research, elsie widdowson laboratory, fulbourn rd, cambridge, cb1 9nl, uk\nschöttker, b., division of clinical epidemiology and Aging research, german cancer research center, heidelberg, germany\nscragg, r., school of population health, university of auckland, auckland, new zealand\nseamans, k.m., school of Food and nutritional sciences, university college cork, cork, ireland\nsegawa, t., department of pediatrics, fuji chuo hospital, shizuoka, japan\nsempos, c.t., office of dietary supplements, national institutes of health, bethesda, md 20852, usa\nsen, a., research unit for Genetic epidemiology, institute of molecular biology and biochemistry, center of molecular medicine, medical university of graz, 8010 graz, austria\nseriolo, b., research laboratories and academic division of clinical rheumatology, department of internal medicine, university of genova, genova, italy\nshaheen, s.o., asthma uk centre for applied research, centre for primary care and public health, barts and the london, school of medicine and dentistry, queen mary university of london, uk\nsharp, s.j., mrc epidemiology unit, university of cambridge school of clinical medicine, box 285 institute of Metabolic science, cambridge biomedical campus, cambridge, cb2 0qq, uk\nshea, r.l., department of clinical biochemistry, sandwell and west birmingham hospitals nhs trust, birmingham b18 7qh, uk\nsheikh, a., allergy & respiratory research group, centre for population health sciences, the university of edinburgh, edinburgh eh8 9ag, uk\nshen, x., xinhua hospital, shanghai jiao tong university school of medicine, shanghai, china\nsheppard, a., liggins institute, university of auckland, new zealand\nshi, h., cancer research center, georgia regents university, georgia 30912, usa\nsilva, s., department of dermatology, school of medicine, pontificia universidad católica de chile, santiago, chile\nsimcock, d., barts health nhs trust, london uk\nsimner, c.l., institute of developmental sciences, university of southampton, southampton so16 6yd, uk\nskaaby, t., research centre for prevention and health, glostrup hospital, university of copenhagen, glostrup, denmark\nskene, d.j., chronobiology, department of biochemistry and physiology, faculty of health and medical sciences, guildford gu2 7xh, uk\nslow, s., department of pathology, university of otago, christchurch, new zealand\nsmith, c.p., department of microbial and cellular sciences, school of biosciences and medicine, faculty of health and medical sciences, university of surrey, guildford, surrey gu2 7xh, uk\nsmith, s., department of medicine, trinity centre for health science, tallaght hospital, dublin 8, ireland\nsmith, v., department of rheumatology, ghent university hospital, ghent, belgium\nsmithers, h., asthma uk centre for applied asthma research, centre for primary care and public health, blizard institute, queen mary university of london, london e1 2ab, uk\nsnieder, h., department of epidemiology, university medical center groningen, university of groningen, groningen, the netherlands\nsohl, e., department of epidemiology and biostatistics, emgo institute for health and care research, vu university medical center, amsterdam, the netherlands\nsollid, s.t., tromsø endocrine research group, institute of clinical medicine, university of tromsø, norway\nsørensen, t.i.a., institute of preventive medicine, bispebjerg and frederiksberg hospital, the capital region, copenhagen, denmark\nspector, s.a., university of california, san diego, la jolla, ca and rady children’s hospital san diego, ca usa\nstangl, g.i., institute for agricultural and nutritional sciences, martin-luther-university halle-wittenberg, germany\nsteel, s.c., imperial college nhs trust, uk\nstevens, n., queen mary, university of london, london uk\nstewart, a.w., school of population health, university of auckland, auckland, new zealand\nstocks, j., portex respiratory unit, university college london, institute of child health, london, uk\nstrachan, a., Musculoskeletal research, university of aberdeen, ab25 2zd\nstrain, j.j., northern ireland centre for Food and health (niche), university of ulster, coleraine, bt52 1sa\nstruthers, a.d., division of Cardiovascular and diabetic medicine, university of dundee, uk\nsu, s., georgia prevention center, institute of public and preventive health, georgia regents university, georgia 30912, usa\nsudfeld, c.r., department of global health and population, harvard school of public health, boston, ma, usa\nsulli, a., research laboratories and academic division of clinical rheumatology, department of internal medicine, university of genova, genova, italy\nsuri, r., centre for paediatrics, blizard institute, queen mary university of london, e1 2ab, uk\nsutcliffe, a., general & adolescent paediatrics unit, ucl institute of child health, london wc1n 1eh\nsuzuki, m., department of neurology, katsushika medical center, jikei university school of medicine\nsvartberg, j., tromsø Endocrine research group, institute of clinical medicine, university of tromsø, norway\nsvirsky, b., chronic mechanical ventilation department b.']	N/A	N/A	[('GO_0008152', 'metabolic process', 286, 'Metabolic'), ('GO_0006897', 'endocytosis', 809, 'Endocrinology'), ('UBERON_0000955', 'brain', 1428, 'Brain'), ('UBERON_0001091', 'calcareous tooth', 2186, 'Dental'), ('UBERON_0001052', 'rectum', 2274, 'Nephrology'), ('GO_0007568', 'aging', 2370, 'Aging'), ('GO_0008152', 'metabolic process', 2492, 'Metabolic'), ('SO_0000704', 'gene', 2823, 'Genetic'), ('NCBITaxon_10088', 'Mus <genus>', 3125, 'Human'), ('GO_0007568', 'aging', 3268, 'Aging'), ('CHEBI_33290', 'food', 3447, 'Food'), ('SO_0000704', 'gene', 3718, 'Genetic'), ('GO_0008152', 'metabolic process', 4317, 'Metabolic'), ('UBERON_0002204', 'musculoskeletal system', 7104, 'Musculoskeletal'), ('CHEBI_33290', 'food', 7205, 'Food'), ('UBERON_0004535', 'cardiovascular system', 7301, 'Cardiovascular'), ('GO_0009790', 'embryo development', 8067, 'Endocrine')]
PMC4113768	7/2014	S3421-PMC4113768	['webb, p.m., population health department, qimr berghofer medical research institute\nwebber, j., school of cancer sciences, university of birmingham, birmingham, b15 2tt, uk\nwegler, c., department of Pharmaceutical biosciences, uppsala university, sweden\nweir, r.r., northern ireland centre for Food and health (niche), university of ulster, coleraine, bt52 1sa\nweyland, p.g., university of california san francisco, department of physiological nursing, san francisco, ca 94143, usa\nwhiteman, d.c., population health department, qimr berghofer medical research institute\nwhiting, s.j., college of pharmacy and nutrition, university of saskatchewan, saskatoon sk s7n 5c9, canada\nwikvall, k., department of Pharmaceutical biosciences, uppsala university, sweden\nwilkinson, r.j., clinical infectious diseases research initiative, university of cape town, observatory 7925, south africa\nwilliams, d., university college london, uk\nwilliamson, e.j., entre for epidemiology and biostatistics, melbourne school of population and global health, the university of melbourne, melbourne, victoria 3010, australia\nwilson, l., department of nutritional sciences, school of biosciences and medicine, faculty of health and medical sciences, university of surrey, guildford, surrey gu2 7xh, uk\nwitham, m.d., Ageing and health, university of dundee, ninewells hospital, dundee dd1 9sy\nwitt, k.d., queen mary, university of london, london uk\nwood, a.d., Musculoskeletal research, university of aberdeen, ab25 2zd\nwood, c.l., child health, newcastle hospitals nhs foundation trust, newcastle upon tyne, uk\nwood, h.e., environmental research group, mrc-phe centre for environmental health, king’s college london, london se1 9nh, uk\nwoodside, p.m., Nutrition and Metabolism group, centre for public health, queen’s university belfast, institute of clinical science block b, belfast, bt12 6bj.uk\nxiao, j.p., wuxi maternity and child health care hospital, nanjing medical university, wuxi, 214002, china\nyakout, s., prince mutaib chair for biomarkers of osteoporosis, biochemistry department, king saud university, riyadh 11451, saudi arabia\nyan, c., xinhua hospital, shanghai jiao tong university school of medicine, shanghai, china\nyoshioka, m., department of neurology, katsushika medical center, jikei university school of medicine\nyoung, i.s., Nutrition and Metabolism group, centre for public health, queen’s university belfast, institute of clinical science block b, belfast, bt12 6bj.uk\nyoung, m.c., harvard medical school, boston, ma 02115\nyoung, s.i., department of anesthesia, critical care and pain medicine, massachusetts general hospital, boston, ma 02114, usa\nyousef, m., health affairs for riyadh region, ministry of health, riyadh 11175, saudi arabia\nyu, c., department of medicine, imperial college london, uk; (4) portex respiratory unit, university college london, institute of child health, london, uk\nyu, x., xinhua hospital, shanghai jiao tong university school of medicine, shanghai, china\nzang, j., wuxi maternity and child health care hospital, nanjing medical university, wuxi, 214002, china\nzehnder, d., department of nephrology, university hospitals of coventry and warwickshire nhs trust, cv2 2dx, uk\nzeldow, b., harvard school of public health, boston, ma, usa\nzhang, j., xinhua hospital, shanghai jiao tong university school of medicine, shanghai, china\nzhang, y., school of Food and nutritional sciences, university college cork, cork, ireland\nzhu, h., georgia prevention center, institute of public and preventive health, georgia regents university, georgia 30912, usa\nzhu, y., wuxi maternity and child health care hospital, nanjing medical university, wuxi, 214002, china\nzostautiene, i., tromsø endocrine research group, department of clinical medicine, university of tromsø, 9037, tromsø, norway\nzwicker, j.d., school of public policy, university of calgary, calgary ab canada\n\npubmed central:']	N/A	N/A	[('CHEBI_52217', 'pharmaceutical', 199, 'Pharmaceutical'), ('CHEBI_33290', 'food', 294, 'Food'), ('CHEBI_52217', 'pharmaceutical', 704, 'Pharmaceutical'), ('GO_0007568', 'aging', 1291, 'Ageing'), ('UBERON_0002204', 'musculoskeletal system', 1435, 'Musculoskeletal'), ('GO_0006754', 'ATP biosynthetic process', 1727, 'Nutrition'), ('GO_0008152', 'metabolic process', 1741, 'Metabolism'), ('GO_0006754', 'ATP biosynthetic process', 2325, 'Nutrition'), ('GO_0008152', 'metabolic process', 2339, 'Metabolism'), ('CHEBI_33290', 'food', 3383, 'Food')]
PMC4113771	7/2014	S46-PMC4113771	['an explanation of the intensity of different levels of physical activity and examples of each were given to participants when completing physical activity questions as follows; strenuous physical activity was defined as physical activity that resulted in “rapid heartbeat”, e.g., running, Jogging, hurling, camogie, football, soccer, squash, basketball, judo, roller skating, vigorous swimming, vigorous long distance cycling, advanced aerobics; moderate physical activity was defined as “not exhausting”, e.g., fast walking, tennis, badminton, easy swimming, easy cycling, popular and folk dancing, intermediate aerobics, heavy gardening; and mild physical activity was defined as “minimal effort” physical activity, e.g., yoga, golf, easy walking, fishing from River bank, bowling, beginners aerobics, archery, light gardening.']	N/A	N/A	[('GO_0007568', 'aging', 289, 'jogging'), ('UBERON_0002067', 'dermis', 763, 'river')]
PMC4143239	8/2014	S172-PMC4143239	['Acquired Immunity\nacquired Immunity is characterized by specialized Cellular and Antibody-Mediated Immune Responses, generated by T- and B-Lymphocytes reacting with high specificity towards pathogens and creating long-Lasting Immunological Memory.']	N/A	N/A	[('GO_0006914', 'autophagy', 0, 'Acquired'), ('GO_0007566', 'embryo implantation', 9, 'immunity'), ('GO_0007566', 'embryo implantation', 27, 'immunity'), ('GO_0000911', 'cytokinesis by cell plate formation', 68, 'cellular ... -mediated immune responses'), ('GO_0042571', 'immunoglobulin complex, circulating', 81, 'antibody'), ('UBERON_0002405', 'immune system', 99, 'immune'), ('CL_0000918', 'Tc2 cell', 130, 'T- ...'), ('CL_0000236', 'B cell', 137, 'B-lymphocytes'), ('GO_0007568', 'aging', 217, '-lasting'), ('GO_0007566', 'embryo implantation', 226, 'immunological'), ('GO_0007613', 'memory', 240, 'memory')]
PMC4144280	9/2014	S79-PMC4144280	['thirteen in-depth interviews were conducted with three husbands, four mothers, two mothers-in-law, and four medical staff in order to understand their perspectives on the information-Seeking process of these Pregnant women.']	N/A	N/A	[('GO_0007568', 'aging', 182, '-seeking'), ('GO_0007565', 'female pregnancy', 208, 'pregnant')]
PMC4192458	9/2014	S160-PMC4192458	['in the us cohort study project viva [47], diet quality, as measured by the alternate healthy Eating index slightly modified for Pregnancy (ahei-p), was not associated with pre-eclampsia (or\u2009=\u20090.96, 95% ci 0.84 to 1.10, 5 point increase) when assessed in the first trimester, but slightly lowered the odds of developing pre-eclampsia when assessed in the second Trimester of Pregnancy (or\u2009=\u20090.87, 95% ci 0.76 to 1.00).']	N/A	N/A	[('GO_0007568', 'aging', 93, 'Eating'), ('GO_0007565', 'female pregnancy', 128, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 361, 'trimester'), ('GO_0007565', 'female pregnancy', 374, 'pregnancy')]
PMC4194375	10/2014	S74-PMC4194375	['to assess adherence to dietary recommendations, Food and drink Consumption was grouped into Food groups as defined by the australian guide to healthy Eating [43].']	N/A	N/A	[('CHEBI_33290', 'food', 48, 'food'), ('GO_0007631', 'feeding behavior', 63, 'consumption'), ('CHEBI_33290', 'food', 92, 'food'), ('GO_0007568', 'aging', 150, 'Eating')]
PMC4208652	6/2014	S236-PMC4208652	['among its functions, P53 Regulates the Expression of target Genes that Modulate Chromatin structure and function (cimoli et al.2004; vousden and lane2007), cell growth, Aging and Apoptosis (ambrogi et al.2006; biganzoli et al.2011).']	N/A	N/A	[('PR_000003035', 'cellular tumor antigen p53', 21, 'p53'), ('GO_0065007', 'biological regulation', 25, 'regulates'), ('GO_0010467', 'gene expression', 39, 'expression'), ('SO_0000704', 'gene', 60, 'genes'), ('GO_0065007', 'biological regulation', 71, 'modulate'), ('GO_0000785', 'chromatin', 80, 'chromatin'), ('GO_0007568', 'aging', 169, 'aging'), ('GO_0006915', 'apoptotic process', 179, 'apoptosis')]
PMC4275593	9/2014	S150-PMC4275593	['trialing Pre-Conceptional Vitamin Supplements and ‘high-risk mothers’\nsmithells’ team at leeds, with collaborators in manchester, chester and london, succeeded in recruiting 137 ‘study mothers’ into a trial of ‘Pregnavite forte f’, a multivitamin containing Folic Acid manufactured by the british pharmaceutical company beecham and available only on prescription.']	N/A	N/A	[('GO_0007568', 'aging', 9, 'pre'), ('GO_0007620', 'copulation', 13, 'conceptional'), ('CHEBI_33229', 'vitamin (role)', 26, 'vitamin'), ('CHEBI_33341', 'titanium atom', 34, 'supplements'), ('GO_0007565', 'female pregnancy', 211, 'Pregnavite'), ('CHEBI_30751', 'formic acid', 258, 'folic acid')]
PMC4280000	12/2014	S5-PMC4280000	['the primary study outcome was the healthy Eating index.']	N/A	N/A	[('GO_0007568', 'aging', 42, 'Eating')]
PMC4280000	12/2014	S50-PMC4280000	['study endpoints\nthe primary study outcome was the woman’s healthy Eating index (hei) during Pregnancy, as determined by self-completed Food frequency questionnaire.']	N/A	N/A	[('GO_0007568', 'aging', 66, 'Eating'), ('GO_0007565', 'female pregnancy', 92, 'pregnancy'), ('CHEBI_33290', 'food', 135, 'food')]
PMC4280000	12/2014	S71-PMC4280000	['sample size\nthe primary endpoint was the healthy Eating index score at 28 and 36\xa0weeks Gestation.']	N/A	N/A	[('GO_0007568', 'aging', 49, 'Eating'), ('GO_0007565', 'female pregnancy', 87, 'gestation')]
PMC4280000	12/2014	S73-PMC4280000	['assuming a mean (sd) healthy Eating index score during Pregnancy of 72.4 (7.1) [14], and accounting for a response rate of 65%, this sample size provides 90% power to detect a difference in mean healthy Eating index of 2 points between the dvd group and the standard materials group (80% power, 2-sided alpha\u2009=\u20090.025 to correct for multiple comparisons due to outcome assessment at 28 and 36\xa0weeks).']	N/A	N/A	[('GO_0007568', 'aging', 29, 'Eating'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy'), ('GO_0007568', 'aging', 203, 'Eating')]
PMC4280000	12/2014	S95-PMC4280000	['at 28\xa0weeks Gestation there was no evidence of a difference in the healthy Eating index of women who did or did not receive the dvd (adjusted mean difference (amd) -0.12, 95% confidence interval (ci) -1.10 to 0.87, p\u2009=\u20090.82).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 12, 'gestation'), ('GO_0007568', 'aging', 75, 'Eating')]
PMC4280000	12/2014	S100-PMC4280000	['caption (table-wrap): table 3\n\nstudy outcomes by treatment groupoutcomedvd group (n\u2009=\u2009541)standard materials group (n\u2009=\u2009564)unadjusted treatment effect (95% ci)unadjusted p-valueadjusted treatment effect (95% ci)adjusted p-value healthy Eating index score28\xa0weeks73.22 (6.79)73.47 (6.45)−0.26 (−1.24, 0.73)0.61−0.12 (−1.10, 0.87)0.8236\xa0weeks73.60 (6.58)72.34 (7.00)1.26 (0.20, 2.31)0.021.20 (0.16, 2.25)0.02physical activity28\xa0weeks7040.20 (3968.84)6967.30 (3943.89)72.90 (−502.19, 648.00)0.80121.48 (−453.94, 696.90)0.6836\xa0weeks5756.54 (4062.39)5865.81 (3858.77)−109.27 (−698.64, 480.09)0.72−125.57 (−717.73, 466.59)0.68total Gestational weight gain (kg)9.09 (5.75)9.66 (5.73)−0.58 (−1.33, 0.18)0.13−0.58 (−1.30, 0.13)0.11average weekly Gestational weight gain (kg)0.43 (0.29)0.46 (0.28)−0.02 (−0.06, 0.01)0.23−0.02 (−0.06, 0.01)0.19increased Knowledge of Healthy Food Choices*201/285 (70.53%)203/301 (67.44%)1.05 (0.94, 1.17)0.421.06 (0.95, 1.18)0.30increased knowledge of exercise*224/285 (78.60%)220/301 (73.09%)1.08 (0.98, 1.18)0.121.05 (0.96, 1.16)0.28improved health during Pregnancy*229/285 (80.35%)228/301 (75.75%)1.06 (0.88, 1.27)0.531.05 (0.96, 1.14)0.28\nvalues are mean (sd) and treatment effects are differences in means unless otherwise indicated.']	N/A	N/A	[('GO_0007568', 'aging', 237, 'Eating'), ('GO_0007565', 'female pregnancy', 627, 'Gestational'), ('GO_0007565', 'female pregnancy', 738, 'Gestational'), ('GO_0006959', 'humoral immune response', 844, 'knowledge'), ('GO_0007481', 'haltere disc morphogenesis', 857, 'healthy food choices'), ('CHEBI_33290', 'food', 865, 'food'), ('GO_0007565', 'female pregnancy', 1081, 'pregnancy')]
PMC4292660	7/2014	S198-PMC4292660	['in this way, the educational material, healthy Eating with regional Food, was considered validated.']	N/A	N/A	[('GO_0007568', 'aging', 47, 'Eating'), ('CHEBI_33290', 'food', 68, 'Food')]
PMC4325128	2/2015	S52-PMC4325128	['in our adjusted models, we identified and selected a priori the following set of covariates: socioeconomic status (based on parental profession, including students and unemployed), maternal age, parity, maternal Pre-Pregnancy body mass index (bmi), maternal height, maternal smoking during Pregnancy, civil status and total energy intake.']	N/A	N/A	[('GO_0007568', 'aging', 212, 'pre'), ('GO_0007565', 'female pregnancy', 216, 'pregnancy'), ('GO_0007565', 'female pregnancy', 290, 'pregnancy')]
PMC4327187	1/2015	S135-PMC4327187	['caption (table-wrap): table 3\n\nadjusted and unadjusted gee models comparing treatment (text4baby group) and control (no text4baby enrollment).questionnaire itemstreatment vs controlunadjustedadjustedaor (95% ci) p or (95% ci) Pkab items Eating 5 or more fruits and vegetables per day is important to the health of my developing baby1.781 (0.409, 7.760).442.261 (0.400, 12.787).36taking a Prenatal Vitamin is important to the health of my developing baby2.931 (0.463, 18.551).251.512 (0.162, 14.092).72i am prepared to be a new mother0.923 (0.563, 1.514).750.976 (0.495, 1.924).94if i visit my health care provider on a regular basis, i will be a healthy new mother1.016 (0.666, 1.549).940.759 (0.461, 1.251).28if i visit my health care provider on a regular basis, my baby will be healthy1.188 (0.771, 1.829).430.949 (0.595, 1.513).83smoking will harm the health of my developing baby0.880 (0.583, 1.328).540.753 (0.473, 1.198).23secondhand smoke will not harm the health of my developing baby (reverse coded)1.189 (0.944, 1.497).140.978 (0.715, 1.336).89drinking Alcohol will harm the health of my developing baby1.018 (0.619, 1.675).941.253 (0.717, 2.188).43taking Prenatal Vitamins will improve the health of my developing baby0.943 (0.722, 1.233).670.709 (0.488, 1.030).07 behaviors \xa0since you found out about your Pregnancy, have you consumed Alcoholic beverages?0.699 (0.293, 1.665).432.310 (0.491, 10.874).29in the last 30 days, did you smoke?0.927 (0.533, 1.615).790.938 (0.318, 2.770).91ate 3 or more servings of fruit a day1.160 (0.924, 1.456).201.107 (0.835, 1.468).48ate 3 or more servings of vegetables a day1.065 (0.846, 1.339).591.042 (0.755, 1.438).80have you ever gone online to search for Prenatal care information?0.853 (0.584, 1.246).410.822 (0.476, 1.420).48\naadjusted for age, parity, imputed marital status, and race.']	N/A	N/A	[('PR_000012724', 'phosphatidylinositol 3-kinase regulatory subunit alpha', 226, 'PKAB'), ('GO_0007568', 'aging', 237, 'Eating'), ('GO_0007565', 'female pregnancy', 388, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 397, 'vitamin'), ('CHEBI_30879', 'alcohol', 1064, 'alcohol'), ('GO_0007565', 'female pregnancy', 1167, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 1176, 'vitamins'), ('GO_0007565', 'female pregnancy', 1319, 'pregnancy'), ('CHEBI_33566', 'catechols', 1348, 'alcoholic'), ('GO_0007565', 'female pregnancy', 1707, 'prenatal')]
PMC4327187	1/2015	S139-PMC4327187	['caption (table-wrap): table 4\n\ncomparison of high and low exposure to text4baby Messages: adjusted and unadjusted gee models.questionnaire itemshigh vs low exposureunadjustedadjustedaor (95% ci) p or (95% ci) p Eating 5 or more fruits and vegetables per day is important to the health of my developing baby0.744 (0.138, 4.003).732.511 (0.158, 39.867).51taking a Prenatal Vitamin is important to the health of my developing baby0.760 (0.115, 5.000).774.216 (0.201, 88.417).35i am prepared to be a new mother1.471 (0.788, 2.746).221.609 (0.607, 4.268).34if i visit my health care provider on a regular basis, i will be a healthy new mother1.033 (0.607, 1.759).901.288 (0.585, 2.834).53if i visit my health care provider on a regular basis, my baby will be healthy0.783 (0.468, 1.313).351.328 (0.737, 2.393).34smoking will harm the health of my developing baby1.139 (0.717, 1.810).581.236 (0.651, 2.350).52secondhand smoke will not harm the health of my developing baby (reverse coded*)0.892 (0.668, 1.193).440.947 (0.631, 1.423).79drinking Alcohol will harm the health of my developing baby1.088 (0.655, 1.808).740.803 (0.451, 1.431).45taking Prenatal Vitamins will improve the health of my developing baby1.090 (0.782, 1.520).611.378 (0.861, 2.204).18behaviorssince you found out about your Pregnancy, have you consumed Alcoholic beverages?1.344 (0.473, 3.820).580.212 (0.046, 0.973).046in the last 30 days, did you smoke?0.938 (0.490, 1.794).851.271 (0.406, 3.980).68ate 3 or more servings of fruit a day0.852 (0.647, 1.122).250.908 (0.649, 1.271).57ate 3 or more servings of vegetables a day0.889 (0.679, 1.164).390.969 (0.673, 1.394).86have you ever gone online to search for Prenatal care information?0.992 (0.661, 1.488).970.893 (0.519, 1.536).68\naadjusted for age (quintile), parity, imputed marital status, and race.']	N/A	N/A	[('CHEBI_33695', 'information biomacromolecule', 80, 'messages'), ('GO_0007568', 'aging', 211, 'Eating'), ('GO_0007565', 'female pregnancy', 362, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 371, 'vitamin'), ('CHEBI_30879', 'alcohol', 1038, 'alcohol'), ('GO_0007565', 'female pregnancy', 1141, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 1150, 'vitamins'), ('GO_0007565', 'female pregnancy', 1290, 'pregnancy'), ('CHEBI_33566', 'catechols', 1319, 'alcoholic'), ('GO_0007565', 'female pregnancy', 1678, 'prenatal')]
PMC4349447	3/2015	S85-PMC4349447	['Eating offal —the Eating of Liver, Heart, Kidney or Liver pate with five responses ranging from never or rarely to more than once per day .']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Eating'), ('GO_0051318', 'G1 phase', 18, 'eating'), ('UBERON_0002107', 'liver', 28, 'liver'), ('UBERON_0000948', 'heart', 35, 'heart'), ('UBERON_0002113', 'kidney', 42, 'kidney'), ('UBERON_0002107', 'liver', 52, 'liver')]
PMC4372177	2/2015	S142-PMC4372177	['in other sites such as cg10092878 in the mets Gene Mlx Interacting Protein-Like ( Mlxipl ), the methylation Aging rates did not show any significant difference between the two groups of subjects (figure\xa06b).']	N/A	N/A	[('SO_0000704', 'gene', 46, 'gene'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 51, 'MLX interacting protein-like'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 82, 'MLXIPL'), ('GO_0007568', 'aging', 108, 'aging')]
PMC4372177	2/2015	S143-PMC4372177	['caption (table-wrap): table 3\n\nmets status on Aging rate in known mets Genescpg sitepagebeta (age, all)beta (age, no mets)beta (age, mets)pdiffchrposition (Bp)genegene regioncg06117072 1.62\u2009×\u200910−150.0300.027−0.0100.004650899344tfap2bbody cg04926134 5.73\u2009×\u200910−140.0290.031−0.0060.0052165186498grb14first Exon cg14683125 1.04\u2009×\u200910−160.0280.023−0.0050.0238126510565trib1tss1500 cg22697325 2.64\u2009×\u200910−18−0.031−0.0200.0040.046139391972macf1bodycg234857385.24\u2009×\u200910−09−0.023−0.006−0.0320.068632044171skiv2lbodycg200696884.22\u2009×\u200910−11−0.026−0.0050.0150.134632049028stk19bodycg246411865.72\u2009×\u200910−230.0360.0270.0110.188650912106tfap2bbodycg002072802.59\u2009×\u200910−100.0160.010−0.0010.2318126510575trib1tss1500cg075707231.53\u2009×\u200910−120.0240.0130.0020.338139647825kiaa07545′Utrcg092470603.22\u2009×\u200910−270.0370.0240.0140.409650895762tfap2bbodycg272607721.03\u2009×\u200910−160.0320.0310.0200.422650899161tfap2bbodycg241616522.25\u2009×\u200910−100.0260.0200.0080.433650921818tfap2b3′Utrcg022443864.45\u2009×\u200910−08−0.020−0.007−0.0170.4342165182240grb14bodycg077377812.39\u2009×\u200910−220.0360.0310.0220.437772676802mlxipl1stexoncg196207242.11\u2009×\u200910−240.0380.0270.0180.461650918811tfap2bbodycg100928786.05\u2009×\u200910−250.0380.0310.0390.472772676795mlxiplfirst exoncg243665572.51\u2009×\u200910−320.0400.0340.0280.569650895609tfap2bbodycg222824053.01\u2009×\u200910−240.0360.0320.0270.686650918641tfap2bbodycg071031297.92\u2009×\u200910−280.0400.0310.0260.703650895923tfap2bbodycg213179655.58\u2009×\u200910−120.0260.0190.0140.720650911809tfap2bbodycg230153414.29\u2009×\u200910−240.0350.0230.0210.843650921300tfap2b3′Utrcg138243022.01\u2009×\u200910−070.0210.0100.0090.929772677002mlxipltss200cg088761033.17\u2009×\u200910−19−0.028convergence failure139344910macf1body\npdiffis the significance value between the betas in the mets and non-mets groups.']	N/A	N/A	[('GO_0007568', 'aging', 46, 'aging'), ('SO_0001026', 'genome', 71, 'genesCpG'), ('SO_0000028', 'base_pair', 156, 'bp'), ('SO_0000147', 'exon', 303, 'exon'), ('SO_0001002', 'cytosolic_25S_rRNA', 751, 'UTRcg092470603'), ('SO_0001587', 'stop_gained', 934, '′UTRcg022443864'), ('SO_0001382', 'five_isopentenylaminomethyl_two_prime_O_methyluridine', 1497, 'UTRcg138243022')]
PMC4372177	2/2015	S145-PMC4372177	['caption (fig): figure 6\n\nmets status and Aging rate of candidate Cpg Site Methylation.']	N/A	N/A	[('GO_0007568', 'aging', 41, 'aging'), ('SO_0000409', 'binding_site', 65, 'CpG site'), ('GO_0032258', 'cytoplasm to vacuole transport by the Cvt pathway', 74, 'methylation')]
PMC4385595	3/2015	S74-PMC4385595	['mothers coping with their own physical changes during Pregnancy may trump healthy Eating and physical activity.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 54, 'Pregnancy'), ('GO_0007568', 'aging', 82, 'Eating')]
PMC4390789	1/2015	S53-PMC4390789	['in particular, the Expression of several Genes that code for Genomic Imprinting, transcriptional Regulation and neural plasticity were significantly altered as a result of higher amounts of maternal Fa.']	N/A	N/A	[('GO_0010467', 'gene expression', 19, 'expression'), ('SO_0000704', 'gene', 41, 'genes'), ('GO_0007568', 'aging', 61, 'genomic'), ('SO_0001026', 'genome', 61, 'genomic'), ('GO_0071514', 'genetic imprinting', 69, 'imprinting'), ('GO_0065007', 'biological regulation', 97, 'regulation'), ('CHEBI_30751', 'formic acid', 199, 'FA')]
PMC4404558	4/2015	S72-PMC4404558	['fifty percent were primigravid, most lived rurally, and more than half pursued an income-Generating activity (table\xa01).']	N/A	N/A	[('GO_0007568', 'aging', 88, '-generating')]
PMC4411147	4/2015	S56-PMC4411147	['this resulted in 4 independent groups: Pre-Conception high (pre h, n = 44; 347.2 ±9.4kg bw), pre-Conception low (pre l, n = 44; 355.5 ±10.8kg bw), Post-Conception high (post h, n = 51; 392.6 ±3.8kg bw) and post-Conception low (post l, n = 49; 393.9 ±3.6kg bw).']	N/A	N/A	[('GO_0007568', 'aging', 39, 'pre'), ('GO_0007620', 'copulation', 43, 'conception'), ('GO_0007620', 'copulation', 97, 'conception'), ('GO_0007567', 'parturition', 147, 'post'), ('GO_0007620', 'copulation', 152, 'conception'), ('GO_0007620', 'copulation', 211, 'conception')]
PMC4414468	4/2015	S39-PMC4414468	['ethics clearance was gained from the sa department of health and Ageing Human research ethics committee (436.02.2014).']	N/A	N/A	[('GO_0007568', 'aging', 65, 'Ageing'), ('NCBITaxon_10088', 'Mus <genus>', 72, 'Human')]
PMC4425150	4/2015	S60-PMC4425150	['the following covariates, which were defined by data extraction from either the enrollment form, the two telephone interviews or the ffq were included in the study: maternal age and Pre-Pregnancy body mass index (bmi in kg m−2) (both continuous), occupational status (unemployed, unskilled, student, skilled, medium, high), Cohabitation status (couple, single), maternal smoking (non-smoker, occasional smoker, <15 cigarettes per day, ≥15 cigarettes per day), parity (no children, 1 child, 2 children, 3 + children), maternal physical activity in minutes per week (0, 1–44, 45–74, 75–149, ≥150), child sex (male, female), season of Birth (winter (december/january/february), spring (march/april/may), summer (june/july/august), autumn (september/october/november)), Gestational age (continuous) and Birth weight (continuous).']	N/A	N/A	[('GO_0007568', 'aging', 182, 'pre'), ('GO_0007565', 'female pregnancy', 186, 'pregnancy'), ('GO_0000238', 'zygotene', 324, 'cohabitation'), ('GO_0007567', 'parturition', 632, 'birth'), ('GO_0007565', 'female pregnancy', 766, 'gestational'), ('GO_0007567', 'parturition', 799, 'birth')]
PMC4448820	5/2015	S1302-PMC4448820	['caption (table-wrap): table 11\n\nsummary of commonly used biomarkers of inflammation1biomarker of inflammationnormal rangesettings where usedclinical vs. population useuse in resource-limited settingscommentswbc4–11,000/μlacute inflammation (usually infection)clinicalyvaries by agecrp0.001–10 mg/lacute, subclinical, chronicclinical, populationyagp0.6–1.0 g/lsubclinicalpopulationyesr0–30 mm/hacute, subclinical, chronicclinicalyincreases with age and higher in femalesalbumin30–50 g/lacute inflammation (usually infection)clinicalndecreased during Pregnancypct≤0.5 μg/lacute inflammation (usually infection)clinicalnil-6—chronicpopulationnuse in Agingtnf-Αr1—chronicpopulationnuse in Aging\nagp, Α1-Acid Glycoprotein; crp, C-Reactive Protein; esr, Erythrocyte sedimentation rate; n, no; pct, procalcitonin; Tnf-Αr1, Tnf-Α Receptor 1; wbc, White Blood Cell; y, yes.']	N/A	N/A	[('GO_0007605', 'sensory perception of sound', 549, 'pregnancyPCT'), ('GO_0006914', 'autophagy', 647, 'agingTNF'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 655, '-αR1'), ('GO_0007568', 'aging', 685, 'aging'), ('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 696, 'α1-acid glycoprotein'), ('CHEBI_37527', 'acid', 699, 'acid'), ('CHEBI_17089', 'glycoprotein', 704, 'glycoprotein'), ('PR_000005890', 'crooked neck-like protein 1', 723, 'C-reactive protein'), ('CL_0000232', 'erythrocyte', 748, 'erythrocyte'), ('PR_000000134', 'tumor necrosis factor alpha', 807, 'TNF-αR1'), ('PR_000001959', 'tumor necrosis factor receptor superfamily member 1B', 816, 'TNF-α receptor 1'), ('CL_0000738', 'leukocyte', 839, 'white blood cell'), ('UBERON_0000178', 'blood', 845, 'blood')]
PMC4452737	6/2015	S55-PMC4452737	['Pre-Pregnancy bmi differed between the groups (p = 0.02).']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy')]
PMC4500842	2/2015	S119-PMC4500842	['based on Pre-Pregnancy bmi category, the intervention effect was statistically significant for normal weight women, but not for overweight women or obese women.']	N/A	N/A	[('GO_0007568', 'aging', 9, 'pre'), ('GO_0007565', 'female pregnancy', 13, 'pregnancy')]
PMC4517992	8/2015	S38-PMC4517992	['Pre-Pregnancy bmi (kg/m2) was calculated with maternal weight and height values obtained from the Premarital examination, and we defined women as underweight (bmi <18.5), normal weight (bmi 18.5–24.9), and overweight/obese (bmi ≥25.0) according to the current world health organization bmi cut-off points.35,36childhood overweight was defined according to international criteria on age- and sex-specific cutoff values for bmi.37specifically, cutoffs of 17.89, 17.69, 17.55, 17.47, 17.42, 17.45, and 17.55 were adopted for boys at ages 3 (33–38 months), 3.5 (39–44 months), 4 (45–50 months), 4.5 (51–56 months), 5 (57–62 months), 5.5 (63–68 months), and 6 (69–74 months) years, respectively.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy'), ('GO_0007565', 'female pregnancy', 98, 'premarital')]
PMC4538752	8/2015	S82-PMC4538752	['caption (table-wrap): table 2\n\noutcomes of the interventiongoal\xa0indicatorhealthy weight gain during Pregnancyabased on Pre-Conceptional nutritional status:normal (bmi 18.5-24.9\xa0kg/m2) =11.5-16.0\xa0kgoverweight (bmi 25.0-29.9\xa0kg/m2)\u2009=\u20097.0-11.5\xa0kgobese (bmi ≥30\xa0kg/m2)\u2009=\u20095.0-9.0\xa0kgadequate Glycaemic Control During Pregnancybfasting Plasma Glucose (fpg) levels <92\xa0mg/dl or\xa02-h values in the 75-g Oral Glucose tolerance test (ogtt) of <153\xa0mg/dl at 24-28 weeks of Pregnancyhealthy infant growthcfrom 0-1 yweight-for-age, height-for-age and bmi-for-age z-scores based on who standards (between -2 and +2sd)\nainstitute of medicine (us) and national research council, weight gain during Pregnancy: reexamining the guidelines, 2009\nbdiabetes care, vol.']	N/A	N/A	[('GO_0006412', 'translation', 100, 'PregnancyaBased'), ('GO_0007568', 'aging', 119, 'pre'), ('GO_0007620', 'copulation', 123, 'conceptional'), ('GO_0006009', 'glucose 1-phosphate phosphorylation', 286, 'Glycaemic control during'), ('GO_0016540', 'protein autoprocessing', 311, 'PregnancybFasting'), ('UBERON_0001969', 'blood plasma', 329, 'plasma'), ('CHEBI_17234', 'glucose', 336, 'glucose'), ('UBERON_0000165', 'mouth', 393, 'oral'), ('CHEBI_17234', 'glucose', 398, 'glucose'), ('GO_0040007', 'growth', 398, 'glucose'), ('GO_0006412', 'translation', 460, 'pregnancyHealthy'), ('GO_0007565', 'female pregnancy', 680, 'Pregnancy')]
PMC4549107	8/2015	S140-PMC4549107	['Eating the right kinds of Food – fruit and vegetables, fish, Chicken, and meat such as Liver were listed – was frequently mentioned as desirable, often without prompting.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Eating'), ('CHEBI_33290', 'food', 26, 'food'), ('NCBITaxon_33208', 'Metazoa', 61, 'chicken'), ('UBERON_0002107', 'liver', 87, 'liver')]
PMC4569192	9/2015	S69-PMC4569192	['Early Pregnancy leptin was available in 98.1% (n = 571, 297 male and 274 female).']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Early'), ('GO_0007565', 'female pregnancy', 6, 'pregnancy')]
PMC4571073	9/2015	S72-PMC4571073	['Pre-Pregnancy body mass index (bmi), a measure of overall maternal adiposity, was calculated as weight in kilograms divided by height in meters squared.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy')]
PMC4592566	10/2015	S36-PMC4592566	['a pragmatic, a priori decision was made to recruit approximately half high investors in pre-Pregnancy care and half low investors (operationalised as those who reported carrying out six or more Pre-Pregnancy activities in the survey versus those who carried out one activity or no activity).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 92, 'pregnancy'), ('GO_0007568', 'aging', 194, 'pre'), ('GO_0007565', 'female pregnancy', 198, 'pregnancy')]
PMC4592566	10/2015	S49-PMC4592566	['the next topic sought information on who women discussed Pre-Pregnancy health and care with.']	N/A	N/A	[('GO_0007568', 'aging', 57, 'pre'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy')]
PMC4592566	10/2015	S73-PMC4592566	['caption (table-wrap): table 1\n\ninterviewees’ characteristics by group according to the a priori sampling criteriasurveyqualitative groupingssampling criterialow investors (11)high investors (9)absent pre-Pregnancy period (6)poor knowledge (5)prepared (9)young age\u2009<\u2009=2310010older age =\u2009>\u20093723113not ‘white british’45315not living with husband/partner22211pre-existing health condition44314\n\nexperience of pre-Pregnancy health and care in this Pregnancy\nwe classified interviewees into three broad groups regarding their experience of Pre-Pregnancy health and care in this Pregnancy: the “prepared” group, the “poor knowledge” group, and the “absent Pre-Pregnancy period” group.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 204, 'pregnancy'), ('GO_0007565', 'female pregnancy', 409, 'pregnancy'), ('GO_0007565', 'female pregnancy', 443, 'pregnancy'), ('GO_0007568', 'aging', 534, 'pre'), ('GO_0007565', 'female pregnancy', 538, 'pregnancy'), ('GO_0007565', 'female pregnancy', 572, 'pregnancy'), ('GO_0007568', 'aging', 649, 'pre'), ('GO_0007565', 'female pregnancy', 653, 'pregnancy')]
PMC4630792	11/2015	S38-PMC4630792	['oxidative stress, Ageing and anti-oxidant Defense mechanisms\nlevels of 4-Hne (4-Hydroxy-Nonenal; a marker of Lipid peroxidation, reflecting oxidative stress levels) were significantly increased in the Ovarian Tissue of the recuperated Animals compared to the control group at 6 months of age (p\u2009<\u20090.001) (fig.']	N/A	N/A	[('GO_0007568', 'aging', 18, 'ageing'), ('GO_0006952', 'defense response', 42, 'defense'), ('CHEBI_72639', '13-HODE', 71, '4-HNE'), ('CHEBI_58968', '(E)-4-hydroxynon-2-enal', 78, '4-hydroxy-nonenal'), ('CHEBI_18059', 'lipid', 109, 'lipid'), ('UBERON_0000992', 'ovary', 201, 'ovarian'), ('UBERON_0000479', 'tissue', 209, 'tissue'), ('NCBITaxon_33208', 'Metazoa', 235, 'animals')]
PMC4632423	10/2015	S57-PMC4632423	['Eating patterns were assessed using principal component analysis.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Eating')]
PMC4636015	9/2015	S30-PMC4636015	['Pre-Pregnancy dams were classified as lean or obese based on percent body fat obtained by dual energy x-ray absorptiometry.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy')]
PMC4641416	11/2015	S101-PMC4641416	['p -valuer2f p -valuebirthweight (kg)\u2003fetal leptin7.6113.0360.0170.4225.688<0.001\u2003father’s weight13.3815.6070.022abdominal circumference (cm)\u2003fetal leptin0.0380.010<0.0010.1123.1370.005\u2003leptin 1sttrimester0.0570.0250.022thigh circumference (cm)\u2003fetal leptin0.0170.0090.0460.0732.0720.066chest circumference (cm)\u2003fetal leptin0.0310.0110.0060.0592.5560.024mid-upper Arm circumference (cm) (cm)\u2003fetal leptin0.0180.005<0.0010.1053.888< 0.001waist-height ratio\u2003fetal leptin0.0010.0000.0150.1351.830.132subscapular Skinfold thickness (mm)\u2003fetal leptin0.0290.007<0.0010.3125.142<0.001\u2003Early Pregnancy leptin−0.0540.0170.002triceps Skinfold thickness (mm)\u2003fetal leptin0.0250.0100.0190.1772.7550.017\u2003Late Pregnancy leptin−0.0370.0160.024biceps skinfold thickness (mm)\u2003fetal leptin0.0270.006<0.0010.1373.6370.003thigh Skinfold thickness (mm)\u2003fetal leptin0.0350.007<0.0010.1735.414<0.001sum of all Skinfolds (mm)\u2003fetal leptin0.1300.022<0.0010.2966.250<0.001ss\u2009+\u2009tr Skinfold thickness (mm)\u2003fetal leptin0.0550.014<0.0010.2534.195<0.001\u2003Late Pregnancy leptin−0.0540.0220.018\nss\u2009=\u2009Subscapular, Tr\u2009=\u2009Triceps, ss/tr\u2009=\u2009central adiposity ss\u2009+\u2009tr\u2009=\u2009general adiposity, sf\u2009=\u2009Skinfolds.']	N/A	N/A	[('UBERON_0001460', 'arm', 363, 'arm'), ('UBERON_0009007', 'superficial inguinal lymph node', 508, 'skinfold'), ('GO_0007568', 'aging', 577, 'Early'), ('GO_0007565', 'female pregnancy', 583, 'Pregnancy'), ('UBERON_0009007', 'superficial inguinal lymph node', 623, 'skinfold'), ('GO_0051318', 'G1 phase', 690, 'Late'), ('GO_0007565', 'female pregnancy', 695, 'Pregnancy'), ('UBERON_0009007', 'superficial inguinal lymph node', 807, 'skinfold'), ('UBERON_0009007', 'superficial inguinal lymph node', 886, 'skinfolds'), ('UBERON_0009007', 'superficial inguinal lymph node', 953, 'skinfold'), ('GO_0051318', 'G1 phase', 1022, 'Late'), ('GO_0007565', 'female pregnancy', 1027, 'Pregnancy'), ('UBERON_0004029', 'canal of Schlemm', 1065, 'Subscapular'), ('UBERON_0002370', 'thymus', 1078, 'TR'), ('UBERON_0001509', 'triceps brachii', 1083, 'Triceps'), ('UBERON_0009007', 'superficial inguinal lymph node', 1152, 'skinfolds')]
PMC4682815	12/2015	S45-PMC4682815	['at the initial pre-Pregnancy interview a dichotomous variable was derived indicating whether mothers had stated they had taken strenuous exercise (for example cycling or Jogging) over the previous three months.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 19, 'pregnancy'), ('GO_0007568', 'aging', 170, 'jogging')]
PMC4690051	12/2015	S37-PMC4690051	[', private vs. medicaid/medicare), marital status (married/single), parity (primiparous/multiparous), Pre-Pregnancy body mass index (bmi), cigarette smoking during Pregnancy (yes/no), alcohol use during Pregnancy (yes/no), and year of initial enrollment (2006–2011).']	N/A	N/A	[('GO_0007568', 'aging', 101, 'pre'), ('GO_0007565', 'female pregnancy', 105, 'pregnancy'), ('GO_0007565', 'female pregnancy', 163, 'pregnancy'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy')]
PMC4690051	12/2015	S38-PMC4690051	['Pre-Pregnancy bmi (kg/m2) was calculated from self-reported height and weight prior to Pregnancy, data which were collected at enrollment.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy')]
PMC4715834	2/2015	S24-PMC4715834	['Pre-Pregnancy body mass index (bmi)\nself-reported Pre-Pregnancy weight and measured height collected at baseline were used to calculate Pre-Pregnancy bmi [9].']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'Pregnancy'), ('GO_0007568', 'aging', 50, 'pre'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy'), ('GO_0007568', 'aging', 136, 'pre'), ('GO_0007565', 'female pregnancy', 140, 'pregnancy')]
PMC4719746	1/2016	S43-PMC4719746	['Pre-Pregnancy body mass index (bmi; calculated from self-reported weight before Pregnancy and height measured at inclusion) was categorized as <25\xa0kg/m2and ≥25\xa0kg/m2.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy')]
PMC4730270	12/2015	S50-PMC4730270	['c, e, Selenium and Folic Acidduring Pregnancy↓ bp prevented Lbw ↑ vascular functionuntil 14–16 weeks of age[30]Genetic hypertension/Agingshr and Aging wky ratshypertension proteinurial-arginine plus antioxidants (vit.']	N/A	N/A	[('CHEBI_27568', 'selenium atom', 6, 'selenium'), ('CHEBI_77866', "1,1'-hexadecane-1,16-diylbis(1-methylpyrrolidinium)", 19, 'folic acidDuring'), ('GO_0007565', 'female pregnancy', 36, 'pregnancy'), ('GO_0007567', 'parturition', 45, '↓'), ('UBERON_0005414', 'zone of polarizing activity', 60, 'LBW'), ('SO_0000704', 'gene', 111, 'Genetic'), ('GO_0006754', 'ATP biosynthetic process', 132, 'AgingSHR'), ('GO_0007568', 'aging', 145, 'aging')]
PMC4736099	1/2016	S4-PMC4736099	['four cohorts typically arise from the periconceptional trial design — two of which are non-Pregnant and two are Pregnant — and this structure provides assessment options related to Pre-Pregnant, maternal, Pregnancy and fetal outcomes.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 91, 'pregnant'), ('GO_0007565', 'female pregnancy', 112, 'pregnant'), ('GO_0007568', 'aging', 181, 'pre'), ('GO_0007565', 'female pregnancy', 185, 'pregnant'), ('GO_0007565', 'female pregnancy', 205, 'pregnancy')]
PMC4736099	1/2016	S32-PMC4736099	['information from recent meta-analyses and systematic reviews addressing the Periconceptional period, pre-Conception, or Pre-Pregnancy Nutrient supplement interventions was reviewed.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 76, 'periconceptional'), ('UBERON_0001844', 'cochlea', 76, 'periconceptional'), ('GO_0007620', 'copulation', 105, 'conception'), ('GO_0007568', 'aging', 120, 'pre'), ('GO_0007565', 'female pregnancy', 124, 'pregnancy'), ('CHEBI_33284', 'nutrient', 134, 'nutrient')]
PMC4739499	2/2016	S124-PMC4739499	['Pre-Pregnancy bmi was examined in four studies (eoi n = 1; ip n = 3).']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy')]
PMC4806285	3/2016	S196-PMC4806285	['Immune-Regulatory Processes are compromised in Aging (Immunosenescence) and also during chronic stress [161] where there is an increased susceptibility to infections as well as Proinflammatory Cytokine Production [162].']	N/A	N/A	[('GO_0002435', 'immune complex clearance by erythrocytes', 0, 'Immune-regulatory processes'), ('GO_0007568', 'aging', 47, 'aging'), ('GO_0006955', 'immune response', 54, 'immunosenescence'), ('GO_0007565', 'female pregnancy', 177, 'proinflammatory'), ('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 193, 'cytokine production')]
PMC4843009	4/2016	S2-PMC4843009	['Nh4Cl treatment prevents Tissue calcification and premature Ageing without affecting 1,25(Oh)2D3-formation.']	N/A	N/A	[('CHEBI_63016', 'nonyl phenoxypolyethoxylethanol', 0, 'NH4Cl'), ('UBERON_0000479', 'tissue', 25, 'tissue'), ('GO_0007568', 'aging', 60, 'ageing'), ('CHEBI_78998', '(15R)-15-hydroxypalmitic acid', 85, '1,25(OH)2D3-')]
PMC4843009	4/2016	S51-PMC4843009	['Plasma Pai-1 levels were assessed as an indicator of Aging in all groups.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('PR_000012319', 'paired box protein Pax-7', 7, 'Pai-1'), ('GO_0007568', 'aging', 53, 'aging')]
PMC4843009	4/2016	S141-PMC4843009	['the Mice do not Express the expected Transgene but cross-breeding of the heterozygous Mice resulted in Animals homozygous for the insertional mutation and a severe Aging-like phenotype.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 4, 'mice'), ('GO_0010467', 'gene expression', 16, 'express'), ('SO_0000902', 'transgene', 37, 'transgene'), ('NCBITaxon_10088', 'Mus <genus>', 86, 'mice'), ('NCBITaxon_33208', 'Metazoa', 103, 'animals'), ('GO_0007568', 'aging', 164, 'aging')]
PMC4846845	4/2016	S277-PMC4846845	['in this context, accelerated Aging refers to an increase in cellular age over chronological age.']	N/A	N/A	[('GO_0007568', 'aging', 29, 'aging')]
PMC4846845	4/2016	S284-PMC4846845	['accelerated Aging\n\n8.1.']	N/A	N/A	[('GO_0007568', 'aging', 12, 'Aging')]
PMC4846845	4/2016	S287-PMC4846845	['the length of telomeres, a hallmark of Aging, is Regulated by the enzyme telomerase, which adds additional nucleotides to the chromosome ends to help correct for telomere shortening that occurs with each Cell Division [215,216].']	N/A	N/A	[('GO_0007568', 'aging', 39, 'aging'), ('GO_0065007', 'biological regulation', 49, 'regulated'), ('GO_0051301', 'cell division', 204, 'cell division')]
PMC4874157	5/2016	S55-PMC4874157	['three Pregnancies (4.7%) occurred in women who had Pregdm and another three Pregnancies (4.7%) occurred in women who had chronic hypertension.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 6, 'pregnancies'), ('GO_0007568', 'aging', 51, 'preGDM'), ('GO_0007565', 'female pregnancy', 76, 'pregnancies')]
PMC4882712	5/2016	S57-PMC4882712	['the maternal health characteristics included were a Pre-Pregnancy self-rating of health (poor/fair through to excellent; seetable 1), the degree of nausea/sickness after the first Trimester and an assessment of Antenatal depression risk.']	N/A	N/A	[('GO_0007568', 'aging', 52, 'pre'), ('GO_0007565', 'female pregnancy', 56, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 180, 'trimester'), ('GO_0007567', 'parturition', 211, 'antenatal')]
PMC4896250	4/2016	S7095-PMC4896250	['methods: the present analyses were performed using the baseline data set of the korean longitudinal study of health and Aging, consisting of 1,000 elderly subjects (aged over 65) randomly recruited from an urban community.']	N/A	N/A	[('GO_0007568', 'aging', 120, 'Aging')]
PMC4896250	4/2016	S7686-PMC4896250	['prevalence of chronic cough increased with Aging in both gender (in males, 2.4% in subjects aged 18-45 years, 3.4% in subjects aged 45-65 years, and 5.4% in subjects aged ≥65 years; in females, 1.2%, 1.9% and 3.9%, respectively; both p for trends <0.01).']	N/A	N/A	[('GO_0007568', 'aging', 43, 'aging')]
PMC4896250	4/2016	S9409-PMC4896250	['methods: healthy Ageing research center (harc) which is a multidisciplinary research platform established at the medical university of lodz, involves research groups with various basic biological (immunologists, biochemists, molecular biologists) and clinical (geriatricians, psychiatrists, cardiologists and pulmonologists) interests and devoted to conduct research addressing key issues related to pathogenesis of increased morbidity in the elderly population.']	N/A	N/A	[('GO_0007568', 'aging', 17, 'Ageing')]
PMC4919537	4/2016	S61-PMC4919537	['the healthy Eating index (2010) (guenther et al., 2013) was calculated for each participant.']	N/A	N/A	[('GO_0007568', 'aging', 12, 'Eating')]
PMC4939634	7/2016	S64-PMC4939634	['the healthy Eating index (hei) was used to analyze 24\xa0h recall.']	N/A	N/A	[('GO_0007568', 'aging', 12, 'Eating')]
PMC4939634	7/2016	S140-PMC4939634	['caption (table-wrap): table 3\n\nrisk estimate and chi square analysis of maternal dietary intake, neonatal outcomes with Antenatal depressiondepressiondepressionr.raa.rb%95\xa0% c. ip-valuecyes (%) n\u2009=\u200935no (%) n\u2009=\u200947maternal dietary Intakebaseline healthy Eating indexpoor51451.151120.707–1.9280.351moderate4955carbohydrate<175 gm57531.07470.720–1.5910.823≥175 gm4347protein<71 gm71701.01710.769–1.3461.000≥71 gm2930fat<55 gm51301.727431.002–2.9760.067≥55 gm4970end of cohort healthy Eating indexpoor71282.582621.603–5.2280.000moderate2972carbohydrate<175 gm66551.188150.836–1.6880.236≥175 gm3445protein<71 gm89661.343261.059–1.7030.021≥71 gm1134fat<55 gm63212.954671.612–5.4160.000≥55 gm3779neonatal outcomesfetal growth retardationyes622.686600.688–3.7020.390no9498preterm birthyes17111.611540.727–2.4520.297no8389low Birth weightyes14250.56−440.292–1.3930.167no8675poor apgar scoreyes622.686600.688–3.7020.390no9498\narelative risk\nbattributable risk\ncchi square\nat the end of cohort neonatal outcomes were evaluated.']	N/A	N/A	[('GO_0007567', 'parturition', 120, 'antenatal'), ('GO_0042432', 'indole biosynthetic process', 230, 'intakeBaseline'), ('GO_0007568', 'aging', 253, 'Eating'), ('GO_0007568', 'aging', 481, 'Eating'), ('GO_0007567', 'parturition', 817, 'Birth')]
PMC4939634	7/2016	S212-PMC4939634	['abbreviations\nakuads, the aga khan university anxiety and depression scale; apgar, appearance, pulse, grimace, activity, Respiration; ar, attributable risk; bmi, body mass index; ci, confidence interval; epds, edinburgh Postnatal depression scale; fgr, Fetal growth retardation; hei, healthy Eating index; icd-10, international classification of diseases; lbw, low Birth weight; rr, relative risk\n\npubmed central:']	N/A	N/A	[('GO_0045333', 'cellular respiration', 121, 'respiration'), ('GO_0007567', 'parturition', 220, 'Postnatal'), ('GO_0008618', '7-methylguanosine metabolic process', 253, 'Fetal'), ('GO_0007568', 'aging', 292, 'Eating'), ('GO_0007567', 'parturition', 365, 'birth')]
PMC4956066	7/2016	S49-PMC4956066	['Pre-Pregnancy bmi was calculated as Pre-Pregnancy weight (kilograms) divided by height (meters) squared.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy'), ('GO_0007568', 'aging', 36, 'pre'), ('GO_0007565', 'female pregnancy', 40, 'pregnancy')]
PMC4976416	7/2016	S75-PMC4976416	['[56] Vitamin E is one of the ingredients in over-the-counter treatments of Skin Aging.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 5, 'Vitamin E'), ('GO_0036331', 'avascular cornea development in camera-type eye', 75, 'skin'), ('GO_0007568', 'aging', 80, 'aging')]
PMC4979959	8/2016	S174-PMC4979959	['supporting information\n\ncaption (supplementary-material): s1 fig\nhealthy Eating index for asian Pregnant women (hei-ap) components breakdown.']	N/A	N/A	[('GO_0007568', 'aging', 73, 'Eating'), ('GO_0007565', 'female pregnancy', 96, 'Pregnant')]
PMC4988629	8/2016	S94-PMC4988629	['szanton, s. l., thorpe, r. j., boyd, c., tanner, e. k., leff, b., agree, e., … & gitlin, l. n.,community Aging in place , advancing better living for elders : a bio‐behavioral‐environmental intervention to improve function and health‐related Quality Of Life in disabled older adults .2011significantusa intervention : a multi-component behavior and home repair intervention; including occupational therapy, nursing, Handyman repairs (capable) study design: prospective randomized controlled trial, 6 months follow-up.']	N/A	N/A	[('GO_0007568', 'aging', 105, 'Aging'), ('GO_0048208', 'COPII vesicle coating', 242, 'Quality of Life'), ('UBERON_0005273', 'nail bed', 416, 'handyman')]
PMC4997421	8/2016	S110-PMC4997421	['lower income Individuals consumed lower quality Foods when compared to those with higher incomes, including fruits and vegetables, as measured by the alternate healthy Eating index [33].']	N/A	N/A	[('NCBITaxon_1', 'root', 13, 'individuals'), ('CHEBI_33290', 'food', 48, 'foods'), ('GO_0007568', 'aging', 168, 'Eating')]
PMC5016860	9/2016	S138-PMC5016860	['the reference level for dependent variable was “normal weight”, which excluded the underweight children\naadjusted for age, gender, only child or not, paternal and maternal educational level, paternal and maternal occupation and monthly household income\n*p \u2009<\u20090.05;**p \u2009<\u20090.01\n\ncaption (table-wrap): table 4\n\nassociations of behavioral factors with overweight/obesitybehavioral factorsoverweightobesecrude modeladjusted modelacrude modeladjusted modeladietary intake\u2003fruits (serving/d)0.98 (0.86, 1.11)0.99 (0.87, 1.13)0.94 (0.82, 1.08)0.96 (0.83, 1.11)\u2003vegetables (serving/d)1.05 (0.95, 1.15)1.05 (0.95, 1.16)1.08 (0.98, 1.19) 1.12 (1.01, 1.24)*\u2003meat products (serving/d)1.01 (0.91, 1.12)0.97 (0.87, 1.08)1.00 (0.90, 1.12)0.96 (0.85, 1.08)\u2003ssbs (cup/d) 1.32 (1.00, 1.74)*1.37 (1.03, 1.83)*1.42 (1.09, 1.86)*1.39 (1.05, 1.85)*\u2003Breakfast (d/week)0.97 (0.83, 1.13)0.93 (0.79, 1.09)0.98 (0.83, 1.16)1.01 (0.83, 1.23)\u2003high-energy snacks (d/week)0.94 (0.85, 1.03)0.91 (0.83, 1.01)0.95 (0.87, 1.05)0.97 (0.87, 1.07)\u2003fried Food (time/week)1.11 (0.97, 1.26)1.10 (0.96, 1.26)1.05 (0.91, 1.20)1.07 (0.93, 1.24)\u2003western fast Food (time/week)1.00 (0.95, 1.06)1.01 (0.95, 1.06)0.99 (0.94, 1.05)0.97 (0.91, 1.04)Eating speed (reference: as fast as peers)\u2003slower than peers 0.60 (0.40, 0.89)*0.55 (0.36, 0.84)**0.58 (0.']	N/A	N/A	[('GO_0001754', 'eye photoreceptor cell differentiation', 826, 'Breakfast'), ('CHEBI_33290', 'food', 1015, 'food'), ('CHEBI_33290', 'food', 1113, 'food'), ('GO_0007568', 'aging', 1197, 'Eating')]
PMC5024431	9/2016	S95-PMC5024431	['caption (table-wrap): table 2\n\ntypes of ready-made goals set and tracked by my goals feature users organized using the different ready-made goal categoriestotal number of goals set from the specified goal category ( % of all ready-made goals set)atotal number of users who had set a goal from the specified goal category ( % all users who set ready-made goals)btotal number of goals tracked from the specified goal category ( % of all goals tracked from the specified goal category)cgoal category\u2003managing your weight4,116 (33.1 %)3,697 (56.4 %)277 (6.8 %)\u2003getting active1,634 (13.1 %)1,527 (23.3 %)131 (8.1 %)\u2003choosing more vegetables and fruit1,622 (13.0 %)1,555 (23.7 %)104 (6.5 %)\u2003Eating less fat, Sugar, and sodium1,380 (11.1 %)1,306 (19.9 %)86 (6.3 %)\u2003Planning and preparing Food1,291 (10.4 %)1,235 (18.8 %)72 (5.7 %)\u2003Eating a healthy breakfast643 (5.2 %)629 (9.6 %)60 (9.4 %)\u2003getting more fibre411 (3.3 %)390 (5.9 %)28 (6.9 %)\u2003Eating a healthy dinner295 (2.4 %)287 (4.4 %)17 (5.8 %)\u2003Eating a healthy lunch284 (2.3 %)280 (4.3 %)23 (8.2 %)\u2003choosing healthier Beverages254 (2.0 %)247 (3.8 %)22 (8.9 %)\u2003choosing healthier grain products223 (1.8 %)220 (3.4 %)14 (6.4 %)\u2003choosing healthier meat and alternatives215 (1.7 %)199 (3.0 %)13 (6.2 %)\u2003choosing healthier Milk and alternatives81 (0.7 %)77 (1.2 %)8 (10.3 %)\nan\u2009= \u200912,449 ready-made goals were set in total; n\u2009= \u200912,449 was the denominator used to calculate all percentages in this column\nbn\u2009= \u20096,560 users in total had set ready-made goals; n\u2009= \u20096,560 was the denominator used to calculate all percentages in this column\ncbecause the my goals tracker was only available to track goals at the start of the next week for ready-made goals, only goals that were active for ≥7 days were included as part of the denominator for the percentage of all goals tracked from the specified goal category\nfew ready-made goals were tracked with the my goals tracker.']	N/A	N/A	[('GO_0007568', 'aging', 685, 'Eating'), ('CHEBI_24870', 'ion', 702, 'sugar'), ('GO_0006260', 'DNA replication', 758, 'Planning'), ('CHEBI_33290', 'food', 781, 'food1'), ('GO_0007568', 'aging', 824, 'Eating'), ('GO_0007568', 'aging', 934, 'Eating'), ('GO_0007568', 'aging', 990, 'Eating'), ('CHEBI_52736', 'FluorX', 1064, 'beverages254'), ('UBERON_0001913', 'milk', 1264, 'milk')]
PMC5024431	9/2016	S104-PMC5024431	[')do 15 min of activity 1 time this week in the weight room (weights, resistance training), go to one yoga class per week,i would like to start weight training 2-3 times a week\u2003unknown exerciseworkout 30 min a day, exercise 150min per weekexercise more, be more active, exercise daily Nutrition behaviour change goals \u2003Eating well with canada’s Food guide Food group goals\u2003\u2003↑/specific serving number amountsconsume four servings of vegetables dailyeat more fruit and vegetables\u2003\u2003limit Food group foodsno dairyeat less bread\u2003\u2003improving quality of Food group foodstwo servings fish each weekto eat more beans and legumes instead of meat this month\u2003limiting unhealthy foods/beverages and/or fat, Cholesterol, Sodium, and/or Sugar in generalno Sugar, avoid junk Food, limit Sodium to <1500 mg/d, give up diet pepsieat less Sodium and fat and Sugar, cut down on Eating Sweets\u2003Alcohol (limit or specific amount)cut Alcohol use to a glass of wine/day, cut out beerreduce Alcohol Intake\u2003Water (increase or specific amount)drink 8 cups of Water per daydrink more Water\u2003limit coffee and/or Caffeinelimit my Coffee Intake to 2 cups/daydrink less Coffee\u2003eat more/specific amounts of certain Nutrients (e.g., protein, fibre, calcium, vitamins d, c, e, iron, potassium, unsaturated fats)consume sufficient iron daily, drink or eat 1000 mg calcium each dayincrease my fibre Intake, increase protein intake at lunch time\u2003eat less/limit certain Nutrients (e.g., Carbohydrates) (except fat, Sodium, Sugar)eat only 1/2 cup of Starch at suppereat less carbs\u2003Caloric/Food Intake amountsconsume <1500kcals, no over-Eating and no Eating my kids left overs!Eat more calories, eat less, limit extra desserts/snacks\u2003portion controlweigh and measure my portions, to eat portion controlled Foodseat smaller portions\u2003self-monitor diet and/or ↑ awarenesskeep a Food diary dailybe aware of what i am Eating.']	N/A	N/A	[('GO_0006754', 'ATP biosynthetic process', 284, 'Nutrition'), ('GO_0007568', 'aging', 318, 'Eating'), ('CHEBI_33290', 'food', 344, 'Food'), ('CHEBI_33290', 'food', 355, 'Food'), ('CHEBI_33290', 'food', 484, 'food'), ('CHEBI_33290', 'food', 545, 'food'), ('CHEBI_16113', 'cholesterol', 692, 'cholesterol'), ('CHEBI_52632', 'potassium-39 atom', 705, 'sodium'), ('CHEBI_24870', 'ion', 720, 'sugar'), ('CHEBI_24870', 'ion', 739, 'sugar'), ('CHEBI_33290', 'food', 757, 'food'), ('CHEBI_52632', 'potassium-39 atom', 769, 'sodium'), ('CHEBI_52632', 'potassium-39 atom', 818, 'sodium'), ('CHEBI_24870', 'ion', 837, 'sugar'), ('GO_0051318', 'G1 phase', 856, 'eating'), ('CHEBI_46659', 'ipratropium bromide', 863, 'sweets'), ('CHEBI_30879', 'alcohol', 870, 'Alcohol'), ('CHEBI_30879', 'alcohol', 908, 'alcohol'), ('CHEBI_30879', 'alcohol', 963, 'alcohol'), ('GO_0007631', 'feeding behavior', 971, 'intake'), ('CHEBI_15377', 'water', 978, 'Water'), ('CHEBI_15377', 'water', 1029, 'water'), ('CHEBI_15377', 'water', 1053, 'water'), ('CHEBI_85388', 'tiagabine hydrochloride', 1079, 'caffeineLimit'), ('CHEBI_23389', 'cobalt-corrinoid heptacarboxylic acid', 1096, 'coffee'), ('GO_0007631', 'feeding behavior', 1103, 'intake'), ('CHEBI_23389', 'cobalt-corrinoid heptacarboxylic acid', 1134, 'coffee'), ('CHEBI_33284', 'nutrient', 1178, 'nutrients'), ('GO_0007631', 'feeding behavior', 1358, 'intake'), ('CHEBI_33284', 'nutrient', 1427, 'nutrients'), ('CHEBI_16646', 'carbohydrate', 1444, 'carbohydrates'), ('CHEBI_52632', 'potassium-39 atom', 1472, 'sodium'), ('CHEBI_24870', 'ion', 1480, 'sugar'), ('CHEBI_28017', 'starch', 1506, 'starch'), ('CHEBI_81905', '3A-Deolivosylpremithramycin B', 1537, 'Caloric'), ('CHEBI_33290', 'food', 1545, 'food'), ('GO_0007631', 'feeding behavior', 1545, 'food intake'), ('GO_0051318', 'G1 phase', 1592, 'eating'), ('GO_0051318', 'G1 phase', 1606, 'eating'), ('GO_0018888', '3-chloroacrylic acid metabolic process', 1632, 'Eat'), ('CHEBI_34763', 'flucythrinate', 1761, 'foodsEat'), ('CHEBI_33290', 'food', 1830, 'food'), ('GO_0051318', 'G1 phase', 1868, 'eating')]
PMC5024431	9/2016	S133-PMC5024431	['n\u2009= \u200924 n\u2009= \u200952\u2003unknown exercise n\u2009= \u200989 n\u2009= \u2009347\u2003other (e.g., fitness classes, exergaming, activity tracking) n\u2009= \u200927 n\u2009= \u20094 nutrition behaviour change goals (n\u2009=\u20091,568 statements included these goals) \u2003canada’s Food guide Food group goals\u2003\u2003vegetables and fruit↑/specific serving number amounts n\u2009= \u200942 n\u2009= \u200980limit certain vegetables and fruit n\u2009= \u20093-improving vegetable and fruit quality n\u2009= \u20092 n\u2009= \u20094\u2003\u2003grain products↑/specific serving number amounts n\u2009= \u20091 n\u2009= \u20092limit grain products (e.g., bread) or specific grain products n\u2009= \u20097 n\u2009= \u20099↑ whole grains/try new grains n\u2009= \u20095 n\u2009= \u20092\u2003\u2003milk and alternatives↑/specific serving number amount n\u2009= \u20092 n\u2009= \u20091limit milk and alternatives n\u2009= \u20098 n\u2009= \u20093choose healthier Milk and alternatives (e.g., low fat products) n\u2009= \u20093-\u2003\u2003meat and alternatives↑/specific serving number amount n\u2009= \u20091 n\u2009= \u20091limit meat and alternatives (including limit red meat) n\u2009= \u20096 n\u2009= \u20094choose fish, lean meats, or meat alternatives n\u2009= \u200912 n\u2009= \u200915\u2003limiting unhealthy Foods/beverages and/or fat, Cholesterol, Sodium, and/or Sugar in general n\u2009= \u2009140 n\u2009= \u200991\u2003Alcohol n\u2009= \u200922 n\u2009= \u200912\u2003Water n\u2009= \u200962 n\u2009= \u200953\u2003limit Coffee and/or Caffeine n\u2009= \u200910 n\u2009= \u20092\u2003eat more/specific amounts of certain Nutrients n\u2009= \u200932 n\u2009= \u200957\u2003eat less/limit certain Nutrients (except fat, Sodium, and Sugar) n\u2009= \u200912 n\u2009= \u200931\u2003Caloric/Food Intake amounts n\u2009= \u200969 n\u2009= \u200928\u2003portion control n\u2009= \u200910 n\u2009= \u200942\u2003self-monitor diet and/or ↑ awareness n\u2009= \u200974 n\u2009= \u200919\u2003Eating out less/Eat at home more n\u2009= \u20098 n\u2009= \u20097\u2003evening/night time Eating n\u2009= \u200960 n\u2009= \u200910\u2003follow\xa0canada’s Food guide n\u2009= \u200936\u2003follow \ufeffvegetarian/vegan diets n\u2009= \u200912\u2003follow\xa0fad diets n\u2009= \u200915\u2003gluten free (includes wheat free) n\u2009= \u200921\u2003follow\xa0other plans n\u2009= \u200938\u2003glycemic index n\u2009= \u20094\u2003clean Eating n\u2009= \u200915\u2003supplements n\u2009= \u20097\u2003planning and Preparing Food n\u2009= \u200929 n\u2009= \u200938\u2003goals describing when Food is Eaten or not Eaten/Eating patterns n\u2009= \u200946 n\u2009= \u200931\u2003breakfast n\u2009= \u200924 n\u2009= \u20091\u2003psychological aspects of Eating n\u2009= \u200931 n\u2009= \u200916\u2003general Eating improvementsan\u2009= \u200971 n\u2009= \u2009261\u2003otherbn\u2009= \u20096 n\u2009= \u20096\nagoals making reference to unspecific Eating for a specific outcome (e.g., disease management) were coded as general healthy Eating (lacks specificity) ( n\u2009= \u200957 entries)\nbincludes alternate/natural Sweeteners, organic Eating, adding/removing miscellaneous Foods, avoiding Allergens, Eating as normal\ntopics included as part of these goals not covered in the ready-made goals included stretching, core exercises, crossfit®, tai chi, sports (e.g., hockey), step count goals (e.g., 10,000 steps/day), walking a certain distance by a specific date, walking Dogs, being active during television commercials, high-intensity interval training, elliptical, exercise videos, activity tracking, and exergaming.']	N/A	N/A	[('CHEBI_33290', 'food', 213, 'Food'), ('CHEBI_33290', 'food', 224, 'Food'), ('UBERON_0001913', 'milk', 712, 'milk'), ('CHEBI_33290', 'food', 984, 'foods'), ('CHEBI_16113', 'cholesterol', 1012, 'cholesterol'), ('CHEBI_52632', 'potassium-39 atom', 1025, 'sodium'), ('CHEBI_24870', 'ion', 1040, 'sugar'), ('CHEBI_30879', 'alcohol', 1074, 'Alcohol'), ('CHEBI_15377', 'water', 1098, 'Water'), ('CHEBI_23389', 'cobalt-corrinoid heptacarboxylic acid', 1126, 'coffee'), ('CHEBI_27732', 'caffeine', 1140, 'caffeine'), ('CHEBI_33284', 'nutrient', 1201, 'nutrients'), ('CHEBI_33284', 'nutrient', 1250, 'nutrients'), ('CHEBI_52632', 'potassium-39 atom', 1273, 'sodium'), ('CHEBI_24870', 'ion', 1285, 'sugar'), ('CHEBI_81905', '3A-Deolivosylpremithramycin B', 1308, 'Caloric'), ('CHEBI_33290', 'food', 1316, 'food'), ('GO_0007631', 'feeding behavior', 1316, 'food intake'), ('GO_0007568', 'aging', 1437, 'Eating'), ('GO_0018888', '3-chloroacrylic acid metabolic process', 1453, 'Eat'), ('GO_0051318', 'G1 phase', 1503, 'eating'), ('CHEBI_33290', 'food', 1542, 'Food'), ('GO_0051318', 'G1 phase', 1722, 'eating'), ('GO_0007128', 'meiotic prophase I', 1769, 'preparing'), ('CHEBI_33290', 'food', 1779, 'food'), ('CHEBI_33290', 'food', 1822, 'food'), ('GO_0036268', 'swimming', 1830, 'eaten'), ('GO_0036268', 'swimming', 1843, 'eaten'), ('GO_0051318', 'G1 phase', 1849, 'eating'), ('GO_0051318', 'G1 phase', 1931, 'eating'), ('GO_0051318', 'G1 phase', 1962, 'eating'), ('GO_0051318', 'G1 phase', 2057, 'eating'), ('GO_0007568', 'aging', 2144, 'Eating'), ('CHEBI_35816', 'leprostatic drug', 2218, 'sweeteners'), ('GO_0051318', 'G1 phase', 2238, 'eating'), ('CHEBI_33290', 'food', 2276, 'foods'), ('CHEBI_33663', 'cyclic hydrocarbon', 2292, 'allergens'), ('GO_0051318', 'G1 phase', 2303, 'eating'), ('NCBITaxon_33208', 'Metazoa', 2573, 'dogs')]
PMC5025575	9/2016	S17-PMC5025575	['background\nEating fruit and vegetables (fv) has numerous health benefits.']	N/A	N/A	[('GO_0007568', 'aging', 11, 'Eating')]
PMC5030620	9/2016	S170-PMC5030620	['we identified 76 Human cohort studies within pubmed that associated adverse phenotype(s) (such as Birth outcomes, Organ-specific abnormalities/disorders, cancer or mortality) with epigenetic change(s) (mainly Dna Methylation to-date, but also Histone Modification, epigenetic machinery and Mirnas) and exposure to environmental factor(s) (including air pollution, chemicals, fibers, radiation or lifestyle factors (alcohol, nutrition or smoking)) at various stages of development (Pre-Conception, in utero , neonatal, childhood, Adolescence, Adulthood and lifetime).']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 17, 'human'), ('GO_0007567', 'parturition', 98, 'birth'), ('UBERON_0000062', 'organ', 114, 'organ'), ('GO_0006306', 'DNA methylation', 209, 'DNA methylation'), ('CHEBI_15358', 'histone', 243, 'histone'), ('GO_0016570', 'histone modification', 243, 'histone modification'), ('PR_000043452', 'core histone', 243, 'histone'), ('SO_0000276', 'miRNA', 290, 'miRNAs'), ('GO_0007568', 'aging', 481, 'pre'), ('GO_0007620', 'copulation', 485, 'conception'), ('GO_0048848', 'neurohypophysis morphogenesis', 529, 'adolescence'), ('UBERON_0000113', 'post-juvenile adult stage', 542, 'adulthood')]
PMC5059968	10/2016	S69-PMC5059968	['caption (table-wrap): table 3\n\nthemes and subthemes identifiedthemessub-themes Eating behaviour of Pregnant women external attribution:1.']	N/A	N/A	[('GO_0007568', 'aging', 79, 'Eating'), ('GO_0007565', 'female pregnancy', 99, 'pregnant')]
PMC5084041	10/2016	S48-PMC5084041	['at both time-points, participants answered a questionnaire regarding sun exposure (sun-Seeking behaviour and clothing style); recent travel <35° n, intake of Foods rich in Vitamin D (Milk and oily fish at t1 with the addition of Margarine, yoghurt and sour Milk in t3) [22]; supplement use; and background characteristics not included in the medical charts (education level and country of Birth).']	N/A	N/A	[('GO_0007568', 'aging', 86, '-seeking'), ('CHEBI_33290', 'food', 158, 'foods'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D'), ('UBERON_0001913', 'milk', 183, 'milk'), ('CHEBI_6784', 'mestranol', 229, 'margarine'), ('UBERON_0001913', 'milk', 257, 'milk'), ('GO_0007567', 'parturition', 389, 'birth')]
PMC5115165	1/2016	S23-PMC5115165	['we excluded Pregnancies if the woman did not return at least one Pre-Pregnancy Food frequency questionnaire, left more than 70 questionnaire items blank, or reported unrealistic total energy Intake (< 2510 or > 14\u2009644 kj/day, equivalent to <600 or >3500 kcal/day).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 12, 'pregnancies'), ('GO_0007568', 'aging', 65, 'pre'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy'), ('CHEBI_33290', 'food', 79, 'food'), ('GO_0007631', 'feeding behavior', 191, 'intake')]
PMC5115165	1/2016	S42-PMC5115165	['Pre-Pregnancy covariates in the multivariable models included age (continuous), parity (0, 1, 2, and ≥3 Pregnancies lasting six or more months), race/ethnicity (white, african-american, hispanic, asian, other, and missing/not reported), family history of diabetes (yes, no), cigarette smoking (never, past, current, and missing/not reported), physical activity (fourths), total energy intake (fourths), and overall diet quality as represented by the ahei-2010 dietary pattern score (fourths).']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy'), ('GO_0007565', 'female pregnancy', 104, 'pregnancies')]
PMC5116101	11/2016	S35-PMC5116101	['the australian guide to healthy Eating (agthe) is a visual Food selection guide providing a representation of the proportions of Food groups recommended for daily Consumption [11].']	N/A	N/A	[('GO_0007568', 'aging', 32, 'Eating'), ('CHEBI_33290', 'food', 59, 'food'), ('CHEBI_33290', 'food', 129, 'food'), ('GO_0007631', 'feeding behavior', 163, 'consumption')]
PMC5116101	11/2016	S66-PMC5116101	['participants collected image-based dietary records in week 1, completed three 24-hour Food recalls (in weeks 2, 3, and 4), received feedback on their dietary Intake in week 6, and completed the australian Eating survey Food frequency questionnaire in week 12 [35].']	N/A	N/A	[('CHEBI_33290', 'food', 86, 'food'), ('GO_0007631', 'feeding behavior', 158, 'intake'), ('GO_0007568', 'aging', 205, 'Eating'), ('CHEBI_33290', 'food', 219, 'food')]
PMC5116101	11/2016	S101-PMC5116101	['agthe: australian guide to healthy Eating .']	N/A	N/A	[('GO_0007568', 'aging', 35, 'Eating')]
PMC5116101	11/2016	S142-PMC5116101	['bagthe: australian guide to healthy Eating [11].']	N/A	N/A	[('GO_0007568', 'aging', 36, 'Eating')]
PMC5153572	11/2016	S21-PMC5153572	['the mechanism for this increase in tbg involves both increased Hepatic Synthesis Of Tbg and Estrogen mediated perpetuation in sialylation of tbg that increases the half-life from 15 min to 3 days to fully sialylated tbg (6).']	N/A	N/A	[('GO_0007568', 'aging', 63, 'hepatic'), ('UBERON_0002107', 'liver', 63, 'hepatic'), ('GO_0034205', 'amyloid-beta formation', 71, 'synthesis of TBG'), ('CHEBI_50114', 'estrogen', 92, 'estrogen')]
PMC5183755	12/2016	S9-PMC5183755	['introduction\nin the broadest sense, we are Aging from the moment of Birth until the moment of death.']	N/A	N/A	[('GO_0007568', 'aging', 43, 'aging'), ('GO_0007567', 'parturition', 68, 'birth')]
PMC5183755	12/2016	S10-PMC5183755	['but the rate and manner of Aging vary markedly among Individuals.']	N/A	N/A	[('GO_0007568', 'aging', 27, 'aging'), ('NCBITaxon_1', 'root', 53, 'individuals')]
PMC5183755	12/2016	S100-PMC5183755	['altered methylation age among newborns and Birth prevalence of fast Aging\nmethylation age was calculated from a total of 613 Cord Blood samples profiled with the illumina infinium 450k ( n = 111) and 27k ( n = 502) arrays (table 1).']	N/A	N/A	[('GO_0007567', 'parturition', 43, 'Birth'), ('GO_0007568', 'aging', 68, 'Aging'), ('UBERON_0002240', 'spinal cord', 125, 'cord'), ('UBERON_0000178', 'blood', 130, 'blood')]
PMC5183755	12/2016	S103-PMC5183755	['fast Aging defined by a detectable methylation age of >0 years was present in 56.4% of babies as shown infigure 1.']	N/A	N/A	[('GO_0007568', 'aging', 5, 'aging')]
PMC5183755	12/2016	S104-PMC5183755	['male infants as a group had higher prevalence of fast Aging compared with female infants at Birth (59.9% versus 52.7%).']	N/A	N/A	[('GO_0007568', 'aging', 54, 'aging'), ('GO_0007567', 'parturition', 92, 'birth')]
PMC5183755	12/2016	S105-PMC5183755	['by race, the Birth prevalence of fast Ageing was highest in mixed race group (63.2%) followed by european-americans (46.0%) and then african-americans (38.7%).']	N/A	N/A	[('GO_0007567', 'parturition', 13, 'birth'), ('GO_0007568', 'aging', 38, 'ageing')]
PMC5183755	12/2016	S107-PMC5183755	['fetal and maternal factors associated with methylation age and fast Aging\nusing data from dataset 10, we conducted partial correlations between ses and methylation age at Birth, controlling for gender, Birth weight, and lead exposure status.']	N/A	N/A	[('GO_0007568', 'aging', 68, 'Aging'), ('GO_0007567', 'parturition', 171, 'birth'), ('GO_0007567', 'parturition', 202, 'birth')]
PMC5183755	12/2016	S113-PMC5183755	['univariate logistic regression analyses were also conducted to explore the risk factors associated with fast Aging (positive age acceleration).']	N/A	N/A	[('GO_0007568', 'aging', 109, 'aging')]
PMC5183755	12/2016	S148-PMC5183755	['infants from mixed race/ethnicity origin had significantly higher methylation age and higher frequency of fast Aging rate than that in african-origin black People.']	N/A	N/A	[('GO_0007568', 'aging', 111, 'aging'), ('NCBITaxon_10088', 'Mus <genus>', 156, 'people')]
PMC5216338	1/2017	S0-PMC5216338	['in ovo injection of betaine alleviates Corticosterone-induced fatty Liver in Chickens through epigenetic modifications\n\nabstract\nbetaine alleviates high-fat diet-induced fatty Liver and Prenatal betaine programs offspring Hepatic Lipid Metabolism.']	N/A	N/A	[('CHEBI_16827', 'corticosterone', 39, 'corticosterone'), ('UBERON_0002107', 'liver', 68, 'liver'), ('NCBITaxon_33208', 'Metazoa', 77, 'chickens'), ('UBERON_0002107', 'liver', 176, 'liver'), ('GO_0007565', 'female pregnancy', 186, 'prenatal'), ('GO_0007568', 'aging', 222, 'hepatic'), ('UBERON_0002107', 'liver', 222, 'hepatic'), ('CHEBI_18059', 'lipid', 230, 'lipid'), ('GO_0006629', 'lipid metabolic process', 230, 'lipid metabolism')]
PMC5241009	1/2017	S83-PMC5241009	['first, data on individual characteristics come from the health and retirement study (hrs), a nationally representative panel study that collects information on the economic, health, marital, and family status of the us population over the age of 50 and their spouses who were not institutionalized at their first interview and sponsored by the national institute of Aging (grant number nia u01ag009740) [55].']	N/A	N/A	[('GO_0007568', 'aging', 366, 'Aging')]
PMC5241009	1/2017	S88-PMC5241009	['additional Individual level data on Adult demographics and socioeconomic status for the years 2006 and 2008 come from the research and development corporation (rand) hrs dataset, a cleaned and processed version of the raw data with consistent naming of variables across waves and imputations for key variables often missing in the raw data, and funded by the national institute on Aging and the social security administration [56].']	N/A	N/A	[('NCBITaxon_1', 'root', 11, 'individual'), ('UBERON_0007023', 'adult organism', 36, 'adult'), ('GO_0007568', 'aging', 381, 'Aging')]
PMC5307851	2/2017	S103-PMC5307851	['caption (table-wrap): table 1\n\ntrial registration datadata categoryinformationprimary registration and trial identification numberclinicaltrials.gov nct02626299date of registrationdecember 8, 2015secondary identifying numbersr01 hd083292; ind 129482; irb study00003455source of monetary or material supportnational institute of child health and Human developmentprimary sponsoruniversity of kansas medical centersecondary sponsor/collaboratorsuniversity of cincinnatiohio state universitynationwide children’s hospitalcontact for public queriesbeth kerling, ms rd (ekerling@kumc.edu)contact for scientific queriessusan carlson, phd (scarlson@kumc.edu)public titleassessment of Dha on reducing Early Preterm Birth (adore) trialscientific titledocosahexaenoic Acid supplementation in Pregnancy to reduce early Preterm Birthcountries of recruitmentunited stateshealth conditions or problem studiedpreterm birthinterventionsactive treatment: 1,000\xa0mg Dha per daystandard of care: 200\xa0mg Dha per daykey inclusion and exclusion criteriaages eligible for study: ≥ 18\xa0yearsgenders eligible for study: femaleaccepts healthy volunteers: yesinclusion criteria: Pregnant female\u2009≥\u200918\xa0years; 12–20 weeks of Gestation, agree to consume study capsules; available by telephoneexclusion criteria: multiple Gestation, unwilling to discontinue use of another Prenatal supplement with Dha, allergy to any component of Dha product (including algae), Soybean Oil or Corn oilstudy typeinterventionalallocation: randomizedendpoint classification: safety/efficacy studyintervention model: parallel assignmentmasking: double blindprimary purpose: preventionphase iiidate of first enrollmentjune 8, 2016recruitment statusactive recruitmentprimary outcomeoccurrence of early Preterm Birthkey secondary outcomesefficacy analysis for subset populationseffect of Dha on inflammationsafety evaluation\n\nmethods/design\nthe standard protocol items: recommendations for interventional trials (spirit) guidelines [87] are followed for design and conduct of this trial.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 345, 'Human'), ('CHEBI_17874', 'dihydrozeatin', 677, 'DHA'), ('GO_0007568', 'aging', 693, 'Early'), ('GO_0019230', 'proprioception', 699, 'preterm Birth'), ('CHEBI_37527', 'acid', 758, 'Acid'), ('GO_0007565', 'female pregnancy', 782, 'Pregnancy'), ('GO_0030324', 'lung development', 808, 'Preterm BirthCountries'), ('CHEBI_17874', 'dihydrozeatin', 947, 'DHA'), ('CHEBI_17874', 'dihydrozeatin', 983, 'DHA'), ('GO_0007565', 'female pregnancy', 1150, 'pregnant'), ('GO_0007565', 'female pregnancy', 1193, 'gestation'), ('GO_0007565', 'female pregnancy', 1288, 'gestation'), ('GO_0007565', 'female pregnancy', 1339, 'prenatal'), ('CHEBI_17874', 'dihydrozeatin', 1364, 'DHA'), ('CHEBI_17874', 'dihydrozeatin', 1397, 'DHA'), ('NCBITaxon_1', 'root', 1428, 'soybean'), ('CHEBI_63708', 'isopimara-8(14),15-diene', 1436, 'oil'), ('CHEBI_33306', 'carbon group element atom', 1443, 'corn'), ('GO_0007565', 'female pregnancy', 1746, 'preterm'), ('GO_0050913', 'sensory perception of bitter taste', 1754, 'birthKey'), ('CHEBI_17874', 'dihydrozeatin', 1831, 'DHA')]
PMC5327873	1/2017	S173-PMC5327873	['four re-interviews checked the household chores and health-Seeking domains amongst women with average scores from the fixed scoring scheme and the remaining two checked work outside the home and group participation amongst women with extremely low or extremely high scores from the fixed scoring scheme.']	N/A	N/A	[('GO_0007568', 'aging', 58, '-seeking')]
PMC5371275	3/2017	S20-PMC5371275	['the Prenatal testing records of the Pre-Pregnancy body mass index (bmi) and maternal bmi at the tested time were collected.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 4, 'prenatal'), ('GO_0007568', 'aging', 36, 'pre'), ('GO_0007565', 'female pregnancy', 40, 'pregnancy')]
PMC5372860	2/2017	S108-PMC5372860	['lower income Individuals consumed lower quality Foods when compared to those with higher incomes as measured by the alternate healthy Eating index, which includes Omega-3 Fatty Acid Intake as one of the components of a healthy diet [47].']	N/A	N/A	[('NCBITaxon_1', 'root', 13, 'individuals'), ('CHEBI_33290', 'food', 48, 'foods'), ('GO_0007568', 'aging', 134, 'Eating'), ('CHEBI_25682', "N(omega),N'(omega)-dimethyl-L-arginine", 163, 'omega-3 fatty acid'), ('GO_0007631', 'feeding behavior', 182, 'intake')]
PMC5386978	4/2017	S20-PMC5386978	['the brainage method is based on a fully-automatic preprocessing pipeline for structural in vivo Brain magnetic resonance imaging (mri) data and uses pattern recognition methods to evaluate individual Brain Aging (franke et al.,2010,2012).']	N/A	N/A	[('UBERON_0000955', 'brain', 96, 'brain'), ('GO_0007567', 'parturition', 200, 'brain'), ('UBERON_0000955', 'brain', 200, 'brain'), ('GO_0007568', 'aging', 206, 'aging')]
PMC5386978	4/2017	S24-PMC5386978	['finally, we employed this non-invasive, non-terminal in vivo biomarker to study structural Brain Aging in mnr and control offspring at about 5 years of age (Human equivalent 17.5 years).']	N/A	N/A	[('GO_0007567', 'parturition', 91, 'brain'), ('UBERON_0000955', 'brain', 91, 'brain'), ('GO_0007568', 'aging', 97, 'aging'), ('NCBITaxon_9606', 'Homo sapiens', 157, 'human')]
PMC5386978	4/2017	S95-PMC5386978	['then, the Brain age is calculated by applying the regression pattern of healthy Brain Aging and aggregating all Voxel-wise information across the whole Brain.']	N/A	N/A	[('UBERON_0000955', 'brain', 10, 'brain'), ('UBERON_0000955', 'brain', 80, 'brain'), ('GO_0007568', 'aging', 86, 'aging'), ('SO_0000466', 'V_gene_segment', 112, 'voxel'), ('UBERON_0000955', 'brain', 152, 'brain')]
PMC5386978	4/2017	S102-PMC5386978	['technical notes\nthe whole Brain Age estimation framework works fully automatically.']	N/A	N/A	[('UBERON_0000955', 'brain', 26, 'brain'), ('GO_0007568', 'aging', 32, 'age')]
PMC5386978	4/2017	S114-PMC5386978	['before analyzing Brain Aging in mnr Baboons, Birth weight, weight and age at time of mr scan, as well as Brain volumes were compared between mnr and ctr groups using analysis of variance (anova).']	N/A	N/A	[('UBERON_0000955', 'brain', 17, 'brain'), ('GO_0007568', 'aging', 23, 'aging'), ('NCBITaxon_33208', 'Metazoa', 36, 'baboons'), ('GO_0007567', 'parturition', 45, 'birth'), ('UBERON_0000955', 'brain', 105, 'brain')]
PMC5386978	4/2017	S121-PMC5386978	['results\n\nbaboon Brain volumes across Adulthood\nthe Lifespan-sample of healthy control subjects used to model healthy Brain Aging in baboon was aged 4–22 years at the time of data acquisition.']	N/A	N/A	[('UBERON_0000955', 'brain', 16, 'brain'), ('UBERON_0000113', 'post-juvenile adult stage', 37, 'adulthood'), ('UBERON_0000104', 'life cycle', 51, 'lifespan'), ('GO_0007567', 'parturition', 117, 'brain'), ('UBERON_0000955', 'brain', 117, 'brain'), ('GO_0007568', 'aging', 123, 'aging')]
PMC5386978	4/2017	S138-PMC5386978	['baboon Brain age estimation model\nthe Baboon-specific Brain age estimation model included a Baboon-specific preprocessing pipeline for in vivo Anatomical mri scans and a machine-Learning algorithm for pattern recognition in order to model a reference curve for normal Aging of the Baboon Brain.']	N/A	N/A	[('UBERON_0000955', 'brain', 7, 'brain'), ('NCBITaxon_33208', 'Metazoa', 38, 'baboon'), ('UBERON_0000955', 'brain', 54, 'brain'), ('NCBITaxon_33208', 'Metazoa', 92, 'baboon'), ('UBERON_0001062', 'anatomical entity', 143, 'anatomical'), ('GO_0007612', 'learning', 178, 'learning'), ('GO_0007568', 'aging', 268, 'aging'), ('NCBITaxon_33208', 'Metazoa', 281, 'baboon'), ('UBERON_0000955', 'brain', 288, 'brain')]
PMC5386978	4/2017	S157-PMC5386978	['caption (fig): figure 6\n\nneurostructural Aging in mnr model Baboon offspring .']	N/A	N/A	[('GO_0007568', 'aging', 41, 'aging'), ('NCBITaxon_33208', 'Metazoa', 60, 'baboon')]
PMC5386978	4/2017	S203-PMC5386978	['for example, these offspring will be maintained to follow the Aging process over the rest of their Life Course.']	N/A	N/A	[('GO_0007568', 'aging', 62, 'aging'), ('UBERON_0001281', 'hepatic sinusoid', 99, 'life course')]
PMC5386978	4/2017	S207-PMC5386978	['we observed premature Brain Aging in young Adult female offspring.']	N/A	N/A	[('GO_0007567', 'parturition', 22, 'brain'), ('UBERON_0000955', 'brain', 22, 'brain'), ('GO_0007568', 'aging', 28, 'aging'), ('UBERON_0007023', 'adult organism', 43, 'adult')]
PMC5392925	4/2017	S84-PMC5392925	['Pre-Pregnancy body mass index is calculated as pre-Pregnancy weight (kg), divided by squared height (m2) measured at the baseline clinic visit.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy'), ('GO_0007565', 'female pregnancy', 51, 'pregnancy')]
PMC5396145	10/2016	S51-PMC5396145	['maternal education, housing, crowding at home, stressful Life events, maternal age, financial difficulty, partner present, maternal smoking in Pregnancy, maternal alcohol use in Pregnancy, parity, Pre‐Pregnancy body mass index (bmi) and ethnic origin were the selected variables included in this study.']	N/A	N/A	[('UBERON_0000104', 'life cycle', 57, 'life'), ('GO_0007565', 'female pregnancy', 143, 'pregnancy'), ('GO_0007565', 'female pregnancy', 178, 'pregnancy'), ('GO_0007568', 'aging', 197, 'pre'), ('GO_0007565', 'female pregnancy', 201, 'pregnancy')]
PMC5396145	10/2016	S55-PMC5396145	['Pre‐Pregnancy bmi [weight (kg)/height (m)2] was calculated from the self‐reported weight and height at 12\u2009weeks Gestation.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy'), ('GO_0007565', 'female pregnancy', 112, 'gestation')]
PMC5396145	10/2016	S221-PMC5396145	['the analysis was adjusted by maternal education, housing, crowding at home, stressful Life events, maternal age, financial difficulty, partner, maternal smoking and alcohol use in Pregnancy, parity, Pre‐Pregnancy bmi, ethnic origin and gender.']	N/A	N/A	[('UBERON_0000104', 'life cycle', 86, 'life'), ('GO_0007565', 'female pregnancy', 180, 'pregnancy'), ('GO_0007568', 'aging', 199, 'pre'), ('GO_0007565', 'female pregnancy', 203, 'pregnancy')]
PMC5417583	5/2017	S154-PMC5417583	['dietary Intake of Nicotinamide, Nicotinamide-riboside, and Nicotinamide mononucleotide improves Metabolic health and restores Mitochondrial function whether measured by Respiration, Membrane Potential, Atp Production Apoptosis, Autophagy, or the unfolded response with less degeneration and more active Stem Cells.358supplementation works for Genetic versions of premature Ageing and defects in Dna Repair with resulting Sirt inactivation.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 8, 'intake'), ('CHEBI_17154', 'nicotinamide', 18, 'nicotinamide'), ('CHEBI_17154', 'nicotinamide', 32, 'nicotinamide'), ('CHEBI_17154', 'nicotinamide', 59, 'nicotinamide'), ('GO_0008152', 'metabolic process', 96, 'metabolic'), ('GO_0005739', 'mitochondrion', 126, 'mitochondrial'), ('GO_0045333', 'cellular respiration', 169, 'respiration'), ('GO_0045121', 'membrane raft', 182, 'membrane potential'), ('GO_0006754', 'ATP biosynthetic process', 202, 'ATP production'), ('GO_0006915', 'apoptotic process', 217, 'apoptosis'), ('GO_0006914', 'autophagy', 228, 'autophagy'), ('CL_0000034', 'stem cell', 303, 'stem cells'), ('SO_0000704', 'gene', 343, 'genetic'), ('GO_0007568', 'aging', 373, 'ageing'), ('GO_0006281', 'DNA repair', 395, 'DNA repair'), ('PR_000014888', 'NAD-dependent protein deacetylase sirtuin-1', 421, 'SIRT')]
PMC5420136	5/2017	S242-PMC5420136	['third, maternal protein deficiency during Gestation and Lactation alters Hepatic Cholesterol Metabolism in weanling Piglets via the epigenetic Regulation of Expression of Hmg-Coa reductase and Cholesterol-7alpha-hydroxylase (Cyp7Α1) [110].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 42, 'gestation'), ('GO_0007595', 'lactation', 56, 'lactation'), ('GO_0007568', 'aging', 73, 'hepatic'), ('UBERON_0002107', 'liver', 73, 'hepatic'), ('CHEBI_16113', 'cholesterol', 81, 'cholesterol'), ('GO_0008203', 'cholesterol metabolic process', 81, 'cholesterol metabolism'), ('NCBITaxon_33208', 'Metazoa', 116, 'piglets'), ('GO_0065007', 'biological regulation', 143, 'regulation'), ('GO_0010467', 'gene expression', 157, 'expression'), ('CHEBI_11814', '3-hydroxy-3-methylglutaryl-CoA', 171, 'HMG-CoA'), ('CHEBI_16113', 'cholesterol', 193, 'cholesterol'), ('PR_000006101', 'cytochrome P450 1A1', 225, 'CYP7α1')]
PMC544881	12/2004	S93-PMC544881	['in late Gestation, Adipose Tissue Lipolysis is greatly augmented generating Ffa and Glycerol, for further Hepatic Vldl Production, contributing to the flux of circulating Tg-fatty acids in Pregnancy [18,19].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 8, 'gestation'), ('GO_0070227', 'lymphocyte apoptotic process', 19, 'adipose tissue lipolysis'), ('UBERON_0001013', 'adipose tissue', 19, 'adipose tissue'), ('CHEBI_30751', 'formic acid', 76, 'FFA'), ('CHEBI_17754', 'glycerol', 84, 'glycerol'), ('GO_0007568', 'aging', 106, 'hepatic'), ('UBERON_0002107', 'liver', 106, 'hepatic'), ('GO_0034397', 'telomere localization', 114, 'VLDL production'), ('CHEBI_17855', 'triglyceride', 171, 'TG'), ('GO_0007565', 'female pregnancy', 189, 'pregnancy')]
PMC5482199	2/2017	S39-PMC5482199	['the Human T-Cell nucleofection kit was from amaxa (lonza, wakersville, md, u.s.a.).']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 4, 'human'), ('CL_0000084', 'T cell', 10, 'T-cell'), ('GO_0007568', 'aging', 10, 'T-cell'), ('GO_0005854', 'nascent polypeptide-associated complex', 11, '-')]
PMC5484502	6/2017	S51-PMC5484502	['maternal Pre-Pregnancy body mass index (pbmi) was computed based on height and Pregestational body weight measurements obtained from medical records and confirmed in the questionnaire (cases with inconsistent data were omitted from the study).']	N/A	N/A	[('GO_0007568', 'aging', 9, 'pre'), ('GO_0007565', 'female pregnancy', 13, 'pregnancy'), ('GO_0007565', 'female pregnancy', 79, 'pregestational')]
PMC5486996	9/2016	S114-PMC5486996	['the healthy Eating index-2010 (hei-2010) is the primary indicator of diet quality.']	N/A	N/A	[('GO_0007568', 'aging', 12, 'Eating')]
PMC5486996	9/2016	S124-PMC5486996	['Eating in the absence of hunger\nthis substudy involves a behavioral experiment that investigates hedonic eating using an Eating in the absence of hunger (eah) paradigm.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Eating'), ('GO_0051318', 'G1 phase', 121, 'eating')]
PMC5526977	7/2017	S201-PMC5526977	['Glucose-6-phosphatase ( g6pc ) Expression, which Controls Hepatic Glucose Production46, was elevated by maternal hfd in wt (p\u2009<\u20090.0001) and kiko (p\u2009<\u20090.05) females (fig.']	N/A	N/A	[('CHEBI_17234', 'glucose', 0, 'Glucose'), ('GO_0010467', 'gene expression', 31, 'expression'), ('GO_0065007', 'biological regulation', 49, 'controls'), ('GO_0007568', 'aging', 58, 'hepatic'), ('UBERON_0002107', 'liver', 58, 'hepatic'), ('CHEBI_17234', 'glucose', 66, 'glucose'), ('GO_0006094', 'gluconeogenesis', 66, 'glucose production46')]
PMC5546866	8/2017	S91-PMC5546866	['association of Snps with baseline 25(Oh)D in Early Pregnancysnpreference Allelecommon Alleleunivariateadjustedacorrected p valuebnβ (95% ci)p valuenβ (95% ci)p value rs12785878 ( dhcr7 )gt6793.7 (1.5 to 5.8)0.0016223.1 (1.0 to 5.2)0.0040.012rs10741657 ( Cyp2R1 )ag672−1.1 (−2.9 to 0.7)0.24616−1.4 (−3.2 to 0.4)0.120.47rs6013897 ( Cyp24A1 )at6701.2 (−1.1 to 3.4)0.316130.8 (−1.4 to 3.0)0.461.0rs2282679 ( gc )ca6792.2 (0.3 to 4.1)0.026221.7 (−0.2 to 3.5)0.080.31\nthe homozygous low-frequency Gene variant was used as the reference group, and β represents the change in 25(Oh)D (nmol/l) per common Allele.']	N/A	N/A	[('SO_0000694', 'SNP', 15, 'SNPs'), ('CHEBI_71657', 'versiconol acetate', 34, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 34, '25(OH)D'), ('GO_0007568', 'aging', 45, 'Early'), ('GO_0010142', 'farnesyl diphosphate biosynthetic process, mevalonate pathway', 51, 'PregnancySNPReference'), ('SO_0001644', 'targeting_vector', 73, 'AlleleCommon'), ('SO_0001423', 'dye_terminator_read', 86, 'AlleleUnivariateAdjustedaCorrected'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 254, 'CYP2R1'), ('PR_000006101', 'cytochrome P450 1A1', 330, 'CYP24A1'), ('SO_0000704', 'gene', 491, 'gene'), ('CHEBI_71657', 'versiconol acetate', 568, '25(OH)D'), ('SO_0001023', 'allele', 596, 'allele')]
PMC5644840	4/2014	S233-PMC5644840	['beside telomere shortening, mutations and aberrations of Mitochondrial dna (mtdna) are Ageing-related hallmarks.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 57, 'mitochondrial'), ('GO_0007568', 'aging', 87, 'ageing')]
PMC5659017	10/2017	S37-PMC5659017	['caption (table-wrap): table 1\n\nsample characteristicsactive ed ( n \xa0=\xa021)past ed ( n \xa0=\xa043)controls ( n \xa0=\xa0126)age, mean (sd)26.4 (5.9)29.1 (5.2)28.4 (5.3)bmi Pre-Pregnancy, mean (sd)20.2 (4.4)21.4 (2.5)23.1 (3.9)smoking in Pregnancy, n (%)12 (57.1%)9 (20.9%)20 (15.9%)achild gender (female), n (%)12 (57.1%)22 (51.2%)69 (54.8%)energy Intake (kj/day), mean (sd)6769 (1969)6714 (2239)7474 (1950)\naone subject had missing data on smoking status\nwomen who self-reported having suffered from an ed prior to Pregnancy, had no ed symptoms in Pregnancy, and did not report any symptoms consistent with an ed in Pregnancy were categorised as having suffered from a past ed ( n \xa0=\xa043).']	N/A	N/A	[('GO_0007568', 'aging', 159, 'pre'), ('GO_0007565', 'female pregnancy', 163, 'pregnancy'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('GO_0007631', 'feeding behavior', 335, 'intake'), ('GO_0007565', 'female pregnancy', 503, 'pregnancy'), ('GO_0007565', 'female pregnancy', 536, 'pregnancy'), ('GO_0007565', 'female pregnancy', 604, 'pregnancy')]
PMC5685050	10/2014	S6-PMC5685050	['many factors can alter Cutaneous Vitamin D Production such as Aging, skin pigmentation, sunscreen usage, time of the day, season and latitude5,7.']	N/A	N/A	[('GO_0050817', 'coagulation', 23, 'cutaneous'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 33, 'vitamin D production'), ('GO_0007568', 'aging', 62, 'aging')]
PMC5689158	11/2017	S76-PMC5689158	['Pre-Pregnancy weight was categorized into data-driven tertiles.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy')]
PMC5708048	11/2017	S3-PMC5708048	['diet quality was assessed by the healthy Eating index for Pregnant women in singapore (hei-sgp) score and previously derived dietary patterns (vegetables-fruit-rice, seafood-noodles, and pasta-cheese-meat pattern).']	N/A	N/A	[('GO_0007568', 'aging', 41, 'Eating'), ('GO_0007565', 'female pregnancy', 58, 'pregnant')]
PMC5708048	11/2017	S4-PMC5708048	['Eating behaviors studied included the longest night-time fasting interval, frequency of Consumption occasions, energy from discretionary Foods, and nighttime Eating.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Eating'), ('GO_0007631', 'feeding behavior', 88, 'consumption'), ('CHEBI_33290', 'food', 137, 'foods'), ('GO_0051318', 'G1 phase', 158, 'eating')]
PMC5708048	11/2017	S44-PMC5708048	['the healthy Eating index for Pregnant women in singapore (hei-sgp) was used as the measure for diet quality [23].']	N/A	N/A	[('GO_0007568', 'aging', 12, 'Eating'), ('GO_0007565', 'female pregnancy', 29, 'Pregnant')]
PMC5708048	11/2017	S60-PMC5708048	['Eating behaviors\nusing the timing of Intake reported during the 24-h Recall, the longest night-time fasting interval was assessed from 19.00 h to 06.59 h. frequency of Eating was defined as the number of Eating occasions that provided ≥50 kcal, with a time interval between Eating occasions of ≥15 min [25].']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Eating'), ('GO_0007631', 'feeding behavior', 37, 'intake'), ('GO_0060033', 'anatomical structure regression', 69, 'recall'), ('GO_0051318', 'G1 phase', 168, 'eating'), ('GO_0051318', 'G1 phase', 204, 'eating'), ('GO_0051318', 'G1 phase', 274, 'eating')]
PMC5758521	1/2018	S48-PMC5758521	['co-variables\nthe available study co-variables included maternal Gestational diabetes (yes/no), age (>35\u2009y: yes/no), ethnicity (white, others), parity (primiparous: yes/no), education (university: yes/no), Pre-Pregnancy body mass index (bmi; kg/m2), smoking (yes/no), alcohol use (yes/no), mode of Delivery (Vaginal, c-section), infant sex (boy/girl), Gestational age (weeks) and Birth weight (z score).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 64, 'gestational'), ('GO_0007568', 'aging', 205, 'pre'), ('GO_0007565', 'female pregnancy', 209, 'pregnancy'), ('GO_0007567', 'parturition', 297, 'delivery'), ('UBERON_0001987', 'placenta', 307, 'vaginal'), ('GO_0007565', 'female pregnancy', 351, 'gestational'), ('GO_0007567', 'parturition', 379, 'birth')]
PMC5924963	4/2018	S254-PMC5924963	['the high-energy outburst variable was created due to the increased prevalence of several unique behaviors which do not fit typical descriptions of Anxious behavior in non-Human Primates.']	N/A	N/A	[('GO_0007568', 'aging', 147, 'anxious'), ('NCBITaxon_9606', 'Homo sapiens', 171, 'human'), ('NCBITaxon_33208', 'Metazoa', 177, 'primates')]
PMC5965027	5/2018	S97-PMC5965027	['p-value\xa0\xa0all womenfirst trimesterbmi categoryhigh vs normallow vs normal\xa0\xa0n\xa0=\xa0388n\xa0=\xa0188lown\xa0=\xa036normaln\xa0=\xa0115highn\xa0=\xa037univariateadjusted orcunivariateknows appropriate gwgyes57 (14.7)28 (14.9)4 (11.1)18 (15.7)6 (16.2)0.935excluded0.500\xa0no331 (85.3)160 (85.1)32 (88.9)97 (84.3)31 (83.8)knows Pre-Pregnancy weightyes203 (52.3)103 (54.8)16 (44.4)66 (57.4)21 (56.8)0.946excluded0.174\xa0no185 (47.7)85 (45.2)20 (55.6)49 (42.6)16 (43.2)return to pre-Pregnancy weightyes149/224 (66.5)65/102 (63.7)9 (60.0)45 (77.6)11 (37.9)<0.001excluded0.166\xa0no75/224 (33.5)37/102 (36.3)6 (40.0)13 (22.4)18 (61.2)perceived activeyes299 (77.1)143 (76.1)25 (69.4)89 (77.4)29 (78.4)0.900excluded0.333\xa0no89 (22.9)45 (23.9)11 (30.6)26 (22.6)8 (21.6)ever exercisedyes113 (29.1)58 (30.9)9 (25.0)38 (33.0)11 (29.7)0.708excluded0.363\xa0no275 (70.9)130 (69.1)27 (75.0)77 (67.0)26 (70.3)knows a healthy dietyes219 (56.4)107 (56.9)16 (44.4)70 (60.9)21 (56.8)0.657excluded0.082\xa0no169 (43.6)81 (43.1)20 (55.6)45 (39.1)16 (43.2)ate a snack in the last 24 hyes301 (77.6)144 (76.6)30 (83.3)89 (77.4)25 (67.6)0.230not-significant0.446\xa0no87 (22.4)44 (23.4)6 (16.7)26 (22.6)12 (32.4)regularly Eats a healthy snackayes141 (36.7)70 (37.2)13 (36.1)40 (34.8)17 (45.9)0.245not significant0.884\xa0no243 (63.3)118 (62.8)23 (63.9)75 (65.2)20 (54.1)consumed sweet drinkno26 (6.7)8 (4.3)1 (2.8)3 (2.6)4 (10.8)0.010referent0.897\xa0≤24h186 (47.9)91 (48.4)15 (41.7)53 (46.1)23 (62.2)2.86 (1.17–7.01),p\xa0=\xa00.022\xa0>24h176 (45.4)89 (47.3)20 (55.6)59 (51.3)10 (27.0)0.44 (0.08–2.40),p\xa0=\xa00.340teenager (t) and/or primigravida (p)t\xa0+\xa0p+72 (18.6)38 (20.2)11 (30.6)24 (20.9)3 (8.1)0.008breferent0.315\xa0t+ or p+100 (25.8)52 (27.7)12 (33.3)34 (29.6)6 (16.2)3.46 (0.87–13.65),p\xa0=\xa00.076\xa0t- p-216 (55.7)98 (52.1)13 (36.1)57 (49.6)28 (75.7)2.89 (1.02–8.16),p\xa0=\xa00.046\nmissing data: regularly eats a healthy snack n\xa0=\xa04 missing (reports Consuming a snack but actual snack Food not reported).']	N/A	N/A	[('GO_0007568', 'aging', 293, 'pre'), ('GO_0007565', 'female pregnancy', 297, 'pregnancy'), ('GO_0007565', 'female pregnancy', 444, 'pregnancy'), ('GO_0006115', 'ethanol biosynthetic process', 1148, 'eats'), ('GO_0007631', 'feeding behavior', 1856, 'consuming'), ('CHEBI_33290', 'food', 1891, 'food')]
PMC5975263	5/2018	S40-PMC5975263	['general information on maternal demographic characteristics, Pre-Pregnancy weight and obstetric history were reported by the interviewee themselves, which could be obtained from Antenatal care booklets.']	N/A	N/A	[('GO_0007568', 'aging', 61, 'pre'), ('GO_0007565', 'female pregnancy', 65, 'pregnancy'), ('GO_0007567', 'parturition', 178, 'antenatal')]
PMC5975263	5/2018	S42-PMC5975263	['Pre-Pregnancy bmi was calculated as maternal Pre-Pregnancy weight in kilograms divided by squared height in meters.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy'), ('GO_0007568', 'aging', 45, 'pre'), ('GO_0007565', 'female pregnancy', 49, 'pregnancy')]
PMC5975263	5/2018	S45-PMC5975263	['Pre-Pregnancy weight status was categorized using both the asian and iom cut-off points (table\xa01).']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy')]
PMC5975263	5/2018	S46-PMC5975263	['caption (table-wrap): table 1\n\niom weight gain recommendations for Pregnancy by Pre-Pregnancy weight statusweight categoryiom bmi category criteriaasian bmi category criteriaiom-recommended weight gainunderweight<\u200918.5\xa0kg/m2<\u200918.5\xa0kg/m212.5–18\xa0kgnormal weight18.5–24.9\xa0kg/m218.5–22.9\xa0kg/m211.5–16\xa0kgoverweight25.0–29.9\xa0kg/m223–24.9\xa0kg/m27–11.5\xa0kgobese≥30\xa0kg/m2≥25\xa0kg/m25–9\xa0kg\nadverse Pregnancy outcomes considered in this study included preterm (Delivered at less than 37\xa0weeks of Gestation), low birthweight (lbw, birthweight <\u20092500\xa0g), macrosomia (birthweight ≥4000\xa0g), large-for-Gestational age (lga, birthweight >90th for Gestational age and sex), small-for-Gestational age (sga, birthweight <10th percentile for Gestational age and sex), Pregnancy-induced hypertension (pih) and Gestational diabetes mellitus (gdm).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 67, 'pregnancy'), ('GO_0007568', 'aging', 80, 'pre'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('GO_0007565', 'female pregnancy', 384, 'pregnancy'), ('GO_0007567', 'parturition', 446, 'delivered'), ('GO_0007565', 'female pregnancy', 481, 'gestation'), ('GO_0007565', 'female pregnancy', 582, 'gestational'), ('GO_0007565', 'female pregnancy', 626, 'gestational'), ('GO_0007565', 'female pregnancy', 662, 'gestational'), ('GO_0007565', 'female pregnancy', 717, 'gestational'), ('GO_0007565', 'female pregnancy', 743, 'pregnancy'), ('GO_0007565', 'female pregnancy', 784, 'gestational')]
PMC6022422	6/2018	S43-PMC6022422	['Pre-Pregnancy bmi based on Pre-Pregnancy weight was calculated using the following equation as defined by the world health organization: weight/height2.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Pre'), ('GO_0007565', 'female pregnancy', 4, 'pregnancy'), ('GO_0007568', 'aging', 27, 'pre'), ('GO_0007565', 'female pregnancy', 31, 'pregnancy')]
PMC6043562	7/2018	S177-PMC6043562	['for example, maternal Pre-Pregnancy body mass index (bmi) was lower for participants with exposure measures (mean 24.6 vs. 26.5\u2009kg/m2, t-test p value\u2009=\u20090.0001).']	N/A	N/A	[('GO_0007568', 'aging', 22, 'pre'), ('GO_0007565', 'female pregnancy', 26, 'pregnancy')]
